Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3030366	p-kysc	mg/l (mg/l)	8601	42452	0.04%
3030366	s-kysc	mg/l (mg/l)	2122	4769	0.00%
3030366	p-kysc	— (—)	1244	2087	100.00%	Distribution not available
3030366	s-kysc	— (—)	475	850	100.00%	Distribution not available
3030366	kystatiinic(p-kysc)	mg/l (mg/l)	16	17	0.00%
3030366	kystatiinic(4507p-kysc)	mg/l (mg/l)	6	6	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Autoimmune diseases excluding thyroid diseases

2790

6728

2.31

309.56

4.4

1.63

1.40

mg/l

32.87

2606

6216

Insulin, combination of fast acting with intermediate-acting or long-acting

1841

6530

2.66

309.32

4.5

4.0

2.02

1.45

mg/l

101.33

1674

6019

Other disorders of kidney and ureter

806

1231

7.51

307.65

8.6

3.7

2.15

1.55

mg/l

41.05

764

1126

Chronic nephritic syndrome

468

312

21.25

307.65

6.9

3.1

1.97

1.50

mg/l

11.11

451

285

Implicit Sepsis

2459

6299

2.95

307.65

5.0

3.2

1.90

1.34

mg/l

131.81

2294

5752

Renal tubulo-interstitial diseases

4501

5363

6.74

307.65

5.8

3.2

1.98

1.13

mg/l

307.65

4186

4918

L04AD Calcineurin inhibitors

1854

1131

26.95

307.65

12.2

5.0

1.90

1.26

mg/l

95.82

1828

1061

Nephropathy related operations

1884

1161

25.20

307.65

10.0

4.4

2.28

1.33

mg/l

175.79

1833

1071

Genitourinary diseases

1744

2907

3.10

307.65

7.5

4.3

1.56

1.07

mg/l

102.46

1649

2703

Unspecified kidney failure

651

571

13.20

307.65

6.1

2.2

2.29

1.25

mg/l

92.38

607

502

Congenital malformations of the urinary system

582

674

11.14

307.65

9.9

10.1

1.84

1.31

mg/l

27.24

570

635

Glomerular diseases

1958

1678

15.06

307.65

7.6

4.2

2.06

1.40

mg/l

98.66

1871

1542

L04AA Selective immunosuppressants

1908

2118

10.79

307.65

10.0

3.6

1.89

1.33

mg/l

97.77

1859

1964

Cystic kidney disease

448

336

19.63

307.65

9.0

6.0

1.93

1.41

mg/l

15.59

439

315

Azathioprine

769

1490

5.66

307.65

12.1

4.4

1.68

1.34

mg/l

18.81

734

1391

Renal failure

4001

2896

14.54

307.65

6.2

2.9

2.15

1.21

mg/l

307.65

3735

2586

Viral Sepsis

834

1784

5.02

307.65

7.4

3.5

2.01

1.39

mg/l

48.89

790

1599

Malignant neoplasm of head and neck

480

609

9.02

307.65

3.1

2.7

1.19

1.69

mg/l

27.10

469

541

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

394

335

17.67

307.65

10.7

7.3

1.78

1.44

mg/l

6.46

384

316

Antihypertensive medication - note that there are other indications

1747

2816

3.39

307.65

8.5

4.2

1.43

1.04

mg/l

78.24

1677

2652

Hypertension

2427

4057

3.50

307.65

6.4

3.1

1.67

1.16

mg/l

136.73

2296

3774

Other disorders of fluid, electrolyte and acid-base balance

1063

2604

4.10

307.65

5.3

3.3

1.93

1.53

mg/l

28.39

969

2348

Anaemias

1093

870

8.80

307.65

8.0

3.5

1.72

1.04

mg/l

89.86

1039

826

Chronic kidney disease

3528

2014

22.21

307.65

6.6

3.2

2.20

1.23

mg/l

307.65

3301

1798

Dialysis, with operation codes

1913

927

31.44

307.65

9.5

4.4

2.30

1.12

mg/l

304.85

1861

860

Glomerulonephritis

934

984

11.93

307.65

9.6

5.3

1.89

1.45

mg/l

24.46

900

906

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3375

6608

3.46

307.65

7.8

2.9

1.72

1.32

mg/l

104.16

3171

6093

Dental caries

1439

2405

6.32

307.65

8.5

2.8

1.77

1.43

mg/l

26.45

1407

2195

Bacterial infection, other or unspecified

1892

4859

3.44

307.65

5.9

3.2

1.95

1.41

mg/l

83.23

1762

4416

Condition for Implicit Sepsis (Organ dysfunction codes)

2502

6428

2.84

307.65

5.0

3.2

1.89

1.33

mg/l

133.79

2341

5884

Septicaemia

1612

3915

4.07

307.65

8.7

3.7

2.02

1.43

mg/l

80.11

1521

3550

Heart failure,strict

1488

3113

3.51

307.65

4.4

2.7

2.21

1.30

mg/l

165.07

1345

2819

All kidney diseases

4751

5554

6.25

307.65

6.0

3.1

1.86

1.10

mg/l

307.65

4444

5104

Bacterial infection, other or unspecified

1792

4521

3.60

307.65

6.0

3.1

1.96

1.43

mg/l

75.49

1670

4088

Extracorporeal dialysis

963

583

27.34

307.65

9.5

4.7

2.54

1.42

mg/l

99.42

931

536

Hypertension, essential

2106

3784

3.25

307.65

4.0

2.3

1.69

1.17

mg/l

118.03

1966

3513

Polycystic kidney disease

394

237

26.90

307.65

7.8

6.3

1.97

1.49

mg/l

10.13

385

219

Preparatory care for dialysis

720

373

34.04

307.65

6.4

3.7

2.37

1.51

mg/l

43.47

698

341

Other dialysis

569

342

32.67

307.65

12.1

6.7

2.25

1.41

mg/l

39.53

559

321

Kidney transplant status

1308

555

63.46

307.65

12.0

6.7

2.04

1.22

mg/l

94.75

1290

521

Nephrotic syndrome

390

343

16.41

307.65

14.9

9.6

1.95

1.24

mg/l

25.39

380

322

Caries of dentine

1237

2105

6.27

307.65

7.4

2.7

1.80

1.44

mg/l

26.87

1208

1923

Cystic kidney disease

444

310

21.91

307.65

9.0

6.2

1.94

1.39

mg/l

16.87

435

292

Persons encountering health services for specific procedures and health care

3526

6990

3.13

307.65

6.1

3.6

1.74

1.28

mg/l

133.04

3335

6422

Hypertensive Renal Disease

285

195

17.69

307.65

5.4

2.1

2.41

1.38

mg/l

31.24

267

168

Implicit viral Sepsis

1019

2632

4.09

307.65

6.8

3.4

1.99

1.40

mg/l

54.44

966

2364

ILD medications: immunosuppressive drugs

2920

5923

4.88

307.65

9.3

2.7

1.73

1.32

mg/l

97.93

2801

5433

Any gastric operation

2162

3383

3.29

307.65

6.6

2.5

1.44

1.24

mg/l

21.93

2063

3080

Congenital malformations of the urinary system

588

697

10.70

307.65

9.8

1.84

1.32

mg/l

25.73

576

657

Other bacterial diseases

3074

7255

2.77

307.65

6.6

3.5

1.80

1.31

mg/l

127.73

2870

6696

ILD medications: prednisolone, methylprednisolone, prednisone

3467

6462

3.10

307.65

7.2

2.5

1.69

1.35

mg/l

75.03

3250

5910

Transplanted organ and tissue status

1844

923

35.33

307.65

12.0

4.4

1.93

1.25

mg/l

102.11

1816

866

Aplastic and other anaemias

1642

4179

3.86

307.65

5.5

3.6

2.03

1.55

mg/l

58.87

1518

3769

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3518

7197

3.52

307.65

5.8

3.8

1.75

1.37

mg/l

91.43

3279

6628

Glomerular disorders in diseases classified elsewhere

1405

968

19.91

307.65

6.1

3.1

2.14

1.47

mg/l

66.10

1335

880

Other bacterial diseases

3022

7128

2.95

307.65

6.7

3.4

1.85

1.34

mg/l

131.28

2814

6562

Metabolic disorders

2755

6459

2.68

307.65

4.7

3.8

1.70

1.38

mg/l

52.97

2552

5976

Liquid cancers, helper endpoint

1319

2979

4.07

307.65

5.7

3.7

1.48

1.65

mg/l

8.79

1238

2658

Other septicaemia

1485

3496

4.34

307.65

8.7

3.6

2.04

1.44

mg/l

74.99

1408

3163

Heart failure and antihypertensive medication

862

1013

5.89

307.65

5.3

2.8

2.17

1.12

mg/l

123.20

803

935

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

916

2083

4.69

307.65

9.2

8.4

1.60

1.31

mg/l

17.53

893

1966

All chronic kidney diseases

4523

3252

13.22

307.65

6.0

3.4

2.00

1.13

mg/l

307.65

4234

2952

Condition for Implicit Sepsis (Organ dysfunction codes)

2570

6648

2.75

307.65

4.9

3.3

1.84

1.31

mg/l

131.50

2410

6106

Heart failure, not strict

2924

4687

4.49

307.65

5.5

3.2

2.04

1.25

mg/l

284.48

2734

4286

Cardiovascular diseases

1761

3105

3.14

307.65

8.0

4.7

1.42

1.05

mg/l

69.88

1689

2943

Implicit bacterial Sepsis

1510

3602

3.80

307.65

5.1

2.9

2.12

1.46

mg/l

98.07

1403

3234

Hypertensive diseases (excluding secondary)

1868

2546

4.46

307.65

7.2

3.4

1.66

1.06

mg/l

140.21

1782

2400

Implicit bacterial Sepsis

1428

3314

4.02

307.65

5.3

2.9

2.14

1.47

mg/l

93.27

1328

2963

GASTRO-related operations

2162

3383

3.29

307.65

6.6

2.5

1.44

1.24

mg/l

21.93

2063

3080

Other anaemias

1426

3943

3.61

307.65

5.0

3.5

1.99

1.56

mg/l

44.03

1312

3547

Implicit viral Sepsis

834

1777

5.04

307.65

7.4

3.5

2.01

1.39

mg/l

48.66

790

1593

Acute tubulo-interstitial nephritis

1712

4086

3.75

307.65

6.5

3.3

1.87

1.15

mg/l

164.49

1597

3723

Implicit Sepsis

2345

5865

3.13

307.65

5.1

3.2

1.94

1.36

mg/l

129.23

2188

5336

Dialysis

754

336

43.11

307.65

12.9

7.8

2.17

1.08

mg/l

127.41

745

319

Care involving dialysis

1413

683

35.59

307.65

9.6

4.9

2.44

1.30

mg/l

166.25

1375

628

ILD medications: azathioprine

769

1301

6.50

307.65

12.1

3.2

1.68

1.25

mg/l

29.11

734

1205

ILD medications

3607

6626

3.05

307.65

7.5

2.7

1.64

1.34

mg/l

63.02

3391

6068

Gout

1051

2393

4.10

307.65

4.6

2.6

2.21

1.60

mg/l

59.12

968

2156

Disorders resulting from impaired renal tubular function

536

357

24.21

307.65

10.4

5.2

2.32

1.48

mg/l

34.76

510

332

IgA nephropathy (IgA glomerulonephritis)

340

229

23.31

307.65

5.9

2.9

1.85

1.53

mg/l

4.30

334

212

Bacterial Sepsis

1610

3823

3.78

307.65

5.5

3.1

2.11

1.44

mg/l

103.60

1497

3441

Fever of other and unknown origin

1939

5078

3.54

307.65

7.0

3.1

1.72

1.42

mg/l

31.83

1832

4642

Secondary hypertension

1091

520

29.04

307.65

8.8

4.3

2.03

1.11

mg/l

124.61

1041

488

Insulin medication

1840

5806

2.76

307.65

4.5

4.2

2.02

1.40

mg/l

115.01

1673

5384

Hypertensive diseases

2429

4063

3.50

307.65

6.4

3.1

1.67

1.16

mg/l

136.85

2298

3780

Gout, FINNGEN

1051

2771

4.01

307.65

4.6

2.5

2.21

1.63

mg/l

55.47

968

2490

Other disorders involving the immune mechanism, not elsewhere classified

406

352

16.94

307.65

10.5

7.1

1.78

1.43

mg/l

7.32

395

333

Other and unspecified anaemias

1417

3910

3.62

307.65

5.0

3.5

1.99

1.56

mg/l

43.33

1303

3518

Explicit Sepsis

1646

4040

4.01

307.65

8.6

3.6

2.01

1.40

mg/l

88.93

1554

3658

First line medication for Crohn's disease

3448

6426

2.99

307.65

7.4

2.8

1.60

1.35

mg/l

45.01

3248

5893

Cardiovascular diseases (excluding rheumatic etc)

1956

3418

3.40

307.65

7.8

4.5

1.49

1.05

mg/l

94.39

1872

3241

Acute renal failure

1237

1405

9.91

307.65

5.4

2.4

2.28

1.22

mg/l

191.93

1160

1256

Diabetic nephropathy, excluding more controls

1029

1167

8.51

307.65

5.3

2.7

2.34

1.50

mg/l

90.78

970

1063

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

903

1975

4.90

307.65

9.3

8.8

1.61

1.31

mg/l

18.12

880

1869

Diabetic nephropathy

1036

1708

6.98

307.65

5.3

2.8

2.33

1.66

mg/l

64.29

977

1530

Autoimmune diseases excluding thyroid diseases, strict definition

2720

6550

2.33

305.55

4.4

1.63

1.39

mg/l

32.59

2540

6053

Other heart diseases

1354

2792

3.27

300.25

5.9

4.6

1.66

1.05

mg/l

92.33

1274

2644

Type 2 diabetes, wide definition

2042

5212

2.58

296.22

3.8

2.7

1.89

1.42

mg/l

82.81

1858

4807

Insulin, fast-acting

1254

4113

3.20

295.96

5.0

4.8

2.04

1.39

mg/l

87.19

1144

3812

Insulin, intermediate and long-acting

1656

6145

2.71

291.77

4.2

4.0

2.02

1.45

mg/l

92.58

1502

5661

2298

5890

2.42

288.96

5.0

3.2

1.73

1.39

mg/l

50.13

2144

5420

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2298

5890

2.42

288.96

5.0

3.2

1.73

1.39

mg/l

50.13

2144

5420

Influenza and pneumonia

2745

8041

2.22

287.91

5.7

3.9

1.69

1.36

mg/l

60.23

2572

7452

Anaemia in chronic diseases classified elsewhere

258

196

18.14

285.42

8.7

4.7

2.53

1.57

mg/l

23.81

244

179

Hypertensive heart and/or renal disease

780

1327

4.59

285.24

4.5

2.3

2.27

1.32

mg/l

86.72

705

1207

Heart failure, strict

1593

4142

2.81

277.87

4.2

3.1

2.21

1.51

mg/l

114.08

1439

3759

Gout, idiopatic and unspecified

879

2426

3.85

274.65

4.6

2.6

2.25

1.63

mg/l

52.28

817

2166

Infections, IBD-co-morbidities

619

839

5.58

273.79

7.3

3.9

1.98

1.20

mg/l

53.04

589

784

Insulin, fast-acting or short human

1260

4334

3.04

273.41

5.0

4.8

2.04

1.43

mg/l

78.44

1150

4005

Any reimbursement code in KELA

1410

2285

3.17

273.33

6.3

2.2

1.42

1.07

mg/l

49.43

1339

2131

Inflammatory bowel disease treatment related agents

2921

7806

2.14

270.48

6.3

3.5

1.59

1.44

mg/l

15.40

2692

7228

Pneumonias (Asthma/COPD co-morbidities)

2592

8113

2.19

267.68

5.5

4.1

1.73

1.36

mg/l

68.88

2411

7519

All-cause Heart Failure

1550

4056

2.79

267.61

4.2

3.1

2.22

1.51

mg/l

110.97

1400

3677

Diseases of arteries, arterioles and capillaries (FINNGEN)

736

1143

4.66

266.53

4.8

2.2

2.01

1.12

mg/l

87.44

694

1067

Gout, unspecified

756

1921

4.21

266.26

4.7

2.6

2.25

1.61

mg/l

47.14

705

1705

Gout, strict definition

702

1709

4.42

262.54

4.6

2.5

2.31

1.63

mg/l

47.44

654

1505

All pneumoniae

2599

8208

2.16

259.18

5.5

4.1

1.73

1.37

mg/l

66.56

2421

7611

Disorders of other endocrine glands

1359

4917

2.82

258.74

7.5

4.9

1.74

1.40

mg/l

27.02

1274

4550

Pneumonia, organism unspecified

2364

7587

2.24

258.10

5.5

4.0

1.76

1.38

mg/l

65.94

2198

7021

Autoimmune diseases

2803

6785

2.14

255.10

4.3

4.4

1.58

1.39

mg/l

21.92

2611

6273

Certain infectious and parasitic diseases

2358

5223

2.31

254.06

5.6

2.8

1.59

1.29

mg/l

45.50

2201

4803

General symptoms and signs

2621

6106

2.19

251.32

4.7

3.0

1.55

1.38

mg/l

15.68

2456

5607

Endocrine, nutritional and metabolic diseases

1993

4173

2.47

249.38

5.7

4.4

1.52

1.19

mg/l

51.45

1871

3914

Diseases of liver

1085

3687

3.08

240.86

4.7

3.3

1.69

1.52

mg/l

7.38

1016

3374

Diarrhoea and gastroenteritis of presumed infectious origin

1904

7564

2.32

240.34

7.5

3.7

1.68

1.41

mg/l

29.22

1798

6983

Certain disorders involving the immune mechanism

728

1956

3.97

237.15

8.3

4.6

1.73

1.46

mg/l

10.31

692

1819

Type 1 diabetes

905

2802

3.39

235.17

5.4

5.9

1.98

1.27

mg/l

74.80

848

2636

Used for control exclusion in common control thyroid runs

2627

6354

2.13

235.13

4.5

1.56

1.39

mg/l

18.52

2451

5886

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2492

8244

2.11

233.44

5.5

4.1

1.74

1.38

mg/l

62.19

2316

7647

Presence of other functional implants

1397

3646

2.73

232.48

3.7

2.3

1.82

1.49

mg/l

27.44

1221

3285

Other medical care

1159

3688

2.92

231.66

4.0

3.0

1.70

1.41

mg/l

19.84

1084

3314

Acute peritonitis

366

573

7.27

228.64

9.4

3.9

2.19

1.57

mg/l

19.48

354

517

Intestinal infectious diseases

2378

8768

2.10

226.99

6.7

3.6

1.69

1.43

mg/l

31.62

2230

8085

Diabetes mellitus

2467

6945

2.12

226.49

3.9

4.1

1.74

1.33

mg/l

82.19

2274

6458

Diabetes, varying definitions

2456

6944

2.11

224.89

3.9

4.1

1.74

1.33

mg/l

81.72

2266

6454

Type 2 diabetes

2267

6212

2.17

222.40

3.6

2.8

1.75

1.37

mg/l

67.19

2080

5742

Hyperkalaemia

300

397

8.50

217.53

5.6

3.2

2.30

1.62

mg/l

17.89

279

356

Malignant neoplasm, wide definition for exclusion

2149

5852

2.20

216.70

6.2

3.7

1.39

1.50

mg/l

7.39

2039

5371

Malignant neoplasm

2067

5654

2.21

211.22

6.3

3.7

1.38

1.51

mg/l

10.17

1958

5180

Tramadol

1872

5160

2.28

207.34

3.9

2.8

1.71

1.45

mg/l

25.93

1728

4745

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2258

6603

2.10

204.90

3.9

4.0

1.81

1.34

mg/l

95.43

2063

6129

Disorders of parathyroid gland

643

1732

3.86

203.22

5.5

2.9

2.11

1.58

mg/l

25.36

611

1552

Isolated proteinuria

235

256

11.44

202.75

5.4

3.8

1.77

1.50

mg/l

3.09

226

236

Fibrosis and cirrhosis of liver

376

684

6.13

201.01

5.2

3.6

1.80

1.56

mg/l

4.87

357

624

Polyarthropathies

1809

5347

2.26

200.15

4.3

3.9

1.87

1.41

mg/l

68.62

1648

4951

Diabetic maculopathy, excluding more controls

428

875

5.26

198.93

5.2

2.6

2.14

1.40

mg/l

37.40

397

811

Failure and rejection of transplanted organs and tissues

172

128

20.02

194.34

13.6

7.3

2.30

1.28

mg/l

16.31

167

119

Persons encountering health services in other circumstances, wide

2769

7501

1.93

192.70

5.0

3.8

1.63

1.42

mg/l

24.07

2574

6911

Other diseases of blood and blood-forming organs, wide

727

2246

3.41

190.59

6.5

4.1

1.51

1.52

mg/l

0.15

678

2072

Hernia of abdominal wall, postoperative

482

1123

4.47

188.86

6.2

2.2

1.84

1.37

mg/l

21.14

447

998

Disorders of lipoprotein metabolism and other lipidaemias

1860

5366

2.19

188.73

3.7

2.9

1.72

1.45

mg/l

30.82

1704

4928

Type 1 diabetes, wide definition, subgroup 1

730

2274

3.37

188.15

5.2

6.2

2.01

1.23

mg/l

71.55

681

2156

Any event in cancer register

2149

6223

2.07

187.35

6.0

3.7

1.38

1.51

mg/l

10.40

2040

5715

Hydronephrosis

362

671

5.73

187.10

5.3

3.0

1.89

1.16

mg/l

33.63

335

616

Diabetes, insulin treatment (Kela reimbursement)

2365

7310

1.99

186.06

4.0

3.9

1.82

1.38

mg/l

90.87

2156

6786

Abnormal findings on examination of urine, without diagnosis

274

398

7.99

184.41

5.4

4.9

1.76

1.56

mg/l

2.29

260

364

Covid-19 confirmed case

1037

3961

2.71

184.16

6.1

3.6

1.84

1.53

mg/l

18.84

969

3593

Hyperparathyroidism

567

1508

3.91

182.89

5.7

2.8

2.17

1.59

mg/l

25.83

541

1350

Diseases of peritoneum

414

887

5.05

182.52

8.6

3.6

2.13

1.54

mg/l

21.51

398

812

Malignant cancer of tonsil and base of tongue, including Hilmo

193

185

13.05

182.37

3.5

2.6

1.13

1.57

mg/l

8.86

193

164

Malignant neoplasm of oral cavity, including Hilmo

249

329

8.65

181.38

2.6

1.19

1.59

mg/l

11.18

244

293

Nausea and vomiting

835

2817

3.02

179.85

9.1

5.0

1.69

1.44

mg/l

10.57

777

2581

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

972

2150

2.92

179.03

4.9

2.6

1.64

1.08

mg/l

61.66

914

2020

Hyperlipidaemia, other/unspecified

970

3316

2.78

178.35

4.1

2.7

1.88

1.56

mg/l

18.72

880

2996

Chronic tubulo-interstitial nephritis

193

187

11.63

177.90

5.8

2.2

2.10

1.14

mg/l

24.71

182

176

Oral corticosteroids

2401

7430

1.95

177.75

3.7

3.2

1.62

1.45

mg/l

15.16

2192

6863

Care involving use of rehabilitation procedures

1459

6027

2.28

176.88

5.7

3.7

1.62

1.31

mg/l

32.56

1358

5514

Type 1 diabetes, wide definition

747

2447

3.19

176.75

5.4

6.3

2.02

1.25

mg/l

69.02

697

2313

Ulcer of lower limb, not elsewhere classified

496

1264

4.18

173.99

4.8

2.8

2.34

1.61

mg/l

33.79

459

1131

Neoplasms

1881

4744

2.14

173.42

7.7

4.1

1.38

1.37

mg/l

0.07

1802

4382

Malignant cancer of tonsil and base of tongue

171

148

14.78

173.28

3.5

2.5

1.13

1.54

mg/l

6.64

171

131

Other heart diseases, wide

2156

6708

2.00

172.85

5.2

4.4

1.66

1.29

mg/l

57.82

2003

6270

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

539

1479

3.89

170.64

5.4

3.4

1.82

1.60

mg/l

5.88

511

1349

Sub-endpoint used in defining T1D endpoints

925

3413

2.77

169.95

5.4

5.5

2.00

1.40

mg/l

56.19

866

3170

Heart failure and coronary heart disease

1101

3077

2.62

168.89

4.4

2.9

2.26

1.57

mg/l

73.04

994

2778

Provisional assignment of new diseases of uncertain etiology

1343

5997

2.30

167.81

5.9

3.8

1.73

1.47

mg/l

17.79

1249

5510

Codes for special purposes

1344

6006

2.29

167.62

5.9

3.8

1.72

1.47

mg/l

17.65

1250

5518

Oesophageal varices

253

377

7.80

166.48

6.7

5.3

1.81

1.56

mg/l

3.45

243

340

Congenital malformations, deformations and chromosomal abnormalities

1477

6541

2.20

165.84

6.6

4.2

1.57

1.38

mg/l

13.57

1407

6090

Insulin, fast-acting (human)

500

1327

3.98

165.28

5.5

3.5

2.00

1.29

mg/l

45.10

471

1237

Solid cancers, helper endpoint

1885

5466

2.08

165.07

5.1

3.5

1.39

1.52

mg/l

9.86

1784

4995

Diabetic retinopathy, excluding more controls

812

1488

3.21

164.10

5.0

2.9

2.08

1.48

mg/l

45.99

744

1360

Diseases of arteries, arterioles and capillaries

1546

5330

2.19

163.39

4.2

2.9

2.02

1.55

mg/l

52.76

1430

4822

Erysipelas

1582

5703

2.16

163.03

3.8

2.7

1.99

1.38

mg/l

87.23

1440

5197

Second line medication for Crohn's disease

1446

6746

2.20

162.68

9.2

3.6

1.52

1.45

mg/l

2.66

1354

6237

Other disorders of skin and subcutaneous tissue

1604

6870

2.12

161.88

4.9

3.4

1.87

1.50

mg/l

38.32

1480

6271

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1306

4627

2.32

160.23

3.5

2.8

2.03

1.55

mg/l

51.37

1160

4221

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2517

7481

1.86

158.10

5.4

3.8

1.66

1.42

mg/l

28.39

2351

6894

Hypothyroidism (congenital or acquired)

577

864

3.87

156.01

5.0

3.0

1.36

1.04

mg/l

19.32

540

818

Oxycodone

932

3275

2.65

155.95

3.4

2.7

1.70

1.57

mg/l

3.44

862

2970

L04AX Other immunosuppressants

1396

6562

2.18

154.10

9.4

3.7

1.54

1.46

mg/l

2.98

1305

6063

Malaise and fatigue

1171

4043

2.38

153.96

4.2

3.1

1.76

1.46

mg/l

21.66

1053

3674

Diabetes medication

2304

7396

1.88

152.62

3.9

4.0

1.76

1.37

mg/l

72.76

2101

6880

Erysipelas

1247

4930

2.29

152.18

3.9

2.6

2.03

1.43

mg/l

66.25

1130

4472

Cirrhosis of liver, NAS

272

476

6.45

152.04

5.4

3.7

1.84

1.62

mg/l

3.39

258

432

Primary_lymphoid and hematopoietic malignant neoplasms

711

2488

2.99

150.10

7.8

3.9

1.52

1.62

mg/l

2.25

664

2239

Persons with potential health hazards related to communicable diseases

1039

4341

2.44

149.23

8.3

5.4

1.45

1.32

mg/l

5.01

990

4107

Atrial fibrillation and flutter

701

1477

3.16

148.29

3.6

2.2

1.80

1.10

mg/l

63.87

657

1379

Complications of surgical and medical care, not elsewhere classified

2188

8138

1.87

148.25

4.9

3.4

1.77

1.46

mg/l

37.49

2029

7471

Disorders of lens

1526

4527

2.15

148.02

5.3

2.9

1.91

1.48

mg/l

48.44

1393

4179

Disorders of mineral metabolism

324

678

5.15

146.85

5.1

4.2

1.88

1.43

mg/l

10.70

300

624

Congenital malformations, deformations and chromosomal abnormalities

1542

7021

2.07

146.54

6.4

4.1

1.56

1.39

mg/l

10.83

1468

6515

Statin medication

1523

4037

2.16

146.26

5.1

2.9

1.61

1.27

mg/l

38.79

1436

3744

Hypothyroidism and >3 levothyroxin purchases

558

858

3.76

145.89

4.8

2.9

1.36

1.04

mg/l

18.25

523

812

Hypothyroidism, levothyroxine purchases

558

858

3.76

145.89

4.8

2.9

1.36

1.04

mg/l

18.25

523

812

Oedema, not elsewhere classified

777

2851

2.77

144.59

4.2

2.8

1.87

1.49

mg/l

20.02

712

2568

Iron deficiency anaemia

1036

4353

2.41

144.56

5.1

3.9

1.90

1.52

mg/l

25.76

951

3957

COPD/asthma related infections

2196

5891

1.89

143.79

4.5

3.2

1.57

1.39

mg/l

15.24

2038

5421

COPD/asthma/ILD related infections

2196

5891

1.89

143.79

4.5

3.2

1.57

1.39

mg/l

15.24

2038

5421

Coagulation defects, purpura and other haemorrhagic conditions

606

1989

3.19

143.53

6.2

5.0

1.60

1.48

mg/l

2.27

573

1841

Nutritional anaemias

1158

5016

2.28

142.09

4.9

3.8

1.89

1.54

mg/l

24.88

1064

4549

Diabetic retinopathy, strict definition

634

1886

3.17

140.81

5.2

3.1

2.14

1.70

mg/l

21.70

586

1725

Opioids

2068

5698

1.91

140.76

3.6

3.0

1.55

1.42

mg/l

8.80

1929

5253

Volume depletion

336

748

4.79

140.75

5.8

4.9

2.08

1.51

mg/l

15.65

318

671

Heart failure and bmi 25plus

862

2221

2.71

139.61

3.7

2.8

2.29

1.55

mg/l

64.30

771

1998

Diarrhoea and gastroenteritis of presumed infectious origin

2266

8337

1.82

139.47

6.0

3.6

1.62

1.44

mg/l

16.96

2127

7681

Hypo-osmolality and hyponatraemia

483

1397

3.59

138.70

5.0

3.2

1.80

1.52

mg/l

8.32

435

1261

Gingival hyperplasia

245

430

6.74

138.26

22.0

9.1

1.72

1.33

mg/l

7.75

238

405

Cerebrovascular diseases (FINNGEN)

667

1581

3.06

137.68

4.8

2.5

1.70

1.09

mg/l

50.67

630

1480

Symptoms and signs involving the urinary system

1734

6868

1.96

137.54

4.7

3.7

1.73

1.50

mg/l

16.86

1586

6292

Bleeding

1881

7137

1.91

136.18

5.5

3.8

1.87

1.46

mg/l

52.28

1754

6523

Persons encountering health services in other circumstances

990

4258

2.37

134.04

4.0

4.1

1.61

1.41

mg/l

10.29

911

3920

Other retinal disorders

1430

5474

2.08

133.79

4.5

3.1

1.92

1.56

mg/l

33.84

1289

4990

Other viral diseases

858

3512

2.52

131.27

10.4

5.7

1.61

1.33

mg/l

16.28

823

3316

Isolated proteinuria with specified morphological lesion

120

17.75

131.23

5.6

2.1

1.97

1.45

mg/l

3.77

114

Unspecified haematuria

1040

3787

2.34

131.05

4.9

3.3

1.78

1.59

mg/l

6.89

958

3437

Autoimmune diseases related-to ILD

1873

8760

1.86

129.81

3.9

3.8

1.53

1.49

mg/l

1.27

1722

8087

Other disorders of urethra and urinary system

1480

5350

2.03

128.93

4.7

3.6

1.70

1.48

mg/l

13.97

1364

4898

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

209

330

7.01

128.85

3.8

2.5

1.85

1.69

mg/l

1.30

192

284

Other and unspecified iron deficiency

829

3381

2.52

128.14

4.9

4.1

1.89

1.52

mg/l

20.78

759

3083

Intestinal infectious diseases

2501

8348

1.74

127.47

5.4

3.6

1.65

1.44

mg/l

23.81

2334

7681

Disorders of choroid and retina

1754

6654

1.91

126.70

4.3

3.1

1.87

1.52

mg/l

38.06

1586

6100

Osteopathies and chondropathies

1279

5819

2.09

126.01

5.1

3.7

1.71

1.50

mg/l

13.43

1182

5336

Cholangitis (primary sclerosing, PSC)

279

592

5.16

125.10

7.9

5.3

1.57

1.46

mg/l

1.25

271

546

Human immunodeficiency virus [HIV] disease

160

199

10.06

124.88

2.9

3.2

1.18

1.37

mg/l

2.79

152

188

Other cataract

998

3302

2.34

124.38

5.7

2.9

1.88

1.52

mg/l

25.71

911

3024

Non-ischemic cardiomyopathy

733

2253

2.70

124.01

4.5

3.2

2.08

1.46

mg/l

44.86

654

2037

Malignant neoplasm of oropharynx, including Hilmo

145

160

10.97

123.40

3.6

2.5

1.11

1.60

mg/l

8.91

145

142

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

207

340

6.86

123.40

6.3

2.8

2.01

1.27

mg/l

22.16

200

330

Hepatic failure, not elsewhere classified

204

331

7.02

123.38

5.5

3.1

1.78

1.56

mg/l

2.43

195

303

Purpura and other haemorrhagic conditions

448

1346

3.52

123.30

6.2

5.1

1.60

1.48

mg/l

1.73

424

1245

Ascites

283

616

4.95

122.44

5.6

3.0

1.97

1.57

mg/l

9.21

272

558

Human immunodeficiency virus [HIV] disease resulting in other conditions

151

181

10.54

121.57

3.0

3.3

1.18

1.36

mg/l

2.62

143

171

Peripheral artery disease

992

3502

2.31

121.10

4.2

2.6

2.21

1.64

mg/l

48.70

907

3120

Hypertensive Heart Disease

506

1238

3.30

121.07

4.3

2.2

2.22

1.34

mg/l

49.15

447

1121

Type 2 diabetes, definitions combined

1853

5949

1.85

118.64

3.1

2.7

1.69

1.37

mg/l

40.37

1690

5489

Malignant neoplasm of tonsil, including Hilmo

129

130

12.26

117.61

3.6

2.5

1.11

1.58

mg/l

7.12

129

115

Gastrointestinal diseases

1278

3032

2.14

117.40

7.1

2.7

1.41

1.27

mg/l

7.64

1209

2804

Ischemic heart diseases

1817

5971

1.86

117.24

4.7

4.2

1.74

1.40

mg/l

42.61

1689

5513

Adjustment and management of implanted device

452

1405

3.34

116.81

3.6

3.2

1.98

1.52

mg/l

18.59

403

1241

Vitreous haemorrhage

351

932

4.02

116.64

5.2

3.1

2.12

1.57

mg/l

15.99

330

851

Bronchitis

2263

8362

1.73

116.16

5.0

3.3

1.61

1.47

mg/l

10.00

2103

7692

Type 2 diabetes, strict (exclude DM1)

1857

6014

1.84

115.70

3.1

2.7

1.69

1.38

mg/l

39.86

1694

5552

Depression medications

582

934

3.19

115.51

4.2

2.7

1.33

1.03

mg/l

17.06

550

884

Hard cardiovascular diseases

1827

5999

1.85

115.33

4.8

4.2

1.71

1.39

mg/l

40.52

1716

5552

Unspecified nephritic syndrome

145

179

9.58

112.67

6.7

2.6

1.87

1.54

mg/l

2.52

138

162

Amputation

328

856

4.06

111.36

4.9

2.6

2.44

1.71

mg/l

21.41

307

756

Infections of the skin and subcutaneous tissue

1399

7319

1.93

111.30

6.6

4.3

1.71

1.41

mg/l

22.24

1321

6790

Other viral diseases

970

4478

2.21

110.26

9.6

5.3

1.56

1.33

mg/l

12.84

930

4221

Valvular heart disease excluding rheumatic fever

1037

3485

2.20

110.05

4.9

4.4

1.85

1.37

mg/l

38.77

949

3201

Type 2 diabetes, definitions combined, including avohilmo

1839

5988

1.81

109.43

3.1

2.7

1.67

1.37

mg/l

37.63

1673

5540

Disorders of gallbladder, biliary tract and pancreas

2032

7446

1.75

108.09

4.6

3.2

1.69

1.50

mg/l

15.96

1890

6814

Malignant neoplasm of oropharynx

121

126

11.84

107.78

3.5

2.4

1.12

1.58

mg/l

6.87

121

110

Complications of procedures, not elsewhere classified

1680

7777

1.82

107.52

4.2

3.2

1.72

1.47

mg/l

21.98

1562

7126

Certain infectious and parasitic diseases

1517

3965

1.94

107.45

5.1

2.8

1.59

1.29

mg/l

29.43

1411

3644

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

407

1252

3.40

107.39

3.7

3.2

1.34

1.66

mg/l

12.79

391

1103

Viral infections characterized by skin and mucous membrane lesions

1050

5088

2.11

107.26

8.9

4.4

1.67

1.44

mg/l

13.45

988

4704

Atherosclerosis, excluding cerebral and coronary sclerosis

907

3244

2.27

105.92

4.0

2.6

2.20

1.66

mg/l

41.53

827

2880

Disorders of calcium metabolism

233

489

5.13

105.36

5.4

4.2

2.05

1.45

mg/l

12.74

213

448

Atrial fibrillation and flutter with reimbursement

524

1118

3.06

104.74

3.2

2.1

1.81

1.13

mg/l

48.76

484

1038

Other diseases of liver

490

1716

2.97

103.38

4.3

3.4

1.70

1.48

mg/l

4.91

452

1583

Acute upper respiratory infections of multiple and unspecified sites

1622

6704

1.82

102.78

6.1

3.4

1.54

1.46

mg/l

3.08

1524

6173

Charcot foot

119

129

10.99

102.35

5.5

2.7

2.28

1.30

mg/l

14.72

110

119

Non-rheumatic valve diseases

1000

3410

2.16

102.10

4.7

4.0

1.87

1.38

mg/l

39.15

913

3126

Osteoporosis

589

2116

2.68

101.89

5.1

3.2

1.72

1.62

mg/l

1.61

534

1902

Diabetic retinopathy

958

2756

2.25

101.71

4.7

3.2

2.08

1.75

mg/l

18.61

872

2506

Diseases of the skin and subcutaneous tissue

2126

6291

1.72

101.58

4.6

3.7

1.57

1.40

mg/l

13.87

1961

5819

Percutaneous Coronary Intervention

1685

5782

1.82

101.58

4.8

4.2

1.78

1.41

mg/l

45.39

1564

5335

Coronary revascularization (ANGIO or CABG)

1685

5786

1.81

100.93

4.9

4.2

1.78

1.41

mg/l

45.15

1565

5339

Cardiac arrhythmias

1204

3945

2.02

100.60

4.0

4.3

1.58

1.20

mg/l

40.26

1114

3706

Codeine

1803

5572

1.78

99.71

3.0

2.8

1.57

1.42

mg/l

8.74

1649

5138

Malignant neoplasm of tonsil

110

113

12.03

98.97

3.5

2.4

1.13

1.61

mg/l

6.28

110

100

Pure hypercholesterolaemia

1415

4967

1.89

98.06

3.3

2.9

1.70

1.47

mg/l

17.31

1289

4547

All influenza

649

2687

2.49

97.48

8.4

4.7

1.74

1.42

mg/l

13.15

608

2469

Abnormalities of breathing

1894

6439

1.73

96.56

4.2

1.60

1.40

mg/l

17.39

1726

5990

2293

7248

1.65

96.30

4.5

3.2

1.58

1.47

mg/l

6.68

2121

6647

Senile cataract

1248

3952

1.97

96.21

4.3

2.6

1.92

1.52

mg/l

34.84

1138

3636

Implicit fungal Sepsis

225

496

4.85

95.74

5.1

3.1

1.95

1.38

mg/l

12.11

213

440

Viral warts

333

978

3.60

95.19

11.9

5.1

1.81

1.38

mg/l

10.95

313

916

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

763

1586

2.45

95.00

4.8

2.8

1.46

1.23

mg/l

10.55

717

1456

Diseases of the digestive system

1042

5237

2.02

94.90

5.6

4.1

1.83

1.54

mg/l

16.07

971

4773

Complications of medical and surgical care

1498

7781

1.80

94.54

4.9

3.3

1.80

1.50

mg/l

23.64

1389

7124

Other diseases of urinary system

2061

6967

1.68

94.36

4.7

4.0

1.64

1.46

mg/l

14.34

1894

6423

364

1133

3.34

94.12

4.7

3.2

1.63

1.33

mg/l

7.24

348

1044

Fungal Sepsis

174

313

6.12

94.10

5.6

3.2

1.97

1.40

mg/l

9.33

165

278

Other diseases of biliary tract

283

751

4.00

94.07

6.4

4.2

1.68

1.53

mg/l

1.93

270

678

Peripheral artery operations in Hilmo

353

1080

3.41

93.92

4.9

2.5

2.36

1.66

mg/l

22.60

328

953

Emergency coronary revascularization (for ACS)

1794

6370

1.74

93.34

4.7

4.1

1.79

1.45

mg/l

39.50

1656

5867

Major coronary heart disease event

1763

6184

1.75

93.22

4.7

4.2

1.78

1.43

mg/l

41.61

1637

5703

Medical observation and evaluation for suspected diseases and conditions

1414

3905

1.88

91.22

4.8

2.8

1.49

1.46

mg/l

0.52

1292

3604

Other special examinations and investigations of persons without complaint or reported diagnosis

1425

3906

1.87

90.98

5.2

2.8

1.51

1.46

mg/l

1.21

1318

3605

Dyspnoea

1821

8054

1.69

89.90

3.5

3.9

1.77

1.47

mg/l

30.78

1649

7428

Explicit bacterial Sepsis

303

868

3.66

89.56

6.9

3.8

2.02

1.37

mg/l

18.95

280

780

Factors influencing health status and contact with health services

646

1275

2.59

89.51

4.2

2.0

1.55

1.28

mg/l

10.90

601

1172

Diseases of oesophagus, stomach and duodenum

2166

8028

1.63

89.46

3.8

3.9

1.63

1.46

mg/l

15.00

1999

7415

Symptoms and signs involving the digestive system and abdomen

2147

6587

1.65

89.37

5.7

3.9

1.53

1.43

mg/l

5.14

1999

6070

Viral hepatitis, IBD co-morbidity

183

359

5.39

89.01

3.9

2.5

1.44

1.15

mg/l

5.16

178

336

Implicit fungal Sepsis

162

288

6.21

88.77

5.4

3.0

1.99

1.42

mg/l

8.50

153

256

Arthropathies in other diseases classified elsewhere

161

287

6.18

87.96

4.9

2.9

2.16

1.48

mg/l

10.11

150

267

Hepatocellular carcinoma, including Hilmo

133

197

7.53

87.37

5.1

3.0

1.67

1.65

mg/l

0.06

124

171

Other nutritional deficiencies

1362

7224

1.80

87.27

3.8

3.9

1.79

1.42

mg/l

34.55

1247

6718

Other necrotizing vasculopathies

240

600

4.28

86.94

5.9

3.2

1.74

1.61

mg/l

1.25

225

541

Exposure to unspecified factor

2072

9302

1.62

86.46

4.3

4.4

1.58

1.46

mg/l

7.13

1902

8624

Tubulo-interstitial nephritis, not specified as acute or chronic

181

361

5.27

86.23

6.1

3.1

2.04

1.14

mg/l

20.85

171

330

Other diseases of blood and blood-forming organs

238

600

4.25

85.29

3.2

1.36

1.58

mg/l

3.65

221

546

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

204

457

4.75

85.03

6.0

2.8

1.61

1.72

mg/l

0.84

189

399

Other CVD (FINNGEN)

257

502

4.11

84.14

4.3

2.0

1.90

1.17

mg/l

26.86

229

464

Other diseases of pleura

966

4324

2.00

83.47

4.3

3.5

1.89

1.64

mg/l

11.71

890

3894

Streptococcal septicaemia

259

710

3.84

81.99

7.4

4.4

2.03

1.42

mg/l

13.77

237

644

Other (not insulin) diabetes medications

1809

6497

1.67

81.79

3.0

2.8

1.72

1.41

mg/l

37.24

1633

6006

Hypokalaemia

299

900

3.46

81.70

5.8

3.4

1.72

1.47

mg/l

4.47

274

815

Other bacterial intestinal infections

443

1668

2.75

81.32

5.7

3.5

2.04

1.51

mg/l

18.02

412

1510

Amputation of toe

236

612

4.11

81.30

5.1

2.8

2.38

1.70

mg/l

15.21

219

544

Other necrotizing vasculopathies (FG)

193

433

4.75

80.38

5.9

3.0

1.71

1.49

mg/l

2.82

182

384

Other pulmonary diagnosis

1554

4496

1.75

80.13

4.1

3.1

1.55

1.36

mg/l

13.58

1453

4151

Invasive ventilation

263

747

3.77

79.60

7.7

6.0

1.79

1.48

mg/l

4.59

244

694

Any death

1256

5022

1.82

79.29

3.9

3.2

1.95

1.54

mg/l

33.40

1167

4552

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

273

794

3.60

78.98

4.8

3.2

1.86

1.71

mg/l

1.65

251

697

Osteomyelitis

233

613

4.07

78.84

5.5

4.8

2.23

1.53

mg/l

16.35

218

564

Parasetamol

1575

4658

1.73

78.53

4.4

3.8

1.53

1.35

mg/l

12.30

1472

4351

Haemolytic anaemias

166

340

5.43

78.14

9.6

6.8

1.65

1.51

mg/l

1.15

161

313

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1210

6730

1.80

78.12

5.0

3.2

1.81

1.52

mg/l

17.91

1125

6145

Excluding asthma or asthma-COPD overlap

1544

4496

1.74

77.86

4.1

3.1

1.54

1.36

mg/l

12.39

1445

4151

Diabetic maculopathy

414

1453

2.84

77.77

5.3

3.1

2.14

1.68

mg/l

16.28

385

1324

Other obstructive and reflux uropathy

138

237

6.21

77.68

4.5

4.4

2.02

1.13

mg/l

13.51

130

218

Venous thromboembolism

1058

5534

1.88

77.64

3.8

2.8

1.83

1.60

mg/l

10.00

970

5015

Drug-induced cataract

131

219

6.87

77.25

14.6

3.8

1.96

1.42

mg/l

5.64

126

201

Thrombocytopenia, unspecified

243

672

3.86

76.41

7.1

4.8

1.65

1.53

mg/l

1.03

227

616

Other problems related to primary support group, including family circumstances

377

1315

2.92

76.23

27.0

6.5

1.21

1.19

mg/l

0.15

369

1259

COPD differential diagnosis

1535

4494

1.73

75.97

4.1

3.1

1.54

1.36

mg/l

12.07

1437

4149

Polyneuropathies and other disorders of the peripheral nervous system

526

2222

2.45

75.95

7.0

3.5

1.87

1.61

mg/l

7.05

489

2005

ILD differential diagnosis

1533

4493

1.73

75.57

4.1

3.1

1.54

1.36

mg/l

12.22

1435

4148

Molar incisor enamel hypoplasia

251

701

3.98

75.38

34.5

12.7

1.29

1.02

mg/l

11.93

245

687

Malignant neoplasm of liver and intrahepatic bile ducts

119

183

7.16

75.30

8.2

3.4

1.72

1.70

mg/l

0.10

108

160

Systemic connective tissue disorders

717

3445

2.13

75.15

4.2

3.3

1.65

1.56

mg/l

2.20

659

3130

Bacterial intestinal infections, IBD co-morbidities

447

1759

2.63

75.13

5.6

3.9

2.03

1.55

mg/l

15.51

417

1593

Coronary atherosclerosis

1247

4438

1.81

74.70

3.9

2.7

1.92

1.48

mg/l

43.34

1143

4044

Other bacterial intestinal infections

515

2170

2.44

74.49

5.2

3.4

1.95

1.49

mg/l

17.31

480

1982

Viral pneumonia

350

1223

2.98

74.33

5.8

4.8

1.93

1.42

mg/l

15.08

327

1121

Obesity due to excess calories

978

5253

1.90

74.25

3.6

4.0

1.88

1.41

mg/l

36.48

887

4892

Hypoplasia of dental enamel , including avohilmo

239

660

4.07

74.07

34.2

13.2

1.30

1.02

mg/l

11.86

233

647

Malignant neoplasm of urinary organs

256

745

3.60

74.02

4.6

3.2

1.87

1.71

mg/l

1.75

235

656

Enterocolitis due to Clostridium difficile

290

914

3.31

73.76

5.7

3.6

2.24

1.58

mg/l

16.32

267

813

Noninfective enteritis and colitis

1041

5712

1.85

73.56

4.8

5.0

1.50

1.44

mg/l

1.51

965

5291

Other acute lower respiratory infections

1162

6275

1.79

73.34

6.1

4.6

1.66

1.47

mg/l

9.73

1081

5781

Artificial opening status

187

445

4.51

72.49

7.1

4.2

1.69

1.35

mg/l

4.50

176

407

Other diseases of the digestive system

707

3427

2.11

72.48

5.9

3.8

1.93

1.60

mg/l

12.36

659

3079

Idiopathic gout

264

797

3.49

72.29

4.2

2.7

2.31

1.64

mg/l

16.24

247

716

Hypothyroidism, strict autoimmune

1294

4895

1.76

72.13

3.7

3.3

1.58

1.45

mg/l

5.36

1187

4496

Other and unspecified polyneuropathies, also in other diseases

462

1885

2.54

72.09

4.8

2.9

1.97

1.64

mg/l

9.02

428

1699

Diseases of the eye and adnexa

1689

5154

1.66

71.83

5.7

4.3

1.52

1.30

mg/l

19.57

1580

4852

Viral infections characterized by skin and mucous membrane lesions

1735

9342

1.61

71.80

6.5

3.9

1.58

1.46

mg/l

7.44

1623

8628

Sleep apnoea

1821

7438

1.60

71.25

3.0

3.4

1.64

1.50

mg/l

8.34

1658

6879

GI-bleeding

706

3442

2.10

71.24

5.8

3.8

1.94

1.60

mg/l

12.96

657

3087

Other reaction to severe stress, and adjustment disorders

775

3935

2.01

69.69

6.9

3.7

1.54

1.35

mg/l

7.32

731

3692

Abdominal and pelvic pain

2038

6582

1.57

69.60

5.3

3.9

1.51

1.43

mg/l

3.66

1876

6065

Chronic hepatitis, not elsewhere classified

143

284

5.52

69.49

4.8

3.3

1.57

1.45

mg/l

0.85

134

263

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

252

499

3.69

69.47

3.5

2.9

1.75

1.29

mg/l

12.02

234

460

Periodontitis

1847

7882

1.59

69.30

3.9

2.9

1.68

1.50

mg/l

14.00

1721

7218

Pacemaker

670

3100

2.12

68.92

3.7

3.3

2.00

1.71

mg/l

10.29

594

2756

Viral and other specified intestinal infections

538

2329

2.31

68.89

12.3

5.6

1.49

1.24

mg/l

11.27

514

2187

Alcoholic liver disease

287

945

3.19

68.08

4.8

2.8

1.89

1.59

mg/l

6.03

269

867

Acute upper respiratory infections

1991

7970

1.55

67.78

5.1

3.3

1.52

1.50

mg/l

0.26

1859

7304

Chronic periodontitis, including avohilmo

1836

7885

1.58

67.70

3.9

2.9

1.69

1.50

mg/l

14.50

1711

7220

Other diseases of intestines

2137

8000

1.54

67.55

4.6

4.5

1.56

1.41

mg/l

12.33

1988

7421

Symptoms and signs involving the circulatory and respiratory systems

2003

6470

1.57

67.53

4.8

4.2

1.50

1.40

mg/l

5.41

1854

6021

Other viral diseases, not elsewhere classified

506

2209

2.36

67.45

13.0

6.9

1.48

1.31

mg/l

4.47

478

2092

Cellulitis

538

2425

2.28

66.75

6.7

4.4

1.80

1.44

mg/l

11.83

509

2242

Dermatitis

1216

7161

1.72

66.47

5.1

3.8

1.62

1.50

mg/l

4.68

1126

6582

Codeine or tramadol medication

2130

7679

1.53

66.41

3.1

3.0

1.59

1.49

mg/l

5.64

1944

7101

Malignant neoplasm of kidney, except renal pelvis

231

677

3.57

66.14

4.8

3.2

1.85

1.70

mg/l

1.53

212

599

Enlarged lymph nodes

367

1396

2.71

66.02

4.6

3.3

1.39

1.40

mg/l

0.13

350

1278

Obesity and other hyperalimentation

1224

6989

1.71

65.86

3.5

3.8

1.83

1.42

mg/l

36.51

1118

6502

Obesity

1218

6964

1.71

65.58

3.5

3.8

1.83

1.42

mg/l

36.74

1112

6477

Viral and other specified intestinal infections

642

3005

2.11

65.21

11.1

5.0

1.49

1.25

mg/l

12.02

611

2825

Ischaemic heart disease, wide definition

1449

5462

1.67

65.18

3.7

2.8

1.85

1.49

mg/l

35.17

1333

4986

Myeloproliferative diseases

232

690

3.54

65.09

3.5

2.8

1.35

1.62

mg/l

6.48

223

620

Colitis, primary sclerosing, strict definition

10.18

64.93

5.4

4.5

1.48

1.29

mg/l

1.09

Reimbursement for rheumatic diseases

1113

6441

1.75

64.76

4.9

3.8

1.50

mg/l

0.00

1029

5914

Paroxysmal tachycardia

413

1379

2.56

64.49

4.5

4.1

1.64

1.09

mg/l

25.76

378

1293

Continuous positive airway pressure

448

1570

2.47

64.41

6.7

5.5

1.72

1.23

mg/l

21.76

409

1470

STROKE

985

3693

1.84

63.89

4.2

2.9

1.70

1.32

mg/l

31.45

908

3406

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1816

7519

1.56

63.82

4.1

3.2

1.70

1.50

mg/l

14.11

1675

6901

Hepatocellular carcinoma

135

7.74

63.53

5.5

2.5

1.74

1.76

mg/l

0.05

118

Neurological diseases, wide definition

657

1535

2.18

63.48

7.5

5.3

1.35

1.12

mg/l

11.14

624

1456

Cardiomyopathy

390

1561

2.57

63.25

5.6

3.8

1.86

1.40

mg/l

19.70

362

1420

Non-Hodgkin lymphoma, all, including Hilmo

298

1047

2.95

62.62

5.2

3.2

1.54

1.71

mg/l

2.65

277

923

Examination and observation for other reasons

1160

3869

1.76

62.59

4.8

2.8

1.53

1.46

mg/l

1.91

1092

3573

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1247

6726

1.68

62.27

3.6

3.5

1.67

1.58

mg/l

2.54

1159

6118

General examination and investigation of persons without complaint and reported diagnosis

1269

3897

1.72

62.12

6.1

2.8

1.53

1.46

mg/l

1.79

1209

3599

Finngen Rheumatological endpoints

1868

6924

1.55

61.86

3.9

1.61

1.39

mg/l

22.41

1736

6423

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

147

328

4.76

61.69

7.2

3.0

1.67

1.70

mg/l

0.15

133

284

Headache

1161

5473

1.71

61.35

5.8

3.0

1.41

1.37

mg/l

0.88

1077

5030

Syncope and collapse

813

3722

1.90

60.84

3.9

2.9

1.70

1.49

mg/l

8.64

744

3374

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1088

6390

1.73

60.71

4.8

3.1

1.83

1.53

mg/l

16.43

1012

5831

Pain in throat and chest

1616

6168

1.59

60.41

4.2

3.8

1.53

1.41

mg/l

5.75

1485

5727

Asthma, unspecified (mode), excluding more controls

903

3718

1.84

60.08

3.8

3.0

1.59

1.31

mg/l

16.64

834

3429

Benign neoplasms

1957

7138

1.53

60.05

4.6

3.8

1.57

1.44

mg/l

8.69

1833

6596

Constipation

1724

7761

1.55

59.98

4.0

4.6

1.60

1.50

mg/l

4.00

1553

7180

Acute bronchitis

853

4605

1.85

59.72

5.6

4.7

1.72

1.50

mg/l

9.03

787

4227

Other renal tubulo-interstitial diseases

129

7.50

59.36

6.2

3.1

1.90

1.10

mg/l

9.67

122

Chronic apical periodontitis

2103

8087

1.50

58.95

3.5

3.4

1.61

1.48

mg/l

9.08

1933

7454

Myeloproliferative diseases (CML excluded)

210

628

3.52

58.49

3.4

2.8

1.35

1.63

mg/l

6.32

203

564

Agranulocytosis

285

1019

2.91

58.24

8.9

4.4

1.51

1.49

mg/l

0.13

267

938

Sleep apnoea, including avohilmo

1857

7628

1.52

57.79

3.0

3.4

1.62

1.49

mg/l

7.05

1686

7066

Carcinoma in situ of skin of other and unspecified parts of face

209

630

3.47

57.35

5.3

2.4

1.98

1.81

mg/l

1.66

193

545

Iron deficiency anaemia secondary to blood loss (chronic)

354

1419

2.57

57.33

5.1

3.4

1.97

1.57

mg/l

9.19

326

1283

Inflammatory bowel disease

687

3590

1.95

57.07

4.1

1.43

1.44

mg/l

0.07

638

3340

Rare circulating lymphoid malignancy, including Hilmo

132

293

4.96

56.46

20.7

8.7

1.13

1.41

mg/l

5.16

123

266

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

254

864

3.03

56.22

4.2

2.4

1.93

1.89

mg/l

0.25

231

742

Hypothyroidism, drug reimbursement

228

484

3.39

56.19

4.4

2.9

1.60

1.06

mg/l

14.73

213

454

Exclusions for E4_PCOS_BROAD

458

2080

2.27

56.01

8.5

7.6

1.48

1.34

mg/l

2.64

425

1968

Other and unspecified dermatitis

999

5876

1.73

55.80

5.3

3.8

1.63

1.49

mg/l

5.17

926

5396

Peripheral arterial reconstruction

369

1532

2.48

55.46

4.0

2.6

2.31

1.74

mg/l

17.89

339

1346

Pain in limb

1613

7032

1.55

55.35

5.1

4.3

1.66

1.44

mg/l

16.81

1492

6522

Presence of cardiac and vascular implants and grafts

748

2960

1.91

55.34

3.2

2.3

2.05

1.54

mg/l

32.69

670

2662

725

3556

1.90

55.09

4.3

2.6

1.82

1.74

mg/l

1.64

662

3167

Abnormal findings on examination of blood, without diagnosis

962

5148

1.75

54.98

5.0

3.7

1.67

1.60

mg/l

1.56

891

4705

Acute pancreatitis

430

1920

2.30

54.62

5.1

3.1

1.80

1.55

mg/l

6.00

388

1734

Hypercalcemia

144

351

4.41

54.27

5.7

4.0

1.98

1.62

mg/l

3.35

133

319

Essential (haemorrhagic) thrombocythaemia

122

261

5.02

54.12

3.3

2.5

1.26

1.59

mg/l

4.69

117

230

Skin changes due to chronic exposure to nonionizing radiation

683

3328

1.93

54.02

4.3

2.6

1.84

1.76

mg/l

1.35

621

2951

Gingivitis and periodontal diseases

1968

6860

1.49

54.00

4.9

3.8

1.56

1.46

mg/l

5.71

1834

6295

Other inflammatory liver diseases

196

591

3.50

53.98

5.1

3.6

1.56

1.51

mg/l

0.35

185

546

DVT of lower extremities and pulmonary embolism

783

4321

1.83

53.88

3.6

2.8

1.80

1.63

mg/l

5.00

723

3890

In situ neoplasms

682

3622

1.92

53.80

4.1

2.7

1.77

1.62

mg/l

3.84

628

3255

Actinic keratosis

667

3251

1.93

53.39

4.3

2.6

1.84

1.77

mg/l

1.35

606

2879

Pulmonary heart disease, diseases of pulmonary circulation

620

3200

1.98

53.37

3.6

3.0

1.83

1.63

mg/l

5.02

575

2872

Chronic periodontitis, complicated

1031

6137

1.69

53.24

3.9

2.9

1.77

1.56

mg/l

10.89

964

5616

Contact with and exposure to communicable diseases

663

3487

1.93

53.22

7.1

5.8

1.32

1.28

mg/l

0.58

622

3320

Budesonide

309

1203

2.64

53.20

3.5

3.1

1.42

1.41

mg/l

0.04

285

1115

Other specified disorders of kidney and ureter

120

261

4.98

52.36

8.8

3.8

1.95

1.56

mg/l

3.10

113

238

5-aminosalicylic acid

455

2113

2.20

52.36

4.1

3.4

1.35

1.38

mg/l

0.33

417

1957

Pneumonia due to other infectious organisms, not elsewhere classified

116

245

5.10

52.31

6.0

3.3

1.87

1.53

mg/l

3.00

110

219

Cutaneous abscess, furuncle and carbuncle

565

2848

2.03

52.26

5.6

3.8

1.79

1.42

mg/l

14.95

538

2641

IBD patients in KELA-register

514

2507

2.10

52.11

3.8

4.2

1.39

1.41

mg/l

0.20

478

2345

Pleural effusion

336

1380

2.51

51.77

3.8

2.8

2.06

1.69

mg/l

8.27

311

1226

AV-block

348

1256

2.49

51.61

4.0

3.7

1.94

1.48

mg/l

13.73

309

1124

Acute sinusitis

967

5316

1.71

51.46

4.8

3.2

1.49

1.42

mg/l

1.71

901

4920

Congenital malformations of gallbladder, bile ducts and liver

150

7.40

51.14

17.7

13.0

1.51

1.20

mg/l

2.53

144

Cystitis

1499

5785

1.56

51.12

4.5

3.9

1.61

1.47

mg/l

7.24

1384

5303

Convulsions, not elsewhere classified

494

2363

2.11

50.72

7.6

3.6

1.54

1.36

mg/l

4.10

461

2164

Other viral diseases, not elsewhere classified

611

3185

1.95

50.41

11.5

6.1

1.42

1.31

mg/l

2.81

578

3016

Other functional intestinal disorders

898

4886

1.73

50.21

5.1

5.3

1.59

1.46

mg/l

3.87

818

4494

Squamous cell neoplasms and carcinomas of the skin

182

546

3.46

50.12

4.1

2.4

1.98

1.87

mg/l

0.66

165

465

Asthma, excluding more controls

1256

4069

1.63

50.08

3.8

3.1

1.50

1.30

mg/l

13.96

1164

3768

Viral warts

486

2359

2.11

50.02

9.2

4.7

1.64

1.35

mg/l

9.28

462

2213

Melanocytic naevi

589

3058

1.97

49.95

6.8

3.6

1.61

1.46

mg/l

4.26

563

2826

Asthma, unspecified (mode)

922

4065

1.73

49.85

3.8

3.0

1.60

1.38

mg/l

10.90

851

3737

Crohn disease

319

1306

2.52

49.61

4.3

4.7

1.44

1.41

mg/l

0.31

304

1227

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

199

637

3.26

49.56

3.1

2.9

1.84

1.63

mg/l

2.21

179

564

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

582

2982

1.97

49.43

19.0

4.6

1.29

mg/l

0.10

565

2816

Other soft tissue disorders, not elsewhere classified

1829

7309

1.48

49.34

4.9

4.4

1.61

1.44

mg/l

12.74

1688

6790

Multiple myeloma, including Hilmo

129

311

4.40

49.15

3.8

2.8

1.85

1.65

mg/l

1.52

119

271

Conduction disorders

544

2217

2.02

48.63

3.7

4.0

1.90

1.40

mg/l

24.76

493

2019

Acute pancreatitis (for exclusion)

430

2014

2.19

48.61

5.1

3.1

1.80

1.56

mg/l

5.56

388

1834

Haemorrhage from respiratory passages

666

3254

1.88

48.54

5.2

3.8

1.83

1.55

mg/l

10.02

622

2974

Inflammatory bowel disease, strict (require KELA)

514

2576

2.04

48.41

3.8

4.2

1.39

1.42

mg/l

0.39

478

2409

Amputation of ankle bones

175

5.86

48.15

5.8

2.7

2.69

1.71

mg/l

9.41

158

Seborrhoeic keratosis

434

2047

2.17

48.11

5.6

2.6

1.75

1.59

mg/l

3.05

401

1847

Cardiomyopathies, Primary/intrinsic

275

1065

2.67

48.01

5.8

3.8

1.92

1.40

mg/l

16.93

258

965

Other diseases of arteries and capillaries

214

728

3.05

47.91

5.0

3.2

2.06

1.51

mg/l

9.13

196

651

Symptoms and signs involving the skin and subcutaneous tissue

1294

8238

1.55

47.69

4.9

3.8

1.50

1.51

mg/l

0.13

1210

7560

Amyloidosis

142

6.38

47.34

3.5

2.5

2.12

1.62

mg/l

2.90

129

Secondary uncertain malignant neoplasm

269

1038

2.67

47.24

3.9

3.1

1.43

1.69

mg/l

5.50

257

916

Cardiomyopathy (excluding other)

278

1091

2.63

47.22

5.7

3.8

1.91

1.39

mg/l

17.06

261

988

Congenital malformations of the circulatory system

410

1857

2.22

46.89

9.6

9.8

1.26

1.31

mg/l

0.86

399

1770

Chronic pancreatitis

296

1204

2.54

46.79

4.8

2.9

1.81

1.55

mg/l

4.96

270

1104

Pneumocystosis

170

5.98

46.74

5.9

3.9

1.96

1.60

mg/l

2.54

155

Congenital malformations of heart and great arteries

383

1694

2.28

46.46

9.3

10.6

1.26

1.31

mg/l

0.63

373

1613

Pre-eclampsia

351

1540

2.33

46.40

3.9

2.8

1.49

1.33

mg/l

4.09

334

1442

Ulcerative colitis

524

2685

1.99

46.30

4.2

4.1

1.45

mg/l

0.05

484

2495

Lymphoid leukaemia

178

565

3.34

45.38

16.1

6.5

1.24

1.56

mg/l

6.73

164

513

Other viral hepatitis

188

615

3.21

45.35

4.4

3.4

1.42

1.35

mg/l

0.64

183

580

L01XX Other antineoplastic agents

160

475

3.55

45.27

3.5

2.9

1.37

1.69

mg/l

5.49

152

427

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

682

3301

1.82

45.16

3.6

2.9

1.49

1.37

mg/l

3.61

642

3070

Myocardial infarction

872

3630

1.71

45.00

3.7

2.7

2.08

1.51

mg/l

45.96

799

3301

Use of hypnotics and sedatives

1963

7927

1.43

44.76

3.5

3.6

1.59

1.50

mg/l

4.38

1816

7319

Retention of urine

636

2847

1.86

44.76

3.4

3.0

1.94

1.64

mg/l

11.12

567

2567

Pre-eclampsia or eclampsia

367

1674

2.24

44.19

3.9

2.8

1.51

1.35

mg/l

4.13

349

1562

Persons encountering health services for examination and investigation

1225

3906

1.59

44.11

4.4

2.8

1.48

1.46

mg/l

0.26

1138

3605

Other noninfective gastroenteritis and colitis

531

2778

1.95

44.07

5.7

6.2

1.57

1.42

mg/l

3.83

499

2584

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

772

3007

1.76

43.99

3.6

2.8

1.79

1.69

mg/l

1.96

698

2675

Pulmonary embolism

548

2898

1.93

43.98

3.4

2.7

1.80

1.63

mg/l

3.63

508

2599

Mycoses

529

2768

1.95

43.96

5.4

3.6

1.68

1.51

mg/l

3.75

491

2539

All influenza (not pneumonia)

344

1537

2.30

43.79

8.6

4.8

1.67

1.36

mg/l

7.32

325

1429

Other metabolic disorders

263

1044

2.59

43.56

6.3

4.1

1.44

1.33

mg/l

1.41

248

971

Dermatitis and eczema

2065

9158

1.41

43.40

4.5

4.1

1.55

1.47

mg/l

3.46

1909

8468

Pulmonary heart disease

548

2911

1.92

43.39

3.4

2.7

1.80

1.64

mg/l

3.33

508

2613

Other symptoms and signs involving the urinary system

246

950

2.68

43.36

5.0

4.0

1.74

1.54

mg/l

2.58

233

872

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

558

2985

1.91

43.33

2.7

2.9

1.79

1.43

mg/l

15.41

504

2796

Glucagon-like peptide-1 (GLP-1) analogues

558

2985

1.91

43.33

2.7

2.9

1.79

1.43

mg/l

15.41

504

2796

Fall on same level

2185

8607

1.40

42.68

4.3

4.5

1.57

1.43

mg/l

10.07

2013

8013

Other respiratory diseases principally affecting the interstitium

365

1689

2.22

42.63

3.6

2.9

1.87

1.69

mg/l

3.04

336

1506

Zoster [herpes zoster]

362

1670

2.22

42.56

5.7

3.2

1.80

1.58

mg/l

4.58

333

1506

Diseases of the respiratory system

1152

3652

1.60

42.39

4.3

3.3

1.52

1.39

mg/l

5.31

1070

3377

Viral hepatitis

202

716

2.95

42.21

4.3

3.5

1.42

1.39

mg/l

0.27

196

672

Other malignant neoplasms of skin (=non-melanoma skin cancer)

718

2805

1.78

42.15

3.5

2.7

1.79

1.70

mg/l

1.34

641

2487

Secondary and unspecified malignant neoplasm of lymph nodes

189

645

3.04

42.14

4.7

3.4

1.48

1.60

mg/l

1.20

180

582

Missing teeth due to accident, extraction or parodontitis

1040

6245

1.59

41.94

3.5

3.0

1.65

1.60

mg/l

1.03

957

5674

ILD, hospital admission 2, with pulmonary infections

212

772

2.84

41.86

3.6

2.7

1.78

1.61

mg/l

2.15

196

691

Major coronary heart disease event excluding revascularizations

1043

4382

1.61

41.55

3.6

2.7

2.00

1.51

mg/l

41.67

941

3983

Acute suppurative otitis media

561

2835

1.88

41.42

10.8

5.3

1.36

1.26

mg/l

2.48

536

2690

ILD, hospital admissions 3, with pneumonia sepsis

190

658

2.99

41.25

3.7

2.9

1.81

1.61

mg/l

2.37

175

577

Pregnancy hypertension

615

3066

1.82

41.03

3.6

3.0

1.48

1.35

mg/l

3.88

579

2857

Abnormal results of function studies

224

850

2.74

41.02

4.0

5.3

1.59

1.46

mg/l

1.18

206

788

SLE (Finngen)

101

232

4.62

41.01

4.3

4.9

1.66

1.37

mg/l

2.44

217

Asthma

1293

4457

1.53

40.61

3.7

3.1

1.50

1.36

mg/l

7.38

1197

4115

Vocal cord dysfunction

247

874

2.59

40.40

3.4

4.0

1.44

1.14

mg/l

6.63

235

832

Chronic viral hepatitis

159

505

3.31

40.40

4.0

3.2

1.42

1.34

mg/l

0.67

154

475

Other gastritis (incl. Duodenitis)

441

2234

2.02

40.35

4.0

3.0

1.88

1.59

mg/l

7.94

404

2031

Other diseases of pancreas

199

717

2.89

40.30

3.9

3.2

1.80

1.56

mg/l

2.87

178

651

Symptoms and signs concerning food and fluid intake

236

927

2.62

39.97

11.6

4.1

1.47

1.41

mg/l

0.55

221

847

Attention to artificial openings

110

275

4.22

39.95

9.2

5.3

1.56

1.41

mg/l

1.13

105

244

Melanocytic naevi of trunk

266

1110

2.47

39.79

7.4

3.7

1.69

1.46

mg/l

4.07

252

1029

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

411

2017

2.05

39.56

3.2

2.9

1.39

1.72

mg/l

14.93

387

1794

Pain, not elsewhere classified

487

2565

1.93

39.54

5.2

3.0

1.55

1.41

mg/l

2.85

447

2342

COPD (mode)

522

2180

1.91

39.50

2.7

1.90

1.54

mg/l

11.27

454

1961

Abnormalities of heart beat

630

3522

1.78

39.37

3.0

3.4

1.53

1.48

mg/l

0.80

556

3228

Multiple myeloma and malignant plasma cell neoplasms

134

389

3.64

39.35

3.8

3.4

1.84

1.72

mg/l

0.65

122

348

Other disorders of glucose regulation and pancreatic internal secretion

226

880

2.67

39.35

6.7

6.4

1.87

1.42

mg/l

8.99

206

815

Hypocalcemia

198

4.98

38.99

4.8

2.18

1.54

mg/l

6.34

181

Persons encountering health services for specific procedures, not carried out

185

651

2.94

38.98

4.5

3.5

1.68

1.24

mg/l

6.84

171

604

Other Crohn's disease

186

661

2.93

38.70

3.7

4.5

1.47

1.37

mg/l

0.80

178

621

Ulcerative colitis, NAS

315

1432

2.26

38.58

4.6

4.9

1.45

1.41

mg/l

0.35

294

1341

Late syphilis

115

6.59

38.51

4.9

3.1

2.08

1.51

mg/l

4.07

105

Cardiomyopathy, other and unspecified

177

613

2.99

38.47

5.0

3.7

1.87

1.39

mg/l

9.47

162

571

Other diseases of the respiratory system

408

2047

2.04

38.44

5.1

4.0

1.89

1.64

mg/l

4.93

367

1842

Other respiratory disorders and diseases

408

2047

2.04

38.44

5.1

4.0

1.89

1.64

mg/l

4.93

367

1842

Pre-eclampsia or poor fetal growth

456

2363

1.95

38.42

3.7

2.9

1.48

1.31

mg/l

4.94

432

2208

Episodal and paroxysmal disorders

2060

7608

1.39

38.36

4.2

4.7

1.48

1.45

mg/l

1.08

1898

7074

Mucosal proctocolitis

290

1277

2.34

38.36

3.5

3.8

1.44

1.41

mg/l

0.25

271

1199

Respiratory insufficiency

173

590

3.02

38.32

5.3

2.9

2.02

1.57

mg/l

5.78

154

525

Protozoal diseases

105

264

4.29

38.20

6.0

3.6

1.92

1.56

mg/l

3.13

244

Nonischemic cardiomyopathy

224

879

2.63

38.18

4.9

3.8

1.90

1.46

mg/l

9.63

209

800

Hypothyroidism, other/unspecified

1542

7064

1.45

38.15

3.7

3.6

1.56

1.51

mg/l

1.24

1413

6515

Sleep disorders (combined)

2026

7712

1.39

38.11

3.1

3.9

1.56

1.48

mg/l

3.36

1856

7143

Diseases of oral cavity, salivary glands and jaws

1068

3509

1.58

38.08

5.0

2.7

1.58

1.51

mg/l

1.65

987

3176

Malignant neoplasm of skin

772

3166

1.69

38.07

3.5

2.8

1.76

1.68

mg/l

1.37

694

2819

Fentanyl

205

772

2.72

37.73

3.8

2.9

1.65

1.63

mg/l

0.11

189

689

Viral pneumonia (unknown virus, not influenza)

185

665

2.90

37.72

5.9

4.8

1.85

1.48

mg/l

5.66

178

616

Diabetic neuropathy

319

1471

2.25

37.70

4.7

3.2

2.07

1.80

mg/l

4.72

290

1322

Cerebrovascular diseases

1277

6061

1.50

37.59

4.0

3.2

1.79

1.58

mg/l

12.43

1153

5527

Hypothyreosis and Thyroxine purchase for inclusion criteria

1579

7271

1.44

37.46

3.7

3.6

1.55

1.51

mg/l

1.02

1444

6699

Asthma (only as main-diagnosis), excluding more controls

1097

4069

1.55

37.36

3.8

3.1

1.48

1.30

mg/l

10.46

1016

3768

Lung transplant status

8.16

37.26

10.0

8.4

1.90

1.44

mg/l

3.05

Lung transplantation

8.15

37.24

10.0

8.4

1.90

1.44

mg/l

3.05

Pain (limb, back, neck, head abdominally)

1434

4908

1.48

37.22

5.9

4.2

1.50

1.43

mg/l

2.39

1335

4537

Biguanides

1611

6912

1.43

37.12

2.7

3.0

1.69

1.46

mg/l

19.63

1442

6392

Late syphilis

133

5.92

37.09

4.7

3.1

2.08

1.51

mg/l

4.19

119

Other arrhythmias

1039

5094

1.55

37.08

3.2

3.4

1.59

1.34

mg/l

16.82

937

4718

Other disorders of white blood cells

153

501

3.21

36.98

5.8

4.1

1.61

1.54

mg/l

0.43

143

461

Other infectious diseases

184

669

2.86

36.63

5.0

4.0

2.11

1.59

mg/l

6.45

167

600

Other disorders of bladder

252

1067

2.43

36.52

3.2

2.8

1.67

1.61

mg/l

0.44

208

964

Other diseases of hard tissues of teeth

1046

3476

1.57

36.51

5.7

2.7

1.53

1.51

mg/l

0.34

974

3149

Syphilis

100

252

4.30

36.35

3.9

2.9

1.95

1.48

mg/l

2.90

235

Syphilis

100

252

4.30

36.35

3.9

2.9

1.95

1.48

mg/l

2.90

235

Acquired absence of organs, not elsewhere classified

6.99

36.06

4.5

3.1

1.88

1.45

mg/l

2.27

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

385

1939

2.03

35.98

3.9

4.0

1.37

1.43

mg/l

0.97

355

1815

Carcinoma in situ of skin of upper limb, including shoulder

196

4.76

35.60

5.5

2.9

2.04

1.85

mg/l

0.99

174

Gastroduodenal ulcer

476

2571

1.88

35.57

4.3

2.9

1.97

1.67

mg/l

7.32

439

2313

Other disorders of skin and subcutaneous tissue, not elsewhere classified

285

1286

2.27

35.53

3.5

3.3

1.93

1.52

mg/l

8.74

262

1173

Ulcerative colitis (strict definition, require KELA)

357

1763

2.07

35.27

4.0

4.1

1.35

1.42

mg/l

1.10

329

1647

Diverticular disease of intestine

1207

5199

1.50

35.13

3.4

2.8

1.75

1.55

mg/l

11.74

1106

4732

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

349

1713

2.09

35.07

4.0

4.2

1.35

1.42

mg/l

1.02

321

1600

6-mercaptopurine

110

303

3.85

35.00

16.4

5.9

1.06

1.27

mg/l

2.95

103

284

Diseases of the musculoskeletal system and connective tissue

1104

3638

1.54

34.63

7.0

5.4

1.41

1.30

mg/l

4.46

1043

3418

Mood disorders, excluding more controls

1673

7162

1.41

34.61

3.6

3.2

1.50

1.48

mg/l

0.51

1546

6624

Other arthritis (FG)

557

3189

1.77

34.61

4.4

3.8

1.74

1.41

mg/l

12.32

517

2930

Other infectious diseases

204

804

2.62

34.60

5.1

4.0

2.07

1.55

mg/l

7.12

185

729

Adrenocortical insufficiency

113

320

3.75

34.59

8.1

5.3

1.66

1.44

mg/l

1.29

108

296

Cholelithiasis, broad definition with cholecystitis

1409

6622

1.44

34.59

3.6

2.9

1.69

1.53

mg/l

8.68

1303

6024

Bacterial pneumoniae

705

3772

1.67

34.55

5.3

3.5

1.78

1.48

mg/l

13.15

640

3433

Suppurative and unspecified otitis media

692

3708

1.68

34.49

9.1

4.6

1.41

1.33

mg/l

1.98

654

3487

Nonsuppurative otitis media

478

2250

1.87

34.48

9.4

5.7

1.36

1.29

mg/l

1.28

459

2117

Other embolism and thrombosis

261

1151

2.33

34.42

4.8

3.0

1.85

1.51

mg/l

4.51

240

1041

Calcific aortic valvular stenosis

512

2783

1.81

34.06

3.4

3.1

2.09

1.75

mg/l

9.29

456

2457

Calcific aortic valvular stenosis, operated

512

2783

1.81

34.06

3.4

3.1

2.09

1.75

mg/l

9.29

456

2457

Any mental disorder

2022

7472

1.36

33.91

4.8

3.7

1.52

1.48

mg/l

1.71

1871

6918

Sulfonylureas

575

2637

1.76

33.65

3.1

2.7

2.27

1.67

mg/l

30.64

502

2377

Hernia of abdominal wall

831

5312

1.59

33.62

5.2

3.3

1.74

1.55

mg/l

7.73

769

4861

1127

6743

1.49

33.51

4.0

3.3

1.66

1.51

mg/l

6.47

1039

6227

Disorders of the thyroid gland

1626

7628

1.40

33.28

3.7

3.6

1.56

1.51

mg/l

1.42

1496

7035

Alcohol use disorder, Swedish definition

1024

6274

1.51

33.26

3.9

3.2

1.68

1.53

mg/l

6.20

945

5788

Disorders of sclera, cornea, iris and ciliary body

977

6484

1.52

33.23

4.3

3.6

1.63

1.49

mg/l

5.74

916

5965

Systemic lupus erythematosus

101

272

3.93

33.20

4.3

4.1

1.66

1.47

mg/l

1.23

252

Anxiety disorders, excluding more controls

1464

6752

1.42

32.94

5.5

3.5

1.49

1.44

mg/l

1.30

1356

6263

Phlebitis and thrombophlebitis (not including DVT)

406

2148

1.93

32.77

4.5

2.9

1.85

1.52

mg/l

6.97

373

1964

Other CVD

364

1857

2.00

32.75

4.2

3.1

1.89

1.70

mg/l

3.23

326

1650

Candidiasis

268

1221

2.25

32.69

5.8

3.6

1.73

1.47

mg/l

3.87

250

1127

Diseases of pulp and periapical tissues and dental caries

1226

4276

1.48

32.65

5.2

3.4

1.58

1.48

mg/l

3.77

1135

3907

Calcific aortic valvular stenosis, diagnosis (helper)

504

2762

1.80

32.63

3.2

2.8

2.11

1.76

mg/l

9.78

449

2436

Operations 2 for CAVS

504

2762

1.80

32.63

3.2

2.8

2.11

1.76

mg/l

9.78

449

2436

Calcific aortic valvular stenosis, including rheumatic fever

506

2775

1.79

32.57

3.2

2.8

2.11

1.76

mg/l

9.80

451

2446

Otitis media, unspecified

286

1228

2.21

32.55

14.3

8.0

1.28

1.21

mg/l

1.11

274

1175

1073

6571

1.49

32.46

3.9

3.3

1.66

1.52

mg/l

5.56

989

6065

Benign neoplasm of colon, rectum, anus and anal canal

1046

6116

1.50

32.45

3.4

2.8

1.80

1.61

mg/l

8.59

966

5525

Elevated blood glucose level

200

807

2.57

32.40

7.3

5.3

1.71

1.47

mg/l

2.99

180

740

Dental caries, including avohilmo

1356

4823

1.45

32.39

5.0

3.4

1.59

1.48

mg/l

3.85

1264

4404

Cholelithiasis

1342

6488

1.44

32.36

3.6

2.9

1.69

1.53

mg/l

8.25

1239

5896

Injuries to the head

2014

9259

1.35

32.25

4.3

1.56

1.46

mg/l

5.23

1836

8591

Decubitus ulcer and pressure area

139

465

3.11

32.25

5.2

3.0

2.37

1.67

mg/l

7.27

127

410

Malignant neoplasm of digestive organs

584

2699

1.73

32.20

4.3

2.8

1.70

1.71

mg/l

0.16

537

2397

Paralytic ileus and intestinal obstruction

463

2566

1.83

32.13

4.6

3.4

1.73

1.59

mg/l

2.60

433

2305

Bacterial pneumonia (organism specified)

800

4632

1.59

32.03

5.4

3.8

1.82

1.57

mg/l

10.31

730

4213

Osteoporosis with pathological fracture (FG)

143

490

3.02

31.74

4.0

3.0

1.70

1.55

mg/l

1.24

132

435

Other disorders of adrenal gland

136

456

3.14

31.70

8.1

7.0

1.60

1.36

mg/l

1.94

131

424

Neurological diseases

1627

5893

1.40

31.61

5.5

4.8

1.44

1.39

mg/l

1.74

1523

5515

Hypothyroidism, strict autoimmune, 3 medication purchases required

1379

6593

1.42

31.48

3.5

3.4

1.57

1.51

mg/l

1.51

1259

6068

Disorders of ocular muscles, binocular movement, accommodation and refraction

872

5671

1.54

31.34

8.0

5.0

1.41

1.40

mg/l

0.09

804

5290

Non-Hodgkin lymphoma, all

104

297

3.66

31.27

2.2

2.7

1.59

1.73

mg/l

0.83

255

Asthma (mode)

1221

4493

1.47

31.26

3.7

3.1

1.48

1.36

mg/l

5.78

1138

4148

Hypotension

313

1543

2.07

31.07

3.9

2.6

1.90

1.75

mg/l

2.34

277

1360

Myocardial infarction, without ST-elevation

684

3865

1.63

31.06

3.5

2.7

2.18

1.69

mg/l

27.32

630

3451

Pericarditis

252

3.92

31.04

8.0

3.7

1.88

1.41

mg/l

3.81

234

Other specified/unspecified arthritis

490

2795

1.78

30.94

4.4

3.9

1.73

1.43

mg/l

9.50

457

2559

Non-follicular lymphoma

207

867

2.47

30.92

6.3

3.5

1.52

1.65

mg/l

1.34

192

780

Benzodiazepine use

1734

8814

1.36

30.82

3.1

3.5

1.56

1.51

mg/l

1.61

1567

8148

Intestinal stricture

551

3253

1.72

30.78

4.7

3.4

1.73

1.61

mg/l

2.27

515

2925

Diseases of middle ear and mastoid

1037

5757

1.49

30.69

6.9

4.0

1.43

1.41

mg/l

0.32

977

5357

Zoster [herpes zoster]

805

5130

1.56

30.67

4.5

3.0

1.69

1.56

mg/l

3.92

733

4647

Bacterial pneumonia, not elsewhere classified

653

3531

1.65

30.63

5.2

3.5

1.79

1.48

mg/l

12.42

594

3210

Other antidepressants

1839

6972

1.36

30.51

3.0

3.4

1.49

1.53

mg/l

0.99

1681

6448

Speech and linguistic disorders, excluding more controls

227

933

2.36

30.49

18.3

9.8

1.22

1.18

mg/l

0.59

217

893

Falls/tendency to fall

2010

7546

1.34

30.48

4.2

4.5

1.52

1.43

mg/l

4.54

1847

7034

Postprocedural endocrine and metabolic disorders, not elsewhere classified

214

913

2.40

30.44

4.8

3.4

1.42

1.35

mg/l

0.63

201

844

Vasculitis limited to skin, not elsewhere classified

203

4.31

30.42

3.9

1.79

1.57

mg/l

0.93

182

Other or unspecified ileus, impaction or obstruction

342

1753

1.99

30.35

4.6

3.2

1.75

1.60

mg/l

2.23

316

1571

Cough

723

4328

1.60

30.31

6.7

4.7

1.47

1.43

mg/l

0.78

669

3992

Other interstitial pulmonary diseases

287

1386

2.12

30.21

3.4

2.9

1.76

1.71

mg/l

0.53

265

1233

Misadventures to patients during surgical and medical care

271

1281

2.17

30.16

4.3

3.1

1.87

1.52

mg/l

6.05

249

1174

Interstitial lung disease

287

1393

2.11

29.82

3.4

2.9

1.76

1.71

mg/l

0.45

265

1237

Interstitial lung disease endpoints

287

1393

2.11

29.82

3.4

2.9

1.76

1.71

mg/l

0.45

265

1237

Other and unspecified vasculitis limited to skin

189

4.42

29.81

4.0

3.9

1.83

1.59

mg/l

0.95

169

Procreative management

685

3572

1.62

29.75

7.2

6.1

1.25

1.33

mg/l

2.57

650

3382

ILD, hospital admissions

283

1371

2.11

29.56

3.4

3.0

1.77

1.71

mg/l

0.53

262

1219

Ulcerative ileocolitis

114

359

3.34

29.51

4.2

2.9

1.45

1.46

mg/l

0.07

106

333

Left ventricular outflow tract obstruction (LVOTO), broad definition

261

1232

2.19

29.46

7.2

7.0

1.57

1.37

mg/l

2.50

244

1162

Noninfectious colitis NAS

281

1360

2.12

29.44

4.8

5.6

1.62

1.44

mg/l

2.88

264

1264

Diseases of the ear and mastoid process

2082

7918

1.33

29.42

4.8

3.6

1.49

1.47

mg/l

0.57

1931

7347

Dental operations

1081

3768

1.49

29.35

4.0

2.8

1.60

1.53

mg/l

1.62

996

3424

Myocardial infarction, strict

763

3471

1.58

29.34

3.6

2.7

2.04

1.52

mg/l

35.50

692

3151

Disorders of psychological development

325

1540

2.01

29.06

15.5

9.9

1.18

mg/l

0.01

312

1474

Dysphagia

427

2385

1.82

29.01

3.9

3.0

1.61

1.58

mg/l

0.20

392

2156

Osteonecrosis

142

511

2.89

28.98

5.6

3.0

1.71

1.56

mg/l

1.09

134

468

Other coagulation defects

164

635

2.67

28.95

4.9

4.5

1.58

1.49

mg/l

0.58

154

593

Cardiodefibrillation

622

3844

1.64

28.89

3.2

2.9

1.89

1.68

mg/l

7.21

567

3456

ILD, hospital admissions 1, main diag only

259

1229

2.16

28.62

3.5

3.0

1.79

1.70

mg/l

0.95

238

1103

SLE, strict definition

272

3.69

28.60

4.4

3.6

1.69

1.46

mg/l

1.59

252

SLE, ICD10

272

3.69

28.60

4.4

3.6

1.69

1.46

mg/l

1.59

252

Disorders of thyroid, IBD co-morbidities

270

891

2.16

28.23

3.1

3.0

1.60

1.18

mg/l

11.57

247

836

Psychiatric diseases

1819

6809

1.35

28.22

4.8

3.9

1.49

1.48

mg/l

0.26

1673

6317

Mood [affective] disorders

1786

8693

1.34

28.14

3.6

1.48

mg/l

0.07

1650

8036

Other diseases of intestine

271

1316

2.11

28.12

5.4

3.3

1.77

1.54

mg/l

3.75

250

1191

Cystic disease of liver

8.38

28.05

9.6

3.3

1.88

1.54

mg/l

1.22

Mood disorders

1788

8697

1.34

27.99

3.6

1.49

1.48

mg/l

0.11

1652

8038

Other skin changes

337

1771

1.94

27.93

5.1

3.7

1.76

1.61

mg/l

2.16

316

1602

Thiazolidinediones

218

977

2.29

27.82

3.0

2.9

2.08

1.58

mg/l

8.56

191

900

Valvular operations

266

1288

2.11

27.80

5.1

1.81

1.39

mg/l

8.66

246

1179

Asthma (only as main-diagnosis)

1111

4457

1.45

27.72

3.8

3.1

1.48

1.36

mg/l

4.82

1027

4115

Intestinal malabsorption

121

410

3.09

27.65

7.1

4.1

1.71

1.46

mg/l

1.90

110

381

Other and unspecified local infections of skin and subcutaneous tissue

213

949

2.31

27.64

9.2

5.1

1.86

1.44

mg/l

5.99

199

878

Crohn's disease of large intestine

135

486

2.90

27.61

4.2

4.5

1.52

1.39

mg/l

0.99

127

455

Drug-induced neutropenia

157

610

2.67

27.60

4.1

3.3

1.51

1.58

mg/l

0.47

148

558

Angina pectoris

894

3992

1.51

27.34

3.3

2.7

1.84

1.50

mg/l

19.16

806

3619

Gastro-oesophageal reflux disease

1142

6973

1.42

27.29

3.6

3.8

1.61

1.49

mg/l

4.62

1055

6411

Open wound of lower leg

308

1584

1.99

27.28

4.8

1.85

1.48

mg/l

8.64

291

1458

Infections with a predominantly sexual mode of transmission

508

3029

1.70

27.20

3.7

3.3

1.51

1.36

mg/l

3.30

470

2850

Disorders of vitreous body

797

5110

1.52

27.09

3.8

2.9

1.80

1.60

mg/l

7.09

729

4639

Acidosis

156

4.60

26.99

5.3

4.9

2.20

1.47

mg/l

7.28

140

Cardiac arrest

119

337

3.10

26.93

5.0

2.8

2.07

1.17

mg/l

12.74

106

311

COPD-related respiratory insufficiency

224

1029

2.23

26.91

3.3

2.7

2.15

1.74

mg/l

6.33

197

920

Stroke, excluding SAH

985

4949

1.47

26.77

3.8

3.0

1.85

1.63

mg/l

9.89

886

4485

Diagnoses used for exclusion with ILD

451

2626

1.74

26.61

3.7

3.1

1.74

1.60

mg/l

2.27

398

2383

Other and unspecified disorders of white blood cells

108

351

3.23

26.58

6.4

4.2

1.54

1.56

mg/l

0.12

101

320

Malnutrition

259

3.75

26.56

14.0

12.6

1.37

mg/l

0.02

241

Hypoparathyroidism

276

3.54

26.51

3.9

4.0

1.73

1.48

mg/l

1.42

251

Abnormal findings on diagnostic imaging of lung

787

5016

1.52

26.51

3.3

3.0

1.76

1.65

mg/l

2.62

730

4515

Other hearing loss

458

2628

1.73

26.19

4.0

3.0

1.79

1.70

mg/l

1.07

409

2371

Haemorrhage, not elsewhere classified

278

3.49

26.13

5.7

3.0

2.28

1.57

mg/l

5.41

244

Viral pneumonia (known virus, not influenza)

266

3.62

26.04

7.0

9.0

1.84

1.48

mg/l

2.43

243

Disorders of vitreous body and globe

814

5255

1.50

26.04

3.9

2.9

1.80

1.60

mg/l

7.11

746

4767

Depression

1651

8416

1.34

25.99

3.7

1.48

1.47

mg/l

0.29

1524

7797

Disorders of skin appendages

832

5622

1.49

25.92

5.3

4.0

1.55

1.42

mg/l

4.32

785

5219

Candidiasis

475

2825

1.71

25.90

4.6

3.7

1.61

1.47

mg/l

2.82

442

2605

Hyperaldosteronism

228

3.82

25.90

2.9

3.6

1.64

1.58

mg/l

0.18

209

Hypoglycaemia, other or unspecified

173

727

2.47

25.82

6.5

6.9

1.84

1.43

mg/l

5.86

158

676

Other local infections of skin and subcutaneous tissue

219

1015

2.22

25.82

9.1

5.0

1.84

1.44

mg/l

5.70

205

942

Benign neoplasm: Colon

865

5630

1.48

25.75

3.5

2.8

1.83

1.64

mg/l

7.91

799

5081

Cyst of kidney

150

590

2.63

25.73

3.8

2.5

1.92

1.60

mg/l

3.69

141

529

Presbycusis

232

1088

2.15

25.67

3.3

2.4

1.86

mg/l

0.01

197

945

Gastric ulcer

311

1641

1.93

25.45

4.1

2.8

1.93

1.68

mg/l

3.97

288

1475

Ventral hernia

420

2435

1.75

25.22

4.9

3.0

1.82

1.57

mg/l

6.75

387

2215

Disorders of refraction and accommodation

521

3187

1.65

25.17

10.1

6.4

1.39

1.34

mg/l

0.68

488

3010

Basal cell carcinoma, including avohilmo

643

2817

1.59

25.13

3.5

2.7

1.77

1.71

mg/l

0.80

574

2497

Stroke, including SAH

1031

5256

1.44

25.06

3.8

3.1

1.84

1.62

mg/l

10.51

929

4768

Benign neoplasm of mouth and pharynx

211

975

2.22

25.04

3.7

3.2

1.34

1.56

mg/l

4.14

199

893

Anxiety disorders

1555

8132

1.34

25.03

5.4

3.8

1.48

1.44

mg/l

1.19

1443

7561

Carcinoma in situ of skin

161

665

2.49

24.86

4.7

2.5

1.95

1.71

mg/l

1.96

149

581

Primary hyperparathyroidism

197

888

2.28

24.84

3.6

2.8

1.84

1.59

mg/l

3.33

182

809

Arthropathies

1655

6312

1.34

24.63

4.2

4.7

1.51

1.37

mg/l

9.26

1538

5882

Other and unspecified tonsillitis

622

3345

1.58

24.59

7.1

4.0

1.37

1.30

mg/l

1.30

607

3155

Neurotic, stress-related and somatoform disorders

1536

8073

1.34

24.58

5.5

3.8

1.47

1.43

mg/l

1.03

1424

7514

Soft tissue disorders

1886

7454

1.31

24.51

5.0

4.5

1.52

1.43

mg/l

4.44

1746

6924

Chronic ulcer of skin, not elsewhere classified

141

551

2.64

24.49

3.9

2.6

2.16

1.57

mg/l

8.01

129

487

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

132

501

2.70

24.22

3.8

2.8

1.45

1.23

mg/l

2.74

125

473

Melanocytic naevi, other sites/unspecified

165

699

2.43

24.12

7.3

3.8

1.67

1.46

mg/l

2.18

157

648

Other external causes of accidental injury

1463

5434

1.36

24.03

4.2

4.5

1.53

1.43

mg/l

4.51

1350

5064

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

429

2247

1.73

24.00

12.0

8.0

1.23

1.18

mg/l

0.90

418

2151

Kidney diseases associated to Fabry's disease

52.45

23.98

4.7

2.8

1.36

1.05

mg/l

—

Hernia

1602

8138

1.33

23.96

4.6

3.7

1.60

1.48

mg/l

6.12

1480

7498

Myocarditis

324

3.15

23.88

3.7

2.4

1.69

1.06

mg/l

8.59

300

Other symptoms and signs involving the digestive system and abdomen

287

1507

1.94

23.87

6.1

3.8

1.56

1.45

mg/l

1.46

267

1376

Nonalcoholic fatty liver disease

201

930

2.22

23.85

3.2

3.6

1.58

1.44

mg/l

1.32

182

874

Asthma-related infections

1031

7220

1.41

23.73

4.9

4.8

1.55

1.48

mg/l

1.83

959

6662

Asthma, hospital admission 2, infections

1031

7220

1.41

23.73

4.9

4.8

1.55

1.48

mg/l

1.83

959

6662

Clear cell adenocarcinoma of kidney

101

338

3.11

23.61

2.6

2.7

1.88

1.63

mg/l

2.01

300

Basal cell carcinoma

612

2705

1.58

23.54

3.5

2.7

1.78

1.72

mg/l

0.81

545

2391

Acute and subacute iridocyclitis

343

1917

1.82

23.46

3.9

3.5

1.66

1.49

mg/l

2.98

317

1768

Malignant neoplasm of respiratory system and intrathoracic organs

318

1430

1.88

23.43

3.4

2.9

1.41

1.81

mg/l

15.71

302

1251

Other systemic involvement of connective tissue (FG)

389

2222

1.75

23.40

3.1

1.64

1.46

mg/l

3.64

351

2011

Retinal detachments and breaks

572

3655

1.58

23.39

3.8

2.7

1.83

1.60

mg/l

6.06

519

3310

Sequelae with surgical and medical care as external cause

354

2000

1.80

23.35

4.5

3.3

1.90

1.58

mg/l

6.59

328

1825

Asthma-related pneumonia

639

4180

1.54

23.30

5.3

4.7

1.72

1.55

mg/l

4.33

585

3815

Asthma, hospital admissions 3, pneumonia

640

4188

1.54

23.29

5.2

4.7

1.72

1.55

mg/l

4.28

586

3821

Asthma-related pneumonia or sepsis

640

4188

1.54

23.29

5.2

4.7

1.72

1.55

mg/l

4.28

586

3821

Unknown and unspecified causes of morbidity

137

542

2.59

23.15

4.8

3.0

1.78

1.42

mg/l

3.90

129

492

Certain conditions originating in the perinatal period

254

1148

2.03

22.99

15.9

11.7

1.20

1.10

mg/l

2.15

248

1110

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

284

1507

1.92

22.91

2.8

1.50

1.72

mg/l

3.96

263

1332

Infections with a predominantly sexual mode of transmission

631

3846

1.54

22.89

3.9

3.5

1.45

1.34

mg/l

3.00

589

3614

Testicular dysfunction

109

389

2.95

22.89

2.8

3.0

1.42

1.40

mg/l

0.10

100

372

Hypoplasia of dental enamel, prenatal

111

11.47

22.88

59.1

16.4

1.36

0.99

mg/l

4.26

111

Depression or dysthymia

1197

4801

1.39

22.84

3.5

3.6

1.51

mg/l

0.02

1094

4444

Other endocrine disorders

199

899

2.23

22.83

21.2

13.6

1.39

1.14

mg/l

4.73

188

867

Sphingolipidosis, other/unspecified

40.82

22.68

4.7

3.0

1.36

1.04

mg/l

0.73

Sequelae of external causes of morbidity and mortality

431

2594

1.69

22.59

4.6

3.5

1.85

1.54

mg/l

7.73

399

2372

Other pleural conditions

188

865

2.23

22.58

3.9

3.2

2.14

1.67

mg/l

6.84

174

761

Vitamin deficiency

112

408

2.85

22.45

6.0

4.3

1.55

1.52

mg/l

0.18

105

377

Vitamin deficiency, wide

112

408

2.85

22.45

6.0

4.3

1.55

1.52

mg/l

0.18

105

377

Iridocyclitis

397

2343

1.72

22.43

4.0

3.6

1.64

1.49

mg/l

3.06

369

2158

Early onset COPD, excluding more controls

324

1802

1.82

22.41

2.9

2.8

1.78

1.47

mg/l

5.69

289

1640

Arterial embolism and thrombosis

118

441

2.76

22.40

4.9

2.8

2.24

1.66

mg/l

5.21

106

381

Single ventricle heart

14.50

22.38

10.7

27.9

1.06

1.05

mg/l

0.08

Caries of enamel

1515

8316

1.32

22.37

6.7

3.5

1.41

1.45

mg/l

1.46

1432

7710

Later onset COPD, excluding more controls

310

1298

1.87

22.34

2.4

2.5

2.04

1.67

mg/l

6.73

266

1140

Malignant neoplasm of gum, including Hilmo

6.55

22.19

2.4

2.2

1.11

1.55

mg/l

4.25

Myelodysplastic syndrome, including Hilmo

185

3.85

22.08

3.2

3.4

1.46

1.70

mg/l

1.73

159

Other ulcerative colitis

134

539

2.57

22.04

5.0

3.9

1.43

1.45

mg/l

0.05

122

502

Collagenous colitis

179

817

2.25

22.00

4.5

4.2

1.56

1.52

mg/l

0.28

167

751

DVT of lower extremities

315

1752

1.83

21.91

3.9

2.7

1.82

1.58

mg/l

4.04

291

1579

Abnormal findings on diagnostic imaging of other body structures

242

1238

2.00

21.87

3.7

3.4

1.58

1.54

mg/l

0.29

225

1130

Ischaemic Stroke, excluding all haemorrhages

889

4647

1.44

21.87

3.6

3.0

1.88

1.65

mg/l

8.88

796

4204

Endocrine disorders, other/unspecified

151

4.23

21.87

5.1

3.2

1.78

1.44

mg/l

1.60

138

Crohn's disease of small intestine

150

639

2.42

21.73

3.7

4.5

1.48

1.40

mg/l

0.59

143

601

Other congenital malformations

222

1112

2.06

21.48

8.7

10.8

1.32

1.25

mg/l

0.62

211

1069

Intracranial trauma

994

5017

1.40

21.35

4.2

4.6

1.57

1.37

mg/l

10.21

914

4699

Erosion of teeth , including avohilmo

443

2733

1.64

21.12

10.3

4.5

1.51

1.39

mg/l

2.43

417

2570

Anterior Iridocyclitis

353

2059

1.74

20.88

4.1

3.6

1.65

1.49

mg/l

2.58

327

1901

Herpesviral [herpes simplex] infections

211

1046

2.06

20.88

6.3

3.9

1.68

1.44

mg/l

3.10

201

968

Neuromuscular dysfunction of bladder

171

783

2.24

20.85

4.3

3.3

1.60

1.52

mg/l

0.59

155

708

Caries of dentine, including avohilmo

1398

5387

1.33

20.71

4.6

4.3

1.59

1.47

mg/l

5.57

1305

4947

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

188

897

2.15

20.68

6.2

3.4

1.77

1.55

mg/l

2.32

172

818

Disorders of magnesium metabolism

6.66

20.52

3.5

2.9

1.85

1.46

mg/l

1.17

Mixed hyperlipidaemia

313

3.02

20.32

3.4

2.6

1.96

1.55

mg/l

2.44

287

External causes of morbidity and mortality

1161

4276

1.37

20.29

4.5

4.6

1.48

1.39

mg/l

3.12

1083

3988

Accidents

1430

5434

1.33

20.25

4.2

4.5

1.52

1.43

mg/l

3.76

1322

5064

Hepatomegaly and splenomegaly, not elsewhere classified

5.27

19.96

8.4

3.2

1.57

1.43

mg/l

0.46

Dilated cardiomyopathy

232

1212

1.96

19.86

4.7

3.5

1.97

1.63

mg/l

6.48

216

1108

Umbilical hernia

482

3089

1.58

19.63

5.4

3.3

1.69

1.52

mg/l

4.14

447

2852

Hyperkinetic disorders, excluding more controls

225

1114

1.97

19.55

11.4

7.5

1.19

1.10

mg/l

1.54

220

1077

Hypopituitarism

188

921

2.11

19.47

9.8

8.6

1.32

1.27

mg/l

0.42

175

875

Extreme obesity with alveolar hypoventilation

333

2.91

19.35

2.7

2.8

2.10

1.52

mg/l

4.33

307

Fracture of lumbar spine and pelvis

352

2093

1.70

19.28

3.6

3.0

1.85

1.65

mg/l

2.85

317

1873

Other complications of surgical and medical care, not elsewhere classified

176

841

2.14

19.27

4.8

3.8

1.58

1.41

mg/l

2.10

166

774

Problems related to lifestyle

188

921

2.08

19.23

3.2

3.0

1.59

1.34

mg/l

3.08

167

852

Personal history of other diseases and conditions

219

1128

1.97

19.22

10.2

5.6

1.30

1.10

mg/l

3.41

211

1076

Immunodeficiencies

123

509

2.52

19.21

12.0

7.0

1.57

1.41

mg/l

1.22

117

475

Neovascular glaucoma

340

2.87

19.18

5.3

3.9

1.90

1.64

mg/l

2.06

310

Injuries to the abdomen, lower back, lumbar spine and pelvis

656

4455

1.47

19.13

3.8

1.70

1.53

mg/l

4.04

603

4057

Disorders of tooth development and eruption

284

1279

1.82

19.08

11.3

3.0

1.31

1.29

mg/l

0.19

277

1185

Substance abuse, excluding more controls

939

5841

1.38

18.93

3.6

3.1

1.57

1.50

mg/l

1.66

860

5408

Diseases of the myoneural junction and muscle

222

1162

1.95

18.87

3.8

4.4

1.91

1.56

mg/l

4.15

200

1066

Alport

29.12

18.87

8.6

12.2

1.83

1.24

mg/l

0.98

Urolithiasis

540

3580

1.53

18.83

4.1

3.2

1.63

1.62

mg/l

0.02

496

3254

Other specified congenital malformation syndromes affecting multiple systems

316

3.07

18.82

9.8

18.0

1.37

1.13

mg/l

1.35

310

Other diseases of lip and oral mucosa

639

4384

1.47

18.76

4.7

3.8

1.41

1.51

mg/l

2.41

601

4019

Pruritus

189

940

2.05

18.58

5.7

4.0

1.79

1.47

mg/l

3.58

171

857

Testicular hypofunction

342

2.86

18.54

2.9

1.42

1.41

mg/l

0.03

326

Other blood glucose lowering drugs, excl. Insulins

257

1418

1.84

18.46

2.9

2.05

1.59

mg/l

9.40

231

1296

Rash and other nonspecific skin eruption

184

910

2.07

18.44

6.9

5.3

1.56

1.51

mg/l

0.28

170

834

Other arterial embolism and thrombosis

204

3.43

18.43

5.0

2.6

2.19

1.65

mg/l

2.80

177

Obesity related asthma

571

3847

1.50

18.42

3.3

3.6

1.70

1.50

mg/l

5.34

522

3547

Injuries to the knee and lower leg

2019

9013

1.25

18.38

3.9

4.2

1.55

1.47

mg/l

3.50

1873

8323

Acute pharyngitis

291

1654

1.77

18.37

10.4

5.0

1.27

mg/l

0.07

277

1562

Fibrosis of liver

5.99

18.36

7.4

3.7

1.61

1.42

mg/l

0.72

Speech and linguistic disorders

251

1327

1.87

18.27

18.6

11.3

1.20

1.17

mg/l

0.46

240

1278

Diseases of pulp and periapical tissues, including avohilmo

1823

7507

1.26

18.16

3.6

4.4

1.56

1.45

mg/l

6.11

1672

6953

Systemic lupus erythematosus, unspecified

242

3.20

18.15

3.9

3.7

1.60

1.46

mg/l

0.69

225

776

5512

1.41

17.97

5.5

5.4

1.47

1.42

mg/l

0.95

729

5126

Other diseases of stomach and duodenum

122

517

2.42

17.95

4.9

3.0

1.89

1.62

mg/l

2.15

107

470

Disorders of eyelid, lacrimal system and orbit

1370

8064

1.30

17.89

4.1

3.7

1.55

1.53

mg/l

0.37

1254

7408

Other ill-defined and unspecified causes of mortality

144

656

2.25

17.88

3.4

2.9

1.98

1.74

mg/l

1.66

132

573

Aortic aneurysm

369

2228

1.65

17.78

3.3

2.7

1.91

1.65

mg/l

5.99

341

1986

Sarcoidosis

232

1259

1.88

17.66

3.3

3.1

1.73

1.50

mg/l

3.01

213

1166

Glaucoma secondary to other eye disorders

356

2.74

17.60

5.3

3.9

1.90

1.68

mg/l

1.53

320

KRA_PSY_EATING, excluding more controls

135

598

2.29

17.60

6.4

5.7

1.21

1.13

mg/l

0.59

120

573

Hypertrophic cardiomyopathy

101

398

2.64

17.52

4.9

4.2

1.72

1.64

mg/l

0.42

361

Other disorders of lacrimal gland

524

3505

1.51

17.52

4.8

3.2

1.53

1.54

mg/l

0.09

477

3207

Other diseases of anus and rectum

470

3066

1.55

17.49

4.4

3.5

1.69

1.55

mg/l

2.70

431

2770

Ulcerative colitis (strict definition, all Crohn cases excluded)

263

1487

1.80

17.49

3.9

4.3

1.34

1.41

mg/l

0.97

241

1392

Other congenital malformations

268

1525

1.79

17.47

7.7

8.9

1.34

1.28

mg/l

0.65

255

1454

Calculus of kidney and ureter

499

3308

1.53

17.47

4.2

3.3

1.65

1.62

mg/l

0.35

458

3007

Other pulmonary heart/vessel disease

364

2.70

17.36

4.0

5.2

2.00

1.69

mg/l

1.93

327

Pulmonary oedema

135

3.99

17.35

5.6

2.4

2.53

1.88

mg/l

3.82

120

Visual disturbances and blindness

840

6139

1.38

17.19

4.7

4.2

1.55

1.51

mg/l

0.76

771

5642

Acute laryngitis and tracheitis

239

1298

1.84

17.16

9.7

5.6

1.25

1.23

mg/l

0.12

231

1230

Duodenal ulcer

189

968

1.99

17.14

4.4

2.9

2.00

1.68

mg/l

4.01

172

872

Other abnormal findings of blood chemistry

101

402

2.60

17.12

4.9

3.5

1.54

1.55

mg/l

0.06

369

Glaucoma

831

5204

1.38

17.11

3.3

3.0

1.71

1.66

mg/l

0.98

753

4690

Chronic gastritis

416

2661

1.58

17.11

3.0

2.8

1.69

1.64

mg/l

0.69

386

2391

Other systemic involvement of connective tissue

404

2567

1.59

17.11

3.4

3.2

1.64

1.57

mg/l

0.85

366

2343

Impotence

121

524

2.39

17.07

4.8

2.8

1.81

1.60

mg/l

1.49

113

481

Lichen simplex chronicus and prurigo

125

550

2.34

16.93

4.1

3.2

1.82

1.55

mg/l

2.20

117

504

Excessive attrition of teeth

908

6740

1.36

16.87

7.5

3.8

1.43

1.44

mg/l

0.23

846

6271

Benign neoplasm of other and ill-defined parts of digestive system

283

1651

1.74

16.86

4.1

2.9

1.82

1.60

mg/l

3.07

265

1500

Multiple myeloma

161

3.63

16.84

2.6

2.4

1.93

1.74

mg/l

0.60

139

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

161

3.63

16.84

2.6

2.4

1.93

1.74

mg/l

0.60

139

Total colectomy operation

394

2.61

16.82

5.7

4.2

1.58

1.45

mg/l

0.78

368

Total colectomy

394

2.61

16.82

5.7

4.2

1.58

1.45

mg/l

0.78

368

Nerve, nerve root and plexus disorders

1703

8338

1.26

16.73

3.3

3.2

1.66

1.51

mg/l

9.38

1553

7665

Type 1 diabetes, definitions combined

229

1258

1.86

16.72

6.1

9.9

1.68

1.11

mg/l

17.72

218

1213

Concussion

832

4956

1.38

16.70

4.1

4.6

1.52

1.37

mg/l

5.68

762

4645

Localized swelling, mass and lump of skin and subcutaneous tissue

512

3445

1.50

16.69

5.3

4.1

1.40

1.51

mg/l

2.57

484

3153

malignant neoplasm of female genital organs

190

977

1.96

16.66

3.9

2.9

1.40

1.64

mg/l

4.02

177

874

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

549

3749

1.48

16.61

5.4

4.9

1.47

1.44

mg/l

0.43

506

3478

Diseases of male genital organs

1057

4001

1.34

16.47

4.6

4.9

1.58

1.46

mg/l

3.57

980

3748

Prurigo nodularis

189

3.39

16.40

3.6

2.9

1.96

1.62

mg/l

1.45

172

Degeneration of macula and posterior pole

665

3733

1.43

16.31

3.3

2.8

1.86

1.69

mg/l

4.11

579

3348

Injuries to the ankle and foot

1186

8147

1.30

16.28

5.1

4.4

1.52

1.41

mg/l

4.12

1118

7588

Injury, poisoning and certain other consequences of external causes

949

3513

1.36

16.25

5.3

4.6

1.46

1.38

mg/l

2.40

874

3266

Unspecified fall

853

6215

1.36

16.24

5.0

4.9

1.59

1.49

mg/l

2.64

769

5733

Undetermined asthma, excluding more controls

187

972

1.95

16.17

4.8

3.2

1.46

1.32

mg/l

1.90

176

890

Disorders of lacrimal system

628

4409

1.43

16.12

4.6

3.4

1.52

1.54

mg/l

0.24

573

4023

Aortic valve malfunction, age under 60 years

200

1070

1.92

16.09

6.1

5.5

1.69

1.41

mg/l

3.38

184

1004

Fitting and adjustment of other devices

450

2671

1.53

16.07

4.0

2.6

1.73

1.49

mg/l

6.83

386

2379

Keratitis

578

4019

1.45

15.92

4.7

3.5

1.65

1.47

mg/l

5.35

543

3703

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

5.64

15.89

2.3

2.4

1.08

1.64

mg/l

5.19

Type 1 diabetes, strict (exclude DM2)

227

1265

1.83

15.85

6.1

10.1

1.68

1.12

mg/l

17.23

216

1220

Protein-energy malnutrition of moderate and mild degree

119

4.23

15.72

11.0

12.8

1.37

1.45

mg/l

0.29

109

Pain in joint

968

4633

1.34

15.63

3.5

3.7

1.51

1.43

mg/l

2.02

899

4281

Exclusion endpoint for clefts

371

2.67

15.59

9.7

17.0

1.41

1.14

mg/l

1.61

362

Injuries to the thorax

732

5321

1.39

15.55

3.4

3.2

1.76

1.56

mg/l

5.83

670

4862

Unspecified acute lower respiratory infection

274

1622

1.72

15.54

4.6

1.65

1.43

mg/l

3.45

259

1504

COPD

695

4081

1.40

15.50

2.6

3.0

1.91

1.67

mg/l

7.16

610

3694

Renal cell carcinoma of kidney

206

3.16

15.42

2.8

2.5

1.86

1.74

mg/l

0.45

179

Cholecystectomy

1042

6875

1.32

15.41

3.4

2.9

1.66

1.56

mg/l

2.93

975

6252

Personal history of malignant neoplasm

109

471

2.37

15.38

13.6

3.4

1.19

1.31

mg/l

1.08

103

440

Hydrocele

221

1235

1.82

15.37

5.0

4.4

1.86

1.59

mg/l

3.82

205

1132

Secondary right heart disease

307

2.72

15.17

3.7

3.6

2.07

1.71

mg/l

2.31

276

Ill-defined and unknown causes of mortality

150

741

2.07

15.17

3.7

2.9

1.97

1.72

mg/l

1.83

138

652

Lung cancer and mesothelioma

267

1343

1.72

15.13

3.1

2.7

1.54

1.61

mg/l

0.82

249

1201

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

137

657

2.13

15.02

4.0

3.3

1.96

1.55

mg/l

3.51

127

600

Malignant neoplasm of bladder, including Hilmo

173

894

1.95

15.00

2.6

2.8

1.87

1.88

mg/l

0.03

147

765

Special screening examination for infectious and parasitic diseases

373

1750

1.58

14.91

2.7

2.6

1.25

1.29

mg/l

0.45

351

1654

Covid-19 suspected case

351

2233

1.59

14.89

5.9

4.1

1.35

1.36

mg/l

0.07

317

2091

Special screening examination for other diseases and disorders

183

977

1.90

14.68

5.4

2.8

1.72

1.49

mg/l

2.80

175

893

Malignant neoplasm of bone and articular cartilage

4.66

14.67

19.1

9.0

1.21

1.50

mg/l

1.42

Chorioretinal inflammation

235

2.97

14.60

3.9

3.0

1.60

1.53

mg/l

0.29

218

Other and unspecified acquired haemolytic anaemias

4.54

14.53

7.9

3.8

2.06

1.56

mg/l

2.24

Open wound of ankle and foot

196

1076

1.86

14.51

5.0

4.7

1.97

1.43

mg/l

9.16

187

1000

Visual impairment including blindness (binocular or monocular)

133

641

2.13

14.43

3.8

5.4

1.82

1.55

mg/l

2.50

126

582

Crohn disease (strict definition, require KELA)

131

630

2.13

14.32

3.5

4.9

1.44

1.38

mg/l

0.37

125

593

Crohn disease (strict definition, require KELA, min 2 HDR)

130

624

2.14

14.28

3.5

4.9

1.44

1.37

mg/l

0.48

124

587

Acute bronchiolitis

194

962

1.88

14.23

17.2

14.5

1.23

1.09

mg/l

2.24

188

932

Postmenopausal osteoporosis with pathological fracture

416

2.39

13.98

2.7

2.5

1.71

1.66

mg/l

0.22

370

Other general symptoms and signs

105

462

2.31

13.96

9.0

5.9

1.33

1.26

mg/l

0.50

437

Exclusions for E4_PCOS_CONSORTIUM

1087

5278

1.30

13.92

5.3

4.8

1.42

1.38

mg/l

0.78

995

4930

Discitis, unspecified

128

3.71

13.89

3.4

3.2

2.32

1.73

mg/l

2.46

118

Other chronic obstructive pulmonary disease

659

3944

1.39

13.85

2.6

3.0

1.92

1.67

mg/l

6.81

576

3561

Spondylopathies

1269

5992

1.27

13.83

2.9

3.2

1.60

1.54

mg/l

1.82

1140

5517

Abnormal spermatozoa

217

1250

1.77

13.72

3.1

2.8

1.74

1.72

mg/l

0.08

192

1124

Open wound of head

920

6796

1.31

13.72

4.7

4.5

1.63

1.50

mg/l

3.87

835

6280

All dysplastic lesions of the vulva

306

2.63

13.67

3.3

3.0

1.60

1.41

mg/l

1.18

286

Other joint disorders

1470

6227

1.25

13.62

3.5

4.4

1.42

1.37

mg/l

1.61

1364

5797

Obesity, other/unspecified

494

3443

1.45

13.50

3.2

3.4

1.72

1.39

mg/l

11.42

453

3206

COPD related to multimorbidity

584

3528

1.41

13.49

2.6

2.9

1.99

1.71

mg/l

7.81

507

3179

Seborrhoeic dermatitis

171

922

1.89

13.45

5.9

4.2

1.59

1.52

mg/l

0.53

158

843

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

135

674

2.05

13.36

3.5

4.8

1.45

1.37

mg/l

0.54

129

636

Anomalies of dental arch relationship, including avohilmo

356

2096

1.55

13.35

14.6

5.7

1.21

1.28

mg/l

1.29

329

1994

Herpesviral [herpes simplex] infections

363

2387

1.54

13.33

5.0

3.4

1.51

1.39

mg/l

1.86

343

2223

Other disorders of ear

1491

7909

1.24

13.29

4.9

4.1

1.58

1.51

mg/l

2.69

1346

7323

Cerebral cysts

114

536

2.18

13.25

7.6

5.0

1.61

1.45

mg/l

1.04

106

496

Undetermined asthma

187

1039

1.82

13.24

4.8

3.2

1.46

1.38

mg/l

0.75

176

951

Vascular disorders of the intestines

110

509

2.21

13.23

4.0

2.7

2.11

1.71

mg/l

2.80

100

439

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

795

4732

1.34

13.23

3.5

2.9

1.50

1.48

mg/l

0.43

744

4347

Other specific joint derangements/joint disorders

1176

5995

1.27

13.21

3.6

4.2

1.51

1.37

mg/l

6.01

1098

5585

Weight loss

182

1008

1.84

13.17

6.4

6.0

1.53

1.50

mg/l

0.22

167

923

Intestinal adhesions without obstruction

138

698

2.02

13.12

3.9

3.7

1.74

1.57

mg/l

1.29

131

621

Benign neoplasm: Skin of trunk

362

2.45

13.03

5.1

3.5

1.85

1.55

mg/l

1.49

336

Unspecified privation

183

1019

1.83

12.98

4.5

4.0

1.72

1.49

mg/l

2.50

175

941

Secondary polycythaemia

196

3.04

12.94

2.0

3.0

1.45

1.56

mg/l

0.47

178

Other benign neoplasms of skin

546

3912

1.41

12.82

4.3

3.1

1.66

1.58

mg/l

1.25

507

3534

Delirium, not induced by alcohol and other psychoactive substances

188

1057

1.80

12.80

3.3

2.6

1.97

1.75

mg/l

2.32

167

933

Abnormal blood-pressure reading, without diagnosis

378

2.39

12.71

7.6

6.3

1.28

1.37

mg/l

0.63

348

Mental and behavioural disorders due to psychoactive substance use

983

7112

1.29

12.70

3.6

3.4

1.57

1.51

mg/l

1.35

903

6582

Low back pain

1205

6893

1.26

12.68

3.2

3.4

1.58

1.49

mg/l

3.30

1085

6383

Thyroiditis, ILD-related definition

179

997

1.82

12.66

3.4

4.4

1.46

1.39

mg/l

0.55

159

937

Visual disturbances

751

5669

1.33

12.63

4.8

4.2

1.52

1.51

mg/l

0.19

688

5202

Specific development disorders of scholastic skills

133

668

2.04

12.61

21.6

12.4

1.20

1.08

mg/l

1.55

128

648

Mycoses

1352

9525

1.24

12.58

3.9

3.8

1.54

1.49

mg/l

1.31

1254

8790

Disorder of lipoprotein metabolism, unspecified

188

1065

1.79

12.55

3.7

2.6

1.96

1.55

mg/l

6.73

172

955

Vascular diseases of the intestine

272

2.65

12.52

3.5

2.8

2.04

1.68

mg/l

1.63

238

Dorsalgia

1632

7175

1.22

12.43

3.3

3.7

1.53

1.48

mg/l

1.59

1489

6653

Acne

191

1092

1.78

12.34

7.6

6.4

1.50

1.19

mg/l

5.08

185

1034

Crowding of teeth, including avohilmo

219

1071

1.73

12.31

22.0

10.8

1.17

1.11

mg/l

0.82

214

1030

Other neurological diseases

1090

6783

1.27

12.28

4.2

3.4

1.66

1.58

mg/l

2.14

987

6195

Bipolar affective disorders

289

1842

1.59

12.27

2.8

3.2

1.39

1.36

mg/l

0.29

270

1729

Other predominantly sexually transmitted diseases, not elsewhere classified

255

1580

1.63

12.19

3.6

3.2

1.45

1.34

mg/l

1.56

243

1495

L01XE Protein kinase inhibitors

100

464

2.22

12.08

7.9

3.2

1.52

1.64

mg/l

0.90

419

COPD, early/later onset

665

4170

1.35

12.08

2.6

3.0

1.92

1.69

mg/l

6.43

581

3759

Varicella [chickenpox]

145

773

1.93

12.00

13.3

8.7

1.47

1.25

mg/l

2.02

140

735

Other or ill-defined heart diseases

445

2.23

11.98

7.2

4.1

1.77

1.32

mg/l

3.40

415

Supplementary factors related to causes of morbidity and mortality classified elsewhere

510

3658

1.41

11.97

6.1

4.1

1.63

1.46

mg/l

3.39

456

3375

Mixed specific developmental disorders

115

529

2.15

11.89

14.9

18.3

1.09

1.03

mg/l

0.87

115

522

Symptoms and signs involving the nervous and musculoskeletal systems

904

7052

1.29

11.89

5.0

4.4

1.52

mg/l

0.05

833

6488

Nonorganic sleeping disorders, excluding more controls

294

1897

1.57

11.84

3.8

3.9

1.47

1.35

mg/l

1.30

272

1777

Colectomy operation

261

1640

1.61

11.84

4.0

3.0

1.78

1.62

mg/l

1.91

239

1479

COPD, hospital admissions

656

4133

1.35

11.81

2.6

3.0

1.92

1.69

mg/l

6.52

572

3725

Chronic lower respiratory diseases

2022

9065

1.19

11.77

3.9

4.5

1.54

1.46

mg/l

4.29

1862

8411

Heart failure and hypertrophic cardiomyopathy

164

3.15

11.75

5.3

3.3

2.07

1.59

mg/l

2.75

146

Use of pramipexole

320

2109

1.53

11.73

3.9

2.9

1.83

1.60

mg/l

3.71

294

1912

Pure hyperglyceridaemia

175

3.03

11.63

4.1

4.5

1.88

1.53

mg/l

1.37

165

Fracture of foot, except ankle

394

2714

1.47

11.61

5.5

4.3

1.59

1.39

mg/l

4.00

370

2530

Polyuria

327

2170

1.52

11.60

3.1

2.9

1.67

1.59

mg/l

0.77

291

1974

Myopia

214

1288

1.69

11.55

7.0

5.3

1.39

1.31

mg/l

0.67

199

1221

Crossbite

198

1083

1.74

11.46

23.1

12.2

1.15

1.14

mg/l

0.04

190

1045

Type of accident

467

3326

1.42

11.45

6.4

4.1

1.62

1.47

mg/l

2.91

419

3081

Amiodarone users

165

927

1.81

11.45

3.4

3.0

2.01

1.69

mg/l

4.43

158

836

Other anxiety disorders

702

4606

1.33

11.38

4.6

3.8

1.39

1.34

mg/l

0.78

644

4328

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

105

511

2.13

11.36

15.1

11.4

1.35

1.12

mg/l

2.12

486

Coronary artery bypass grafting

378

1916

1.48

11.35

3.4

2.5

2.18

1.61

mg/l

20.65

343

1713

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

110

545

2.11

11.34

9.5

15.1

1.34

1.14

mg/l

1.43

103

529

Symptoms and signs involving cognition, perception, emotional state and behaviour

1525

8592

1.21

11.33

3.5

3.7

1.59

1.50

mg/l

3.41

1400

7934

Malignant melanoma, including Hilmo

228

1402

1.65

11.28

3.7

2.7

1.70

1.72

mg/l

0.08

214

1237

Non-invasive ventilation

302

1762

1.54

11.28

4.9

3.8

1.83

1.22

mg/l

20.08

278

1643

Malignant neoplasm of palate, including Hilmo

5.45

11.26

3.4

2.4

1.12

1.56

mg/l

2.63

ILD-related respiratory insufficiency

270

2.57

11.23

2.6

3.0

2.01

1.78

mg/l

1.15

240

Other and unspecified myopathies

143

776

1.88

11.12

3.7

2.09

1.58

mg/l

4.56

127

704

Use of antiglaucoma preparations and miotics

124

642

1.97

11.10

3.9

2.6

1.79

1.72

mg/l

0.36

114

561

Rosacea

172

987

1.77

11.07

5.5

3.3

1.53

1.49

mg/l

0.24

159

911

COPD, hospital admission 2, with asthma infections

469

2872

1.41

11.07

2.6

3.0

2.01

1.70

mg/l

7.23

409

2580

Coxarthrosis [arthrosis of hip](FG)

759

4090

1.31

11.01

3.0

2.7

1.71

1.53

mg/l

6.83

685

3712

Malignant melanoma

190

1122

1.72

11.01

3.8

2.7

1.74

1.70

mg/l

0.19

178

987

Astigmatism

141

765

1.89

11.01

14.0

10.1

1.32

1.28

mg/l

0.28

134

730

Gestational [pregnancy-induced] hypertension

293

1916

1.54

10.99

3.2

2.8

1.45

1.30

mg/l

2.87

274

1801

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

4.21

10.98

20.3

7.6

1.25

1.51

mg/l

1.22

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

392

2714

1.45

10.97

3.0

3.2

1.44

1.36

mg/l

1.37

364

2550

Abnormal weight loss

161

911

1.80

10.94

4.1

5.8

1.54

1.51

mg/l

0.20

147

833

Other and unspecified types of non-Hodgkin lymphoma, hilmo

335

2.36

10.90

3.7

3.2

1.71

1.72

mg/l

0.03

303

Disease of hard tissues of teeth, NOS

818

3295

1.31

10.83

3.1

2.5

1.47

1.50

mg/l

0.53

753

2984

Amenorrhoea

102

497

2.09

10.81

6.0

4.6

1.34

1.22

mg/l

0.92

470

Substance abuse

939

6997

1.27

10.80

3.6

3.4

1.57

1.51

mg/l

1.15

860

6481

Hyperfunction of pituitary gland

400

2.23

10.76

6.9

5.2

1.49

1.31

mg/l

0.99

375

Other predominantly sexually transmitted diseases, not elsewhere classified

296

1955

1.53

10.76

3.8

3.5

1.43

1.31

mg/l

2.05

281

1854

Dermatophytosis

210

1286

1.66

10.66

5.0

3.5

1.69

1.54

mg/l

1.38

195

1183

Crohn's disease (strict) with PSC

18.61

10.65

5.8

10.9

1.64

1.76

mg/l

0.11

Spondyloarthritis

261

1681

1.57

10.65

3.2

3.1

1.67

1.50

mg/l

2.14

237

1552

Other disorders of optic [2nd] nerve and visual pathways

122

639

1.95

10.64

7.6

6.8

1.61

1.45

mg/l

1.08

114

594

All anxiety disorders

964

6056

1.26

10.60

4.9

3.9

1.39

1.37

mg/l

0.17

893

5679

Alcohol-induced chronic pancreatitis

124

655

1.94

10.56

4.0

2.9

1.84

1.55

mg/l

2.98

109

608

Retinal vascular disorders

180

1061

1.72

10.55

4.2

2.5

2.08

1.71

mg/l

4.64

163

944

Lung diseases due to external agents

212

1304

1.65

10.54

4.3

3.2

1.75

1.70

mg/l

0.35

178

1172

Abnormalities of gait and mobility

202

1230

1.67

10.51

4.9

5.6

1.62

1.61

mg/l

0.08

186

1123

Retinal detachment with retinal break

197

1193

1.68

10.44

3.4

2.7

1.84

1.59

mg/l

2.67

177

1089

Other chronic obstructive pulmonary disease, including avohilmo

778

5000

1.29

10.34

2.5

3.0

1.86

1.66

mg/l

6.25

683

4531

Urticaria and erythema

561

4189

1.35

10.29

7.1

5.2

1.44

1.40

mg/l

0.52

525

3909

Other and unspecified disorders of skin and subcutaneous tissue

102

508

2.05

10.26

2.5

3.4

1.82

1.52

mg/l

1.82

462

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

146

819

1.82

10.24

2.9

3.1

1.38

1.58

mg/l

2.40

136

757

Anxiety (asthma-related co-morbidities)

940

5790

1.26

10.19

4.9

4.1

1.39

1.37

mg/l

0.30

870

5426

Retinal vascular occlusion

176

1042

1.71

10.17

4.2

2.5

2.08

1.70

mg/l

4.55

160

928

COPD, hospital admissions 3, with asthma pneumonia sepsis

390

2341

1.44

10.16

2.7

2.9

2.09

1.75

mg/l

6.97

336

2096

Polyarthrosis

266

1612

1.55

10.14

2.9

2.7

1.65

1.53

mg/l

1.36

232

1457

Spondylosis

811

5184

1.28

10.09

2.7

3.0

1.58

mg/l

0.01

713

4749

Recurrent or chronic depression

621

3300

1.33

9.97

3.3

1.41

1.42

mg/l

0.08

568

3083

Other congenital malformations of kidney

4.50

9.92

8.8

17.4

1.44

1.23

mg/l

0.60

Fracture of rib(s), sternum and thoracic spine

457

3327

1.39

9.92

3.2

3.0

1.82

1.59

mg/l

4.82

414

3009

Other diseases of oesophagus

148

841

1.79

9.91

3.7

2.8

1.67

1.61

mg/l

0.37

137

762

Lower back pain or/and sciatica

1625

8941

1.19

9.81

3.1

3.4

1.56

1.51

mg/l

1.55

1468

8262

Pneumonitis due to solids and liquids

130

713

1.85

9.81

4.5

3.6

1.73

1.66

mg/l

0.34

106

636

Functional dyspepsia

371

2613

1.43

9.76

3.2

1.56

1.49

mg/l

0.70

335

2393

Toxic liver disease

150

3.01

9.65

7.4

3.2

1.67

1.49

mg/l

0.66

137

Sensorineural hearing loss

1123

6218

1.23

9.63

4.3

3.5

1.67

1.59

mg/l

2.29

985

5703

Coxarthrosis

714

3646

1.30

9.62

3.0

2.7

1.70

1.52

mg/l

6.82

646

3323

Glaucoma suspect

494

3658

1.36

9.62

3.4

2.9

1.65

1.64

mg/l

0.10

450

3290

Stomatitis and related lesions

304

2071

1.48

9.60

11.9

4.5

1.38

1.43

mg/l

0.67

287

1919

Deep bite

246

1404

1.56

9.58

16.3

10.1

1.23

1.21

mg/l

0.22

234

1349

Dermatitis due to substances taken internally

501

2.02

9.57

5.7

5.8

1.55

1.46

mg/l

0.48

464

Other postsurgical states

106

549

1.97

9.56

12.2

4.6

1.28

1.29

mg/l

0.04

100

502

Malignant neoplasm of endocrine gland

103

528

1.99

9.56

7.4

4.0

1.51

1.47

mg/l

0.18

479

Other disorders of veins

531

3956

1.34

9.53

2.9

2.7

1.65

1.52

mg/l

2.84

498

3606

Alcohol-induced acute pancreatitis

356

2.23

9.52

3.5

3.0

1.90

1.53

mg/l

2.36

332

Hyperplasia of prostate

590

2521

1.34

9.47

3.1

3.0

1.73

1.64

mg/l

1.35

532

2313

Open wound of forearm

158

928

1.73

9.46

4.8

3.6

1.70

1.47

mg/l

2.39

143

852

Acne vulgaris

147

847

1.76

9.43

6.4

6.3

1.45

1.19

mg/l

4.03

142

801

Irregular menses

584

3495

1.33

9.38

5.0

3.3

1.43

1.35

mg/l

1.65

548

3257

Excessive, frequent and irregular menstruation

484

1936

1.38

9.35

5.0

3.6

1.41

mg/l

0.00

456

1788

Conductive and sensorineural hearing loss

1191

6615

1.22

9.34

4.7

3.7

1.64

1.57

mg/l

2.27

1050

6085

Benign neoplasm: Colon, unspecified

359

2537

1.43

9.33

3.6

2.7

1.94

1.65

mg/l

6.32

332

2282

Vitamin B12 deficiency anaemia

145

836

1.76

9.25

2.8

2.7

1.78

1.65

mg/l

1.01

132

739

Injuries to the hip and thigh

702

4962

1.29

9.25

3.9

3.6

1.71

1.59

mg/l

2.62

637

4503

Papulosquamous disorders

577

4398

1.32

9.24

3.4

1.57

1.51

mg/l

0.70

520

4036

Other and unspecified rosacea

129

720

1.82

9.23

3.4

3.2

1.55

1.51

mg/l

0.17

119

663

Combinations of oral blood glucose lowering drugs

400

2885

1.40

9.23

2.6

2.9

1.76

1.54

mg/l

4.58

352

2664

Sicca syndrome [Sjögren]

120

655

1.86

9.22

2.7

2.9

1.57

1.52

mg/l

0.33

111

605

Meniscus derangement

825

4406

1.27

9.17

2.7

2.8

1.55

1.46

mg/l

2.29

758

4055

Malignant neoplasm of bronchus and lung, including Hilmo

264

1470

1.52

9.12

3.1

2.8

1.54

1.81

mg/l

5.80

247

1283

Mental and behavioural disorders due to opioids

336

2.23

9.10

3.5

3.2

1.56

1.29

mg/l

1.55

315

Fracture of femur

373

2411

1.41

9.09

3.9

3.4

1.88

1.70

mg/l

2.65

327

2141

Cerebral palsy and other paralytic syndromes

183

1132

1.64

9.00

7.2

5.3

1.49

1.43

mg/l

0.39

163

1047

Other obstetric conditions, not elsewhere classified

358

1597

1.43

9.00

3.1

3.2

1.23

1.22

mg/l

0.15

337

1512

Selective serotonin reuptake inhibitors

1622

7168

1.19

9.00

3.2

3.8

1.47

1.51

mg/l

1.32

1494

6643

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

350

1553

1.44

8.98

3.2

1.25

1.22

mg/l

0.42

329

1471

Thoracic aortic aneurysm

214

1376

1.58

8.95

3.4

2.7

1.82

1.58

mg/l

3.11

204

1242

Orchitis and epididymitis

160

960

1.69

8.89

4.1

3.9

1.62

1.55

mg/l

0.47

144

885

Other noninflammatory disorders of vulva and perineum

126

707

1.81

8.84

3.2

3.1

1.41

1.42

mg/l

0.05

119

657

Crohn disease (strict definition, all UC cases excluded)

468

2.01

8.81

2.8

4.9

1.42

mg/l

0.01

439

Strabismus

431

3165

1.37

8.79

8.2

6.4

1.39

1.38

mg/l

0.15

395

2968

Oesophagitis

482

1.99

8.79

4.6

3.4

1.76

1.58

mg/l

1.28

436

Rheumatoid arthritis

427

2809

1.37

8.75

2.9

2.7

1.67

1.49

mg/l

3.88

375

2552

Inflammatory diseases of female pelvic organs

723

4178

1.28

8.74

3.4

3.2

1.43

1.42

mg/l

0.07

678

3843

Degenerative macular diseases

169

1033

1.66

8.72

3.6

2.5

1.95

1.67

mg/l

2.52

146

922

Digestive system disorders of fetus and newborn

6.84

8.71

13.3

25.6

1.14

1.08

mg/l

0.21

Intracranial injury

901

6905

1.24

8.68

4.2

4.5

1.60

1.49

mg/l

3.57

816

6395

Infective dermatitis

172

1058

1.65

8.67

3.9

3.2

1.61

1.52

mg/l

0.75

154

970

Other strabismus

356

2541

1.41

8.60

9.0

6.7

1.35

1.33

mg/l

0.23

329

2399

Conjunctivitis (acute, non atopic)

457

3395

1.35

8.59

7.5

6.0

1.44

1.38

mg/l

0.79

438

3176

Superficial injury of lower leg

374

2705

1.39

8.53

4.4

1.66

1.43

mg/l

4.46

347

2508

Abnormality of white blood cells, not elsewhere classified

3.74

8.45

6.8

4.7

1.70

1.36

mg/l

1.11

Presence of other devices

271

1847

1.47

8.38

3.7

2.2

1.73

1.58

mg/l

2.21

248

1645

Other sleep disorders

175

1091

1.63

8.37

3.4

3.7

1.58

1.47

mg/l

0.80

164

1007

Benign neoplasm: Transverse colon

158

962

1.67

8.33

3.6

2.9

1.77

1.66

mg/l

0.74

146

873

Personality disorders, excluding more controls

349

2509

1.40

8.23

3.0

3.1

1.43

1.36

mg/l

0.98

321

2365

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

809

6338

1.25

8.22

3.3

3.7

1.44

1.52

mg/l

2.38

748

5865

Non-small cell lung cancer, including Hilmo

186

1111

1.59

8.18

3.0

2.7

1.41

1.82

mg/l

11.60

175

965

Substance use, excluding alcohol

306

2156

1.43

8.16

3.2

3.5

1.48

1.41

mg/l

0.67

283

2011

Mental and behavioural disorders due to alcohol

808

6269

1.25

8.14

3.6

3.3

1.58

1.53

mg/l

1.02

743

5796

Polycystic ovarian syndrome, consortium definition

859

4103

1.25

8.11

4.2

3.2

1.50

1.40

mg/l

3.04

795

3787

Hypermetropia

147

886

1.69

8.10

16.6

10.0

1.46

1.29

mg/l

1.81

136

840

Unspecified misadventure during surgical and medical care

483

1.95

8.08

3.7

3.4

1.83

1.59

mg/l

1.29

441

Myalgia

329

2351

1.41

8.08

3.0

3.3

1.37

1.42

mg/l

0.63

298

2168

Abdominal aortic aneurysm (AAA)

135

788

1.72

8.05

3.2

2.5

2.20

1.81

mg/l

4.36

119

675

Ovarian cyst

424

1797

1.37

8.03

3.7

3.2

1.43

1.44

mg/l

0.08

395

1653

Mental retardation, excluding more controls

102

541

1.89

8.01

12.8

12.6

1.12

1.18

mg/l

0.55

526

Corneal ulcer

278

1932

1.45

8.01

4.3

3.7

1.71

1.45

mg/l

5.17

263

1794

Pyogenic arthritis

101

548

1.87

7.98

4.9

3.5

2.12

1.48

mg/l

5.27

503

Fracture of shoulder and upper arm

549

4242

1.30

7.96

4.9

4.4

1.62

1.50

mg/l

2.14

504

3886

Asthma (diagnoses ohter than nonallergic)

1352

9511

1.18

7.95

3.9

4.4

1.52

1.48

mg/l

0.85

1251

8782

Use of anticholinesterases

222

2597

0.67

7.94

2.0

2.6

1.64

1.86

mg/l

3.92

186

2267

N06DA Anticholinesterases

222

2597

0.67

7.94

2.0

2.6

1.64

1.86

mg/l

3.92

186

2267

Other and unspecified glaucoma

100

542

1.88

7.93

3.0

2.9

1.84

1.71

mg/l

0.75

477

Abscess of anal and rectal regions

141

846

1.69

7.89

4.3

4.4

1.68

1.42

mg/l

2.33

133

786

Eating disorder

136

807

1.71

7.86

6.4

6.9

1.20

1.17

mg/l

0.20

121

768

Other localized connective tissue disorders

133

2.88

7.86

4.8

3.3

2.09

1.52

mg/l

1.90

122

Diseases of external ear

517

3978

1.31

7.83

6.3

4.6

1.64

1.49

mg/l

2.87

469

3661

Idiopathic pulmonary fibrosis

112

632

1.80

7.81

2.5

2.7

1.82

1.78

mg/l

0.19

555

Leisure time condition

275

1917

1.45

7.81

6.2

4.5

1.61

1.45

mg/l

1.94

242

1773

Methotrexate

184

1181

1.57

7.78

2.6

3.0

1.54

1.46

mg/l

0.73

165

1088

L04AC Interleukin inhibitors

103

568

1.85

7.78

2.7

4.4

1.39

1.40

mg/l

0.03

537

Fracture of lower leg, including ankle

817

6572

1.24

7.76

4.5

3.7

1.62

1.49

mg/l

4.38

751

6040

Eating disorders

160

996

1.62

7.69

6.1

6.2

1.32

1.24

mg/l

0.59

145

945

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

4.03

7.69

2.0

2.5

1.13

1.59

mg/l

3.02

Tooth eruption problems

256

1722

1.47

7.68

15.5

7.9

1.31

1.18

mg/l

2.45

248

1644

Other dorsopathies, not elsewhere classified

1611

7233

1.17

7.68

3.3

3.7

1.51

1.47

mg/l

0.84

1475

6709

Injuries to the shoulder and upper arm

1307

8932

1.18

7.67

4.0

3.9

1.56

1.51

mg/l

1.24

1196

8240

Diseases of salivary glands

444

3356

1.33

7.65

3.5

3.4

1.50

1.49

mg/l

0.08

418

3088

Alzheimer’s disease, strict definition

138

1850

0.61

7.64

2.1

2.5

1.67

1.90

mg/l

2.40

111

1608

Exposure to other specified factors

1181

9136

1.19

7.61

4.1

4.3

1.52

1.46

mg/l

1.48

1088

8482

Seropositive rheumatoid arthritis

308

2191

1.41

7.60

2.7

2.6

1.68

1.48

mg/l

3.33

276

1978

Follow-up examination after treatment for conditions other than malignant neoplasms

598

3090

1.29

7.60

4.0

2.7

1.50

1.48

mg/l

0.27

564

2837

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

112

637

1.78

7.59

3.6

2.9

1.53

1.40

mg/l

0.83

104

596

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

133

796

1.69

7.53

6.7

4.4

1.67

1.45

mg/l

1.71

121

731

Poisoning by drugs, medicaments and biological substances

353

2585

1.38

7.53

3.3

4.0

1.44

1.37

mg/l

0.84

326

2429

259

1688

1.45

7.50

3.0

2.5

1.96

1.81

mg/l

1.50

221

1474

Other follicular disorders

114

655

1.77

7.49

5.2

3.4

1.83

1.41

mg/l

3.64

107

611

Familial hypercholesterolemia

192

1256

1.54

7.48

3.5

3.2

1.81

1.59

mg/l

2.81

171

1123

Psoriasis

414

3116

1.34

7.38

3.6

3.4

1.56

1.51

mg/l

0.55

374

2871

Dizziness and giddiness

1091

7250

1.20

7.34

3.4

1.61

1.54

mg/l

1.61

992

6655

Pneumonia derived septicemia

347

2.07

7.31

11.6

7.5

1.61

1.50

mg/l

0.46

321

Disorders of optic nerve and visual pathways

150

934

1.63

7.30

6.5

5.7

1.59

1.43

mg/l

1.27

136

875

Other and unspecified follicular disorders

368

2.03

7.27

4.6

3.0

1.80

1.48

mg/l

1.61

342

Benign neoplasm of eye and adnexa

147

912

1.63

7.25

3.8

3.5

1.56

1.58

mg/l

0.09

133

825

356

2283

1.37

7.19

3.3

2.6

1.94

1.80

mg/l

1.70

304

2009

Congenital malformations and deformations of the musculoskeletal system

188

1233

1.54

7.17

10.9

11.7

1.20

mg/l

0.04

179

1184

Early onset COPD

324

2361

1.38

7.17

2.9

3.1

1.78

1.59

mg/l

2.47

289

2155

Noninflammatory disorders of female genital tract

517

1993

1.31

7.12

5.8

4.0

1.35

1.40

mg/l

0.63

484

1844

Other disorders of eyelid

588

4431

1.27

7.09

3.1

3.0

1.63

1.65

mg/l

0.30

534

3993

Olecranon bursitis

108

622

1.77

7.09

3.4

2.7

1.80

1.55

mg/l

2.54

102

567

Fissure and fistula of anal and rectal regions

339

2492

1.37

7.08

3.4

3.1

1.52

1.48

mg/l

0.37

302

2285

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

162

1023

1.59

7.02

12.3

11.1

1.28

1.14

mg/l

1.72

156

983

Campylobacter enteritis

227

2.31

7.00

5.1

4.0

1.65

1.49

mg/l

0.70

207

Arterial embolism and thrombosis of lower extremity artery

259

2.21

6.97

5.0

2.9

2.22

1.66

mg/l

2.67

225

Childhood asthma (age<16), excluding more controls

192

998

1.53

6.96

8.3

4.6

1.19

1.11

mg/l

1.01

186

959

Nonorganic sleeping disorders

294

2119

1.40

6.96

3.8

4.5

1.47

1.38

mg/l

0.83

272

1985

Symptoms and signs involving speech and voice

445

3414

1.31

6.95

3.5

3.3

1.50

1.55

mg/l

0.76

401

3123

Reactive arthropathies

130

791

1.67

6.94

3.4

3.7

1.59

1.39

mg/l

1.67

119

736

Post-traumatic stress disorder

119

709

1.70

6.88

6.2

4.7

1.25

1.22

mg/l

0.26

113

677

Recurrent aphthous stomatitis , including avohilmo

215

1469

1.48

6.86

15.5

4.9

1.30

1.43

mg/l

2.57

205

1365

Dorsopathies

1678

7405

1.16

6.85

3.6

4.2

1.48

1.46

mg/l

0.22

1534

6880

Other abnormal uterine and vaginal bleeding

274

1389

1.42

6.84

2.8

3.2

1.54

1.51

mg/l

0.26

247

1267

Ulcerative rectosigmoiditis

126

764

1.67

6.84

3.4

1.36

1.48

mg/l

0.92

113

715

Benign neoplasm: Tongue

236

2.27

6.83

3.5

3.0

1.36

1.62

mg/l

1.49

217

Generalized skin eruption due to drugs and medicaments

356

2.01

6.82

6.1

6.0

1.45

1.49

mg/l

0.16

330

Injuries to the elbow and forearm

1061

7865

1.19

6.82

5.2

4.3

1.53

1.45

mg/l

2.27

971

7277

Nail disorders

133

819

1.65

6.81

5.5

5.0

1.72

1.44

mg/l

2.53

122

765

Alzheimer’s disease (Late onset)

125

1697

0.62

6.76

2.2

2.4

1.68

1.92

mg/l

2.21

101

1466

Hypogonadotropic hypogonadism

324

2.07

6.75

2.4

3.4

1.18

1.40

mg/l

1.52

310

Specific development disorders of speech and language

146

890

1.61

6.72

18.0

12.7

1.19

1.18

mg/l

0.05

140

851

Unstable angina pectoris

483

2956

1.30

6.72

3.1

2.5

1.93

1.58

mg/l

11.42

419

2662

Myositis

225

2.29

6.71

4.7

3.4

1.77

1.55

mg/l

0.71

210

Other and unspecified vascular occlusions

129

791

1.65

6.70

4.3

2.5

2.04

1.69

mg/l

3.71

117

701

Endometriosis

396

1741

1.34

6.70

2.8

3.1

1.40

1.46

mg/l

0.77

364

1599

Unspecific neurodegenerative disorder

310

2882

0.73

6.69

2.2

2.6

1.70

1.84

mg/l

2.22

255

2546

Other disorders of nervous system

104

603

1.75

6.69

4.0

3.0

1.70

1.57

mg/l

0.65

552

Suppurative and necrotic conditions of lower respiratory tract

515

1.82

6.68

3.9

3.8

1.90

1.62

mg/l

1.77

465

Melanoma in situ

345

2.01

6.67

4.8

2.7

1.86

1.73

mg/l

0.49

313

Atopic dermatitis, strict definition with reimbursement

460

3441

1.30

6.66

6.9

6.1

1.34

1.28

mg/l

0.94

442

3257

Irritable bowel syndrome

356

2663

1.35

6.65

2.7

3.4

1.39

1.42

mg/l

0.31

325

2448

Alzheimer disease, including avohilmo

252

2490

0.71

6.64

2.3

2.5

1.76

1.86

mg/l

1.02

202

2179

Benign neoplasm of other and unspecified endocrine glands

188

1260

1.51

6.63

3.0

3.4

1.52

1.54

mg/l

0.10

175

1160

Other disorders of conjunctiva

199

1350

1.49

6.60

4.3

3.4

1.76

1.61

mg/l

1.46

184

1227

Psoriatic and enteropathic arthropathies

162

1053

1.56

6.58

2.8

2.9

1.46

1.37

mg/l

0.77

143

986

Migraine

684

4499

1.24

6.53

4.9

4.8

1.28

1.36

mg/l

2.42

649

4208

Childhood asthma (age<16)

193

1020

1.50

6.52

8.3

4.7

1.19

1.13

mg/l

0.66

187

981

Single spontaneous delivery

294

2134

0.73

6.49

2.6

3.5

1.41

1.52

mg/l

1.87

276

1947

Malignant neoplasm of bladder

469

1.83

6.42

2.9

2.4

1.97

1.85

mg/l

0.45

401

Moderate visual impairment, binocular

236

2.21

6.39

4.6

4.5

1.91

1.71

mg/l

0.76

210

Other/unspecified dorsalgia

531

4178

1.27

6.36

3.8

3.4

1.58

1.51

mg/l

1.14

479

3847

Other eating disorders

472

1.83

6.33

7.7

8.3

1.14

mg/l

0.03

448

Corns and callosities

553

1.76

6.33

5.9

3.5

2.07

1.49

mg/l

5.77

500

Restrictive cardiomyopathy

4.55

6.30

21.5

6.3

2.08

1.59

mg/l

0.75

Speech disturbances, not elsewhere classified

126

783

1.63

6.24

3.4

3.3

1.59

1.62

mg/l

0.18

111

701

Congenital malformations and deformations of the musculoskeletal system

212

1467

1.46

6.22

10.2

10.6

1.20

1.22

mg/l

0.24

202

1412

Coeliac disease

187

1270

1.49

6.21

4.8

6.3

1.61

1.38

mg/l

3.17

174

1179

Cholecystitis

183

1237

1.49

6.19

3.8

2.7

1.70

1.63

mg/l

0.52

172

1100

Injuries to unspecified part of trunk, limb or body region

158

1037

1.54

6.19

4.3

5.6

1.90

1.46

mg/l

4.25

143

959

Disturbance of activity and attention

213

1454

1.45

6.19

11.9

9.1

1.19

1.13

mg/l

0.86

207

1398

Menorrhagia

401

1691

1.32

6.17

3.8

3.4

1.41

1.46

mg/l

0.58

375

1552

Emphysema

105

625

1.70

6.16

2.1

3.2

1.92

1.71

mg/l

1.50

556

Primary open-angle glaucoma

394

2924

1.31

6.15

2.9

2.7

1.80

1.76

mg/l

0.42

355

2599

Subjective visual disturbances

337

2534

1.34

6.14

3.0

3.7

1.52

1.50

mg/l

0.15

315

2330

Otitis externa

322

2406

1.35

6.14

7.9

4.9

1.62

1.45

mg/l

2.85

301

2240

Fracture of skull and facial bones

321

2398

1.35

6.13

5.2

4.0

1.49

1.47

mg/l

0.22

294

2225

Congenital malformations of great veins

3.35

6.11

15.7

23.5

1.15

1.07

mg/l

0.48

Psoriasis vulgaris

266

1931

1.39

6.11

3.9

3.5

1.56

1.52

mg/l

0.38

245

1786

Primary open-angle glaucoma, strict

329

2463

1.34

6.08

2.9

2.7

1.75

mg/l

0.03

298

2178

Mental and behavioural disorders due to alcohol, excluding acute intoxication

677

5524

1.23

6.06

3.5

3.1

1.60

1.54

mg/l

0.95

621

5100

Other abnormal findings in urine

141

2.58

6.06

6.5

4.9

1.77

1.61

mg/l

0.59

126

Hyperkinetic disorders

237

1655

1.42

6.05

11.2

10.1

1.19

1.12

mg/l

1.00

231

1596

Sulfasalazine

362

2755

1.32

6.05

2.6

2.8

1.47

1.45

mg/l

0.25

324

2530

Bitten or struck by other mammals

164

1091

1.52

6.03

3.6

4.9

1.38

1.36

mg/l

0.11

149

1026

Sequelae of cerebrovascular disease

472

3203

1.28

6.01

3.4

2.8

1.92

1.70

mg/l

4.86

415

2858

Other specified/unspecified bacterial intestinal infections

586

1.72

5.96

5.0

4.2

1.81

1.52

mg/l

1.74

535

Disorders of continuity of bone

139

896

1.57

5.92

4.2

1.72

1.41

mg/l

2.73

126

837

Poisoning by medicine

310

2318

1.35

5.89

3.3

4.0

1.45

1.37

mg/l

1.09

287

2179

Bronchiectasis

111

679

1.66

5.89

5.2

3.8

1.65

mg/l

0.01

619

Muscular dystrophy

103

2.90

5.88

3.9

11.5

1.20

1.35

mg/l

0.60

Type 1 diabetes, strict definition, subgroup 1

153

1008

1.54

5.88

5.4

10.5

1.67

1.06

mg/l

16.18

145

981

Ulcer of oesophagus

100

596

1.70

5.87

3.5

2.8

2.04

1.67

mg/l

2.16

536

Cerebral aneurysm, nonruptured

120

750

1.62

5.84

3.9

3.1

1.52

mg/l

0.02

110

680

Macular pucker

200

1395

1.45

5.81

3.2

2.9

1.85

1.69

mg/l

1.38

173

1241

Excessive earwax

799

6523

1.20

5.79

4.6

4.1

1.57

1.56

mg/l

0.03

730

5969

Biological medication for rheuma

258

1883

1.38

5.76

3.2

5.1

1.29

1.35

mg/l

0.84

244

1783

Other perinatal digestive system disorders

8.87

5.76

16.4

23.4

1.23

1.07

mg/l

0.46

Non-allergic asthma (mode), excluding more controls

226

1596

1.41

5.75

6.6

3.7

1.48

1.31

mg/l

2.26

214

1459

Diaphragmatic hernia

467

3700

1.27

5.75

3.4

2.8

1.65

1.62

mg/l

0.36

430

3339

Delivery

304

2144

0.74

5.74

2.8

3.5

1.41

1.52

mg/l

1.79

284

1957

Early syphilis

127

2.62

5.73

2.0

2.8

1.14

1.35

mg/l

1.93

120

Type 1 diabetes, strict definition

161

1078

1.51

5.73

6.3

10.7

1.66

1.07

mg/l

16.39

153

1047

Use of other anti-dementia drugs

166

2014

0.68

5.72

2.0

2.5

1.63

1.90

mg/l

4.94

125

1752

Use of memantine

166

2014

0.68

5.72

2.0

2.5

1.63

1.90

mg/l

4.94

125

1752

Type1 diabetes, definitions combined, early onset

155

1031

1.52

5.70

6.7

12.1

1.63

1.12

mg/l

14.02

147

1000

Pneumococcal septicemia

331

1.95

5.67

10.7

8.1

1.54

1.50

mg/l

0.11

307

Unspecified chronic bronchitis

268

2.05

5.67

4.3

3.9

1.75

1.71

mg/l

0.13

245

Other and unspecified drugs and medicaments

122

772

1.60

5.66

7.0

4.1

1.71

1.50

mg/l

1.36

110

711

Complications of internal orthopaedic prosthetic devices, implants and grafts

280

2077

1.36

5.63

3.8

2.7

1.89

1.60

mg/l

4.95

253

1852

Acute generalized exanthematous pustulosis

418

1.83

5.61

5.9

5.5

1.45

1.47

mg/l

0.10

388

Other shoulder lesions

136

884

1.56

5.60

3.1

1.56

1.41

mg/l

1.12

130

818

Complications of other internal prosthetic devices, implants and grafts

325

1.94

5.60

6.5

4.0

1.98

1.51

mg/l

1.83

291

Marasmic kwashiorkor

5.87

5.59

33.7

18.3

1.32

1.47

mg/l

0.36

Other diseases of upper respiratory tract

1777

8199

1.13

5.56

4.2

4.4

1.47

1.51

mg/l

1.47

1638

7575

Complications following infusion, transfusion and therapeutic injection

129

2.57

5.55

8.0

3.8

1.53

1.43

mg/l

0.24

117

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

392

3056

1.29

5.52

3.0

3.6

1.44

1.38

mg/l

0.94

364

2870

Urticaria

428

3375

1.28

5.51

7.6

5.4

1.40

1.37

mg/l

0.26

400

3158

Transport accidents

669

4752

1.22

5.51

4.1

3.9

1.45

1.43

mg/l

0.33

615

4432

Disorders of conjunctiva

1253

8746

1.15

5.49

5.1

4.5

1.44

1.45

mg/l

0.19

1166

8098

Trigger finger

196

1378

1.43

5.47

4.6

3.0

1.78

1.47

mg/l

4.63

181

1266

Other/unspecified crystal arthropathies

3.49

5.44

4.3

2.2

1.59

1.71

mg/l

0.28

Varicose veins

785

4966

1.20

5.44

2.8

2.7

1.68

1.58

mg/l

2.83

701

4499

Visual field defects

121

772

1.59

5.44

5.4

3.8

1.67

1.58

mg/l

0.58

111

699

Early syphilis

113

2.68

5.41

1.8

2.8

1.16

1.36

mg/l

1.49

106

Faecal incontinence

111

694

1.62

5.41

2.9

2.5

1.66

1.57

mg/l

0.42

100

626

Paraplegia, diplegia of upper limbs

187

2.25

5.40

4.1

4.6

1.62

1.56

mg/l

0.16

171

Disturbances of skin sensation

359

2778

1.30

5.38

3.3

3.1

1.40

1.44

mg/l

0.34

333

2566

Alcohol use disorder, ICD-based

620

5107

1.22

5.37

3.5

3.1

1.60

1.54

mg/l

1.12

570

4710

Oxicams

238

1849

0.73

5.34

2.1

4.0

1.48

1.79

mg/l

6.52

215

1702

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

230

1671

1.39

5.32

3.0

4.0

1.45

1.36

mg/l

0.90

214

1579

Ulcerative proctitis

552

1.69

5.31

2.9

3.8

1.31

1.44

mg/l

1.26

517

All dysplastic lesions of the cervix uteri, vagina or vulva

311

2330

1.32

5.27

3.7

2.9

1.43

1.31

mg/l

1.85

293

2173

Non-small cell lung cancer

115

724

1.59

5.26

2.8

2.6

1.44

1.81

mg/l

5.80

107

633

Cardiac murmurs and other cardiac sounds

159

1072

1.48

5.24

11.2

9.6

1.40

1.26

mg/l

1.78

151

1012

Abnormal findings in secretions and smears from cervix uteri vagina vulva

544

3337

1.24

5.22

3.6

2.9

1.40

1.38

mg/l

0.34

518

3094

Ingrowing nail

540

1.69

5.22

5.9

5.1

1.66

1.38

mg/l

1.80

506

Chronic rhinitis, nasopharyngitis and pharyngitis

458

3667

1.26

5.20

3.8

4.5

1.43

1.46

mg/l

0.30

417

3415

Colonic or urogenital fistula

369

2880

1.29

5.20

3.7

3.1

1.56

1.53

mg/l

0.25

331

2647

Alzheimer disease

217

2183

0.72

5.18

2.4

2.5

1.80

1.88

mg/l

0.58

172

1907

Pyothorax

394

1.81

5.10

3.5

3.1

1.97

1.68

mg/l

1.46

356

Phobic anxiety disorders

191

1353

1.42

5.10

8.6

4.9

1.30

1.23

mg/l

0.83

184

1289

Cystic fibrosis, other manifestations/unspecified

8.99

5.09

5.8

7.2

1.64

1.18

mg/l

—

Myocardial infarction, with ST-elevation

235

1727

1.37

5.08

3.3

2.6

2.12

1.73

mg/l

6.40

208

1537

Other melanin hyperpigmentation

147

2.37

5.07

3.7

3.0

1.77

1.70

mg/l

0.15

132

Embedded teeth, including avohilmo

137

914

1.51

5.05

6.2

6.4

1.46

1.24

mg/l

2.76

132

866

Degenerative diseases of the nervous system

261

2552

0.75

5.03

2.5

2.6

1.77

1.83

mg/l

0.61

214

2245

Malignant melanoma of skin, including Hilmo

165

1143

1.46

5.02

3.7

2.7

1.66

1.70

mg/l

0.26

155

1005

Other and unspecified psoriasis

615

1.63

5.02

3.8

3.7

1.67

1.55

mg/l

0.64

568

Respiratory conditions due to other external agents

148

2.36

5.01

3.0

2.9

1.70

1.71

mg/l

0.01

131

Use of donepezil

112

1645

0.65

5.00

2.1

2.4

1.64

1.86

mg/l

2.07

1420

Inflammatory diseases of the central nervous system

123

804

1.55

5.00

5.6

4.3

1.61

1.47

mg/l

0.96

116

749

Soft tissue disorders related to use, overuse and pressure

363

2842

1.28

5.00

3.1

2.9

1.60

1.52

mg/l

1.23

330

2594

Embedded and impacted teeth

392

2551

1.28

4.97

7.6

5.6

1.35

1.25

mg/l

2.37

372

2423

Pediculosis, acariasis and other infestations

617

1.63

4.97

7.1

4.6

1.69

1.44

mg/l

1.41

581

Urethral stricture

511

1.69

4.90

4.7

3.0

1.91

1.64

mg/l

1.67

450

Suicide or other Intentional self-harm

337

2622

1.29

4.89

3.1

3.7

1.48

1.40

mg/l

1.20

317

2455

Atopic dermatitis, strict definition

451

3557

1.25

4.89

7.3

6.8

1.31

1.27

mg/l

0.65

434

3379

Bulimia nervosa (incl. atypical)

222

2.06

4.85

3.7

4.1

1.23

1.21

mg/l

0.06

207

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

113

731

1.57

4.84

3.4

3.7

1.41

1.30

mg/l

0.69

106

690

Allergic asthma (mode), excluding more controls

276

2047

1.33

4.83

3.2

3.5

1.26

1.23

mg/l

0.38

258

1910

Bilateral cryptorchidism (undescended testicles)

3.29

4.82

24.7

26.1

1.23

1.10

mg/l

0.64

Arthrosis

1007

4760

1.16

4.81

2.9

2.8

1.60

1.45

mg/l

5.79

921

4391

Complications of genitourinary prosthetic devices, implants and grafts

190

2.15

4.79

4.5

3.0

2.14

1.52

mg/l

3.05

173

Bullous disorders

508

1.68

4.76

4.4

3.6

1.87

1.62

mg/l

1.68

462

Superficial injury of head

340

2661

1.29

4.72

4.2

5.2

1.53

1.47

mg/l

0.74

305

2461

Chronic laryngitis and laryngotracheitis

183

1308

1.41

4.72

2.7

2.9

1.45

1.57

mg/l

1.04

165

1208

Benign neoplasm: Caecum

141

962

1.48

4.70

3.0

2.9

1.93

1.68

mg/l

2.11

127

868

Malignant neoplasm of lip, including Hilmo

3.20

4.69

3.5

2.0

1.68

1.90

mg/l

0.47

Poor fetal growth

131

880

1.50

4.68

3.6

3.0

1.37

1.24

mg/l

1.22

123

831

Disorders of adult personality and behaviour

383

3045

1.26

4.68

2.9

3.6

1.41

1.36

mg/l

0.49

351

2876

Nummular dermatitis

115

753

1.55

4.67

5.0

3.5

1.63

1.53

mg/l

0.52

107

687

Pain and other conditions associated with female genital organs and menstrual cycle

222

1505

1.36

4.65

5.0

3.7

1.28

1.34

mg/l

0.81

209

1409

Malignant neoplasm of bronchus and lung

203

1223

1.39

4.65

3.1

2.7

1.51

1.82

mg/l

5.86

191

1064

Spondylopathies (FG)

178

1270

1.41

4.64

2.7

3.1

1.45

1.35

mg/l

0.92

165

1193

Other specified and unspecified personality disorders

125

835

1.51

4.62

3.1

3.3

1.48

1.39

mg/l

0.62

119

791

Disorders of tyrosine metabolism

9.13

4.62

7.3

9.2

1.46

1.44

mg/l

—

Otitis externa, unspecified

163

1147

1.44

4.62

10.1

5.5

1.68

1.41

mg/l

3.20

154

1080

Other nutritional anaemias

2.90

4.62

2.5

2.8

1.89

1.62

mg/l

0.54

Deforming dorsopathies

390

3116

1.26

4.58

3.7

4.4

1.43

1.46

mg/l

0.35

359

2887

Hyperprolactinaemia

255

1.95

4.58

3.2

3.7

1.59

1.29

mg/l

1.33

237

Internal derangement of knee

511

4182

1.22

4.56

2.8

3.2

1.54

1.44

mg/l

1.52

461

3856

Spirochaetal infections, other/unspecified

249

3273

0.76

4.56

2.9

3.5

1.26

1.53

mg/l

10.27

229

3006

Malignant neoplasm of breast

417

2178

1.25

4.51

2.5

2.7

1.37

1.49

mg/l

2.66

371

1984

Need for immunization against other single infectious diseases

6.56

4.49

14.0

16.9

1.82

1.05

mg/l

1.72

Lyme disease

247

3242

0.76

4.48

2.9

3.5

1.25

1.53

mg/l

10.64

227

2975

Adhesive capsulitis of shoulder

218

1621

1.35

4.43

3.4

2.8

1.67

1.53

mg/l

1.46

198

1478

Other disorders of cornea

130

884

1.49

4.43

3.7

3.3

1.60

1.54

mg/l

0.41

118

813

Anogenital herpesviral [herpes simplex] infection

487

1.66

4.43

3.8

3.1

1.40

1.34

mg/l

0.37

461

Transient ischemic attack

665

4541

1.19

4.41

3.1

2.8

1.73

1.66

mg/l

1.37

592

4095

Rheumatoid arthritis, including avohilmo

475

3895

1.23

4.40

2.8

3.0

1.64

1.57

mg/l

0.79

418

3544

Superficial injury of thorax

204

1505

1.37

4.38

3.7

1.71

1.51

mg/l

1.77

187

1392

Other peripheral vascular diseases

100

645

1.57

4.36

2.8

3.1

1.49

1.47

mg/l

0.07

589

Other disorders of bone

259

1980

1.32

4.35

5.8

3.9

1.33

1.40

mg/l

1.10

239

1840

Pneumonia due to Streptococcus pneumoniae

332

1.80

4.34

7.0

4.3

1.59

1.47

mg/l

0.45

301

Other disorders of pigmentation

347

1.79

4.34

4.4

4.8

1.82

1.46

mg/l

1.93

315

Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms

13.61

4.34

2.6

1.9

1.32

1.57

mg/l

—

Normotensive glaucoma

105

686

1.55

4.34

3.0

2.8

1.71

1.73

mg/l

0.06

610

Viral agents as the cause of diseases classified to other chapters

233

1.98

4.33

13.7

7.9

1.57

1.38

mg/l

0.64

217

Drug-induced hypopituitarism

10.02

4.33

14.3

14.5

1.49

1.60

mg/l

—

Asthma and allergy, excluding more controls

160

1120

1.42

4.32

3.7

4.2

1.22

1.16

mg/l

0.65

151

1058

Gonarthrosis [arthrosis of knee](FG)

1000

5054

1.15

4.32

2.7

1.65

1.47

mg/l

7.92

907

4636

Superficial injury of abdomen, lower back and pelvis

205

1518

1.36

4.30

4.4

4.9

1.52

1.43

mg/l

0.68

192

1409

Other inflammation of eyelid

178

1289

1.39

4.30

5.1

4.2

1.48

1.50

mg/l

0.12

167

1184

Pain associated with micturition

146

1022

1.44

4.28

4.6

4.9

1.50

1.47

mg/l

0.20

138

945

Tonsillectomy and adenotomy

872

5240

1.16

4.27

6.6

5.4

1.22

1.32

mg/l

4.55

825

4967

Other spirochaetal diseases

254

3298

0.77

4.27

3.0

3.6

1.27

1.52

mg/l

8.39

234

3027

Other condition

203

1504

1.36

4.26

6.8

4.1

1.59

1.45

mg/l

1.29

187

1398

Scleritis and episcleritis

516

1.63

4.25

3.4

3.3

1.54

1.43

mg/l

0.67

481

Benign neoplasm of middle ear and respiratory system

107

706

1.53

4.24

2.8

3.4

1.44

1.60

mg/l

1.25

101

647

Paralytic ileus

306

1.83

4.22

3.8

3.5

1.76

1.68

mg/l

0.30

269

Eustachian salpingitis and obstruction

117

788

1.50

4.21

5.3

3.9

1.41

1.28

mg/l

1.11

112

746

Right bundle-branch block

249

1.92

4.19

3.1

3.2

1.72

1.46

mg/l

1.37

227

Somatoform disorder

204

1516

1.35

4.19

2.9

3.4

1.37

1.42

mg/l

0.46

181

1414

Malignant neoplasm of breast, HER2-negative, including Hilmo

423

2217

1.24

4.18

2.5

2.7

1.38

1.48

mg/l

2.11

376

2021

Malignant neoplasm of breast, including Hilmo

423

2217

1.24

4.18

2.5

2.7

1.38

1.48

mg/l

2.11

376

2021

Other disorders of eye and adnexa

192

1415

1.37

4.17

6.9

5.2

1.51

1.41

mg/l

0.90

182

1320

Other and unspecified mononeuropathies, also in other diseases

250

1.92

4.17

3.9

3.0

1.90

1.64

mg/l

0.94

226

Persons encountering health services in circumstances related to reproduction

930

5444

1.15

4.16

6.5

5.3

1.24

1.38

mg/l

7.66

878

5139

Malignant neoplasm of breast, HER2-negative

409

2160

1.24

4.16

2.5

2.8

1.38

1.49

mg/l

2.55

365

1967

Other symptoms and signs involving the nervous and musculoskeletal systems

582

4894

1.19

4.15

5.1

4.3

1.49

mg/l

0.06

541

4509

Panic disorder

187

1374

1.37

4.13

4.0

3.8

1.38

1.31

mg/l

0.72

177

1310

Benign neoplasm: salivary glands, exclude unknown (D119)

113

759

1.50

4.12

3.3

2.9

1.54

1.58

mg/l

0.19

100

693

Aggressive periodontitis

182

2.08

4.11

2.6

3.1

1.48

1.53

mg/l

0.17

168

Listeriosis

4.44

4.11

3.7

1.8

2.07

1.64

mg/l

0.74

Benign neoplasm: Rectum, anus and anal canal

257

1982

1.31

4.09

3.0

2.8

1.68

1.65

mg/l

0.22

236

1791

Injury of unspecified body region

113

761

1.50

4.08

4.7

5.6

1.90

1.48

mg/l

2.81

102

698

Open bite

108

722

1.52

4.08

20.7

11.6

1.15

1.17

mg/l

0.18

103

695

Propionic acid derivatives

412

2548

0.81

4.08

4.2

6.6

1.44

1.60

mg/l

3.54

373

2382

Congenital absence, atresia and stenosis of small intestine

5.73

4.07

17.2

16.8

1.03

1.09

mg/l

0.18

Asthma mixed form (mode), excluding more controls

354

1.74

4.05

3.6

4.0

1.48

1.30

mg/l

1.15

326

Anorexia (incl.atypical)

531

1.60

4.02

5.4

5.7

1.34

1.31

mg/l

0.15

497

Redundant prepuce, phimosis and paraphimosis

334

2640

1.26

4.02

4.5

4.2

1.66

1.43

mg/l

4.56

303

2468

Benign neoplasm: Descending colon

611

1.56

4.02

4.0

2.9

1.76

1.65

mg/l

0.57

555

113

736

1.52

4.01

23.3

19.1

1.13

1.03

mg/l

1.76

113

724

Tobacco use

470

1.64

4.01

3.5

3.0

1.78

1.48

mg/l

1.95

434

Paget disease

3.45

4.00

2.4

2.1

1.90

1.70

mg/l

0.41

Other noninflammatory disorders of vagina

603

1.56

4.00

3.2

3.1

1.56

1.43

mg/l

0.73

563

Maternal care for other conditions predominantly related to pregnancy

216

1598

1.33

4.00

3.4

3.0

1.34

1.26

mg/l

0.92

202

1505

Later onset COPD

341

2168

1.26

3.99

2.3

2.7

2.05

1.83

mg/l

3.39

292

1902

COPD, hospital admissions 1, only main diagnosis

442

3110

1.22

3.97

2.5

3.0

1.93

1.72

mg/l

3.67

380

2793

Paracetamol or NSAID medication

331

1315

1.27

3.97

6.5

8.1

1.42

1.38

mg/l

0.38

309

1248

Benign neoplasm: Pituitary gland, craniopharyngeal duct

456

1.65

3.96

3.1

3.7

1.40

1.49

mg/l

0.56

420

Non-allergic asthma (mode)

227

1711

1.32

3.96

6.6

3.7

1.48

1.39

mg/l

0.81

215

1558

Impacted cerumen

144

1022

1.42

3.96

5.6

5.4

1.72

1.53

mg/l

1.16

125

932

Other spirochaetal diseases

261

3341

0.78

3.96

3.0

3.6

1.28

1.52

mg/l

7.85

241

3070

Endometriosis of pelvic peritoneum

173

1204

1.38

3.96

2.2

3.1

1.22

1.41

mg/l

3.59

160

1121

Erectile dysfunction

113

767

1.49

3.95

6.2

3.9

1.75

1.74

mg/l

0.05

690

Hypothyroidism due to medicaments and other exogenous substances

2.58

3.95

6.4

4.0

1.66

1.56

mg/l

0.23

Other headache syndromes

527

4412

1.20

3.93

3.7

3.6

1.35

1.45

mg/l

2.30

484

4076

Striking against or struck by other objects

517

4325

1.20

3.92

4.8

5.4

1.47

1.40

mg/l

1.25

477

4047

Benign neoplasm: Sigmoid colon

240

1847

1.31

3.90

3.4

2.8

1.75

1.65

mg/l

0.93

223

1671

malignant neoplasm of male genital organs

370

1813

1.25

3.90

2.8

1.71

1.76

mg/l

0.39

331

1608

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

13.81

3.89

3.5

2.0

1.20

1.64

mg/l

—

Benign neoplasm: Rectum

228

1744

1.32

3.88

3.0

2.8

1.61

1.64

mg/l

0.18

208

1590

Hypertrophy of tongue papillae

101

2.45

3.88

3.2

2.9

1.81

1.53

mg/l

0.48

Atrophic disorders of skin

170

1245

1.38

3.87

5.3

3.6

1.44

mg/l

0.00

154

1145

Benign neoplasm: Ascending colon

172

1265

1.37

3.83

3.9

2.8

1.86

1.67

mg/l

1.90

164

1141

Amblyopia ex anopsia

556

1.58

3.82

15.5

12.2

1.37

1.26

mg/l

0.83

525

Benign neoplasm: Parotid gland

103

691

1.51

3.82

3.3

2.9

1.56

1.59

mg/l

0.18

629

Other and unspecified injuries of lower leg

108

732

1.49

3.81

3.7

5.3

1.49

1.38

mg/l

0.65

688

Adverse effects, not elsewhere classified

266

2082

1.29

3.80

6.1

5.8

1.50

1.38

mg/l

1.74

247

1948

HSIL lesion of the cervix uteri, vagina or vulva

205

1550

1.33

3.78

3.5

2.9

1.43

1.31

mg/l

1.28

196

1460

Epilepsy

455

3768

1.21

3.77

5.5

5.6

1.54

1.45

mg/l

1.38

417

3496

Malignant neoplasm of renal pelvis

4.01

3.76

2.1

1.83

1.84

mg/l

0.01

Behavioural syndromes associated with physiological disturbances and physical factors

1366

8687

1.12

3.76

3.9

4.0

1.38

1.47

mg/l

3.85

1262

8051

Single delivery by forceps and vacuum extractor

864

0.66

3.75

1.8

3.8

1.11

1.34

mg/l

3.32

812

Emotionally unstable personality disorder

153

1108

1.39

3.74

2.7

3.7

1.32

1.29

mg/l

0.21

143

1058

Injuries to the wrist and hand

1517

9481

1.11

3.73

3.7

4.3

1.43

1.49

mg/l

2.33

1401

8778

Haemorrhoids and perianal venous thrombosis

391

3196

1.23

3.72

2.7

2.8

1.63

1.57

mg/l

0.77

353

2882

Conjunctivitis

1094

8106

1.13

3.72

5.2

4.6

1.39

1.42

mg/l

0.84

1021

7524

Acute nasopharyngitis (common cold)

182

1348

1.35

3.72

4.6

3.7

1.50

1.37

mg/l

1.34

172

1267

Asthma and allergy

160

1153

1.38

3.71

3.7

4.2

1.22

1.19

mg/l

0.29

151

1084

Melanoma of uvea

2.56

3.70

2.8

2.7

1.85

1.63

mg/l

0.43

Fall on same level involving ice and snow

782

6803

1.15

3.69

4.0

3.6

1.59

1.51

mg/l

1.77

715

6236

Other/unspecified rheumatoid arthritis

145

1044

1.40

3.68

3.6

2.9

1.75

1.61

mg/l

1.00

131

936

Follow-up examination after treatment for malignant neoplasms

126

885

1.44

3.68

3.2

2.5

1.74

1.71

mg/l

0.16

115

781

Melanocytic naevi of upper limb, including shoulder

204

1.95

3.68

8.5

4.8

1.69

1.45

mg/l

0.89

186

Reactive arthropathies, FINNGEN

616

1.53

3.67

3.5

4.2

1.53

1.37

mg/l

1.32

571

Cystic fibrosis with pulmonary manifestations

7.11

3.67

6.1

6.2

1.68

1.34

mg/l

—

Arthropathy in hypersensitivity reactions classified elsewhere

7.11

3.67

13.9

6.6

0.97

1.13

mg/l

—

Superficial injury of hip and thigh

183

1368

1.35

3.66

3.5

3.6

1.66

1.58

mg/l

0.53

164

1226

Dysplasia of cervi uteri

251

1412

1.29

3.63

3.9

3.1

1.38

1.41

mg/l

0.26

236

1321

Benign neoplasm of major salivary glands

122

855

1.44

3.63

3.3

2.9

1.56

1.59

mg/l

0.16

108

779

Heterophoria

117

814

1.45

3.63

9.2

7.9

1.41

1.32

mg/l

0.51

108

768

Persistent mood disorders

237

1840

1.30

3.63

3.6

3.1

1.53

1.45

mg/l

0.78

214

1695

Allergic asthma (mode)

276

2137

1.27

3.61

3.2

3.6

1.26

1.27

mg/l

0.14

258

1990

Monoarthritis, not elsewhere classified

352

1.70

3.61

3.8

3.3

1.64

1.42

mg/l

0.86

326

Use of levodopa decarboxylase inhibitor

1230

0.65

3.60

2.6

2.8

1.62

1.75

mg/l

0.82

1088

Retinal breaks without detachment

198

1504

1.33

3.58

3.7

2.8

1.57

1.54

mg/l

0.22

180

1383

Congenital malformations of genital organs

146

1053

1.39

3.57

8.8

9.9

1.23

1.22

mg/l

0.06

140

1015

Marginal zone B-cell lymphoma, including Hilmo

105

2.34

3.57

3.4

2.5

1.74

1.68

mg/l

0.14

Other disorders of penis

162

1196

1.37

3.57

6.2

6.6

1.58

1.44

mg/l

1.12

144

1114

Personality disorders

349

2842

1.23

3.56

3.0

3.3

1.43

1.37

mg/l

0.70

321

2686

Benign neoplasm: Stomach

118

826

1.44

3.54

4.5

3.0

1.84

1.62

mg/l

1.87

110

748

Other keratitis

150

1095

1.38

3.53

5.9

3.6

1.64

1.44

mg/l

1.75

142

1019

Unspecified protein-energy malnutrition

2.90

3.51

7.4

6.5

1.51

1.50

mg/l

0.02

Chronic sinusitis

572

4877

1.18

3.50

3.6

3.3

1.45

1.51

mg/l

0.98

524

4481

Nutritional and metabolic disorders in diseases classified elsewhere

9.80

3.50

41.1

23.5

1.43

0.90

mg/l

—

Seronegative rheumatoid arthritis

132

945

1.41

3.49

2.6

2.7

1.60

1.45

mg/l

0.97

111

860

Non-selective monoamine reuptake inhibitors

470

3804

1.20

3.47

2.6

2.9

1.54

1.59

mg/l

0.52

410

3470

Viral agents as the cause of diseases classified to other chapters

260

1.81

3.44

13.5

7.9

1.55

1.37

mg/l

0.62

242

Other and unspecified urticaria

265

2102

1.27

3.44

7.0

5.8

1.40

1.38

mg/l

0.21

246

1966

Allergic bronchopulmonary aspergillosis (ABPA)

5.25

3.43

2.1

3.3

1.37

1.22

mg/l

—

Achalasia of cardia

147

2.09

3.41

2.9

2.7

1.45

1.65

mg/l

0.78

133

Other and unspecified effects of external causes

385

3183

1.22

3.40

5.3

1.49

1.38

mg/l

2.02

354

2988

Ethmoidectomy

168

1257

1.35

3.39

2.8

3.3

1.35

1.47

mg/l

1.18

149

1174

Impacted teeth

274

1942

1.26

3.38

8.3

6.2

1.30

1.22

mg/l

1.22

259

1853

Paralytic strabismus

629

1.49

3.36

4.3

4.0

1.59

mg/l

0.02

568

Anisometropia and aniseikonia

322

1.71

3.36

15.6

7.4

1.35

1.39

mg/l

0.18

299

Migraine without aura

254

2011

1.27

3.35

6.7

6.0

1.23

1.27

mg/l

0.40

242

1902

Follicular cysts of skin and subcutaneous tissue

235

1845

1.28

3.34

4.3

3.4

1.60

1.51

mg/l

0.86

226

1702

Periapical abscess

639

5526

1.16

3.33

4.0

1.50

1.48

mg/l

0.31

589

5126

Intermittent heterotropia

112

787

1.44

3.33

15.7

11.6

1.23

mg/l

0.00

101

752

Ascorbic acid deficiency

5.71

3.33

31.1

12.9

1.00

1.14

mg/l

—

Dentofacial anomalies [including malocclusion]

965

6876

1.13

3.32

6.2

3.7

1.28

1.42

mg/l

7.14

893

6429

Other, unspecified and serous retinal detachments

263

1.78

3.31

3.6

3.3

1.62

1.65

mg/l

0.11

244

FESS (DNB20)

162

1211

1.35

3.31

2.9

3.3

1.35

1.47

mg/l

1.29

143

1131

Specific personality disorders

298

2409

1.24

3.29

3.0

3.4

1.40

1.37

mg/l

0.24

278

2275

Other (seronegative) rheumatoid arthritis, wide

223

1744

1.29

3.27

3.0

2.9

1.67

1.58

mg/l

0.71

195

1593

Dextrocardia

6.09

3.26

18.1

31.9

1.08

1.02

mg/l

—

Disorders of synovium and tendon

720

5503

1.15

3.25

4.5

3.3

1.60

1.47

mg/l

3.56

665

5075

Myocardial infarction, unclassifiable

266

1895

1.26

3.24

3.3

2.7

2.12

1.79

mg/l

5.59

247

1674

Speech therapy

338

2775

1.22

3.23

4.4

3.7

1.56

1.55

mg/l

0.06

293

2548

Asthma, hospital admissions , main diagnosis only

1200

9531

1.11

3.23

4.4

1.47

mg/l

0.05

1115

8819

Asthma mixed form (mode)

379

1.62

3.21

3.6

4.1

1.48

1.36

mg/l

0.67

343

Polymyalgia rheumatica

151

1122

1.36

3.21

2.4

2.6

1.88

1.73

mg/l

1.13

127

990

Unspecified event, undetermined intent

251

1.79

3.21

3.4

5.7

1.65

1.40

mg/l

0.98

238

Alcohol induced polyneuropathy

2.43

3.21

3.3

3.0

1.69

1.65

mg/l

0.06

Malignant neoplasm of breast, ER-positive, including Hilmo

305

1904

1.24

3.21

2.6

2.7

1.38

1.52

mg/l

2.66

271

1726

Endometriosis of ovary

176

1304

1.32

3.20

2.9

3.1

1.33

1.46

mg/l

1.67

165

1205

Mixed and other personality disorders

106

743

1.44

3.20

3.0

3.2

1.52

1.37

mg/l

0.85

705

Anaemia due to enzyme disorders

6.86

3.18

9.4

9.2

1.02

1.44

mg/l

—

Superficial injury of ankle and foot

179

1371

1.32

3.11

6.8

6.5

1.49

1.29

mg/l

1.71

166

1297

LSIL lesion of the cervix uteri, vagina or vulva

144

1068

1.36

3.10

3.8

2.8

1.40

1.34

mg/l

0.52

133

1007

Sudden idiopathic hearing loss

124

899

1.39

3.10

3.7

3.0

1.72

1.60

mg/l

0.64

112

824

Ptosis of eyelid

137

1010

1.37

3.09

3.3

3.5

1.50

1.63

mg/l

1.14

128

914

Ectropion of eyelid

300

1.69

3.05

3.4

2.9

1.83

1.86

mg/l

0.08

260

671

1.47

3.03

23.4

19.9

1.13

1.03

mg/l

1.71

660

Mental and behavioural disorders due to sedatives or hypnotics

661

1.45

3.01

3.0

3.4

1.51

1.39

mg/l

0.67

619

Parkinson's disease

1394

0.71

3.01

2.3

2.7

1.59

1.73

mg/l

1.17

1237

Disorders of muscles

134

989

1.37

3.01

4.2

3.4

1.62

1.46

mg/l

1.12

123

909

Haemangioma, any site

114

820

1.40

3.00

5.6

5.4

1.46

1.48

mg/l

0.08

106

760

Use of rivastigmine

1226

0.69

3.00

2.0

2.4

1.68

1.87

mg/l

1.37

1046

Other sexually transmitted chlamydial diseases

124

904

1.38

3.00

3.6

4.2

1.20

1.18

mg/l

0.12

118

852

Parkinson's disease, including avohilmo

104

1451

0.71

2.99

2.3

2.8

1.57

1.73

mg/l

1.41

1291

Adalimumab

132

974

1.37

2.98

3.2

5.3

1.27

1.35

mg/l

0.80

126

931

Intracerebral haemorrhage

151

1137

1.34

2.97

6.0

3.0

1.79

1.71

mg/l

0.47

139

1004

Parkinson's disease, strict definition

1272

0.70

2.96

2.2

2.7

1.54

1.75

mg/l

1.91

1123

Voice disturbances

320

2640

1.22

2.95

3.5

3.3

1.46

1.53

mg/l

0.98

291

2427

Congenital malformations of eye, ear, face and neck

111

799

1.41

2.94

9.4

10.4

1.38

1.26

mg/l

0.87

103

763

Anogenital herpesviral [herpes simplex] infection

123

902

1.37

2.88

4.0

3.2

1.34

1.30

mg/l

0.32

114

849

Other infective otitis externa

544

1.49

2.87

5.2

4.0

1.60

1.50

mg/l

0.49

504

Thyrotoxicosis, other and/or unspecified

228

1820

1.26

2.87

3.1

3.3

1.62

1.47

mg/l

1.96

211

1681

Malignant melanoma of skin

115

835

1.39

2.87

3.5

2.7

1.64

1.69

mg/l

0.27

108

742

Diabetes mellitus in pregnancy

328

1731

1.22

2.86

3.5

3.2

1.41

1.22

mg/l

5.15

311

1635

Family history of malignant neoplasm

108

776

1.40

2.86

3.6

2.4

1.29

1.24

mg/l

0.39

722

Malignant neoplasm of breast, HER-positive

295

1882

1.23

2.85

2.6

2.8

1.37

1.52

mg/l

2.76

263

1704

Traumatic subdural haemorrhage

159

1164

1.32

2.85

4.7

2.8

2.06

1.68

mg/l

4.19

137

1052

Benign neoplasm: Other parts of oropharynx

2.47

2.85

3.4

2.5

1.24

1.53

mg/l

1.25

Benign neoplasm: Adrenal gland

669

1.43

2.85

2.7

3.0

1.54

1.58

mg/l

0.23

613

Haemangioma and lymphangioma, any site

122

897

1.37

2.84

5.8

5.4

1.46

mg/l

0.01

114

834

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

172

1328

1.30

2.84

3.5

3.6

1.31

1.34

mg/l

0.27

162

1241

Tumor necrosis factor alpha inhibitors

210

1664

1.27

2.84

3.3

5.2

1.29

1.35

mg/l

0.62

198

1579

Malignant neoplasm of pancreas, including Hilmo

595

1.46

2.82

1.9

2.6

1.50

1.75

mg/l

2.45

521

Short Achilles tendon (acquired)

221

0.36

2.81

2.0

2.7

1.36

1.44

mg/l

—

207

Oesophageal obstruction

277

1.68

2.80

3.4

2.6

1.67

1.77

mg/l

0.27

248

Injury of muscle and tendon at lower leg level

205

1623

1.27

2.80

3.3

3.1

1.53

1.52

mg/l

0.04

192

1501

Valgus deformity, not elsewhere classified

2.44

2.78

21.6

5.1

1.32

1.38

mg/l

0.12

Obstructed labour due to malposition and malpresentation of fetus

145

1773

0.76

2.77

2.6

3.2

1.32

1.31

mg/l

0.06

138

1670

Perforation of tympanic membrane

126

937

1.36

2.73

5.8

4.5

1.48

1.45

mg/l

0.14

120

862

219

1.77

2.73

13.5

9.6

1.14

1.05

mg/l

0.55

210

Gonococcal infection

326

1.62

2.72

2.4

3.8

1.16

1.38

mg/l

2.67

309

Schizophrenia

132

1745

0.75

2.71

3.0

3.2

1.57

1.43

mg/l

1.21

122

1641

Scabies

470

1.51

2.71

8.2

4.9

1.73

1.39

mg/l

1.57

440

Perforation of oesophagus

2.91

2.70

4.8

2.3

1.19

1.67

mg/l

2.14

Migraine with aura

293

2421

1.21

2.69

4.5

4.4

1.28

1.33

mg/l

0.67

275

2267

Scoliosis

117

863

1.37

2.68

5.1

7.0

1.26

1.38

mg/l

1.12

108

813

Seropositive rheumatoid arthritis, wide

308

2559

1.21

2.68

2.7

2.9

1.68

1.60

mg/l

0.87

276

2328

Nosocomial condition (hospital)

2.76

2.67

5.2

2.1

1.75

1.58

mg/l

0.27

Factitial dermatitis

3.05

2.67

3.2

4.0

1.81

1.42

mg/l

0.62

Injury of eye and orbit

201

1598

1.27

2.67

5.0

4.3

1.38

1.43

mg/l

0.34

188

1491

Other mycoses, not elsewhere classified/unspecified

134

1.98

2.64

6.3

2.9

1.67

1.41

mg/l

0.75

121

Multiple delivery

767

0.63

2.62

2.8

3.6

1.37

1.47

mg/l

0.35

713

Car occupant injured in other and unspecified transport accidents

237

1924

1.24

2.61

4.3

3.8

1.56

1.42

mg/l

1.56

222

1796

Malignant neoplasm of rectum, including Hilmo

126

946

1.34

2.58

2.4

2.7

1.74

mg/l

0.01

114

827

Calculus of lower urinary tract

476

1.49

2.56

3.1

2.9

1.55

1.70

mg/l

0.93

422

Dementia due to Parkinson's disease

195

0.35

2.56

1.0

2.6

1.39

1.91

mg/l

—

170

Barrett oesophagus

412

1.52

2.53

2.9

3.1

1.78

1.58

mg/l

0.94

372

Pleural plaque

113

838

1.36

2.53

2.5

2.6

1.81

1.80

mg/l

0.06

101

716

Left bundle-branch block

526

1.46

2.53

2.7

1.82

1.46

mg/l

3.22

481

Aneurysms, operations, SAH

193

1539

1.26

2.51

3.8

2.9

1.62

1.58

mg/l

0.27

176

1390

Adenomyosis (Endometriosis of uterus)

139

1063

1.31

2.51

2.4

3.0

1.44

1.51

mg/l

0.45

126

975

Psoriatic arthropathies

123

925

1.34

2.51

2.6

2.8

1.49

1.39

mg/l

0.65

105

862

Dislocation of lens

102

2.10

2.50

4.3

2.5

2.04

1.65

mg/l

0.95

Leukaemia of unspecified cell type

2.20

2.50

33.1

4.6

1.18

1.54

mg/l

1.73

Sexual dysfunction

130

1.96

2.49

4.2

3.2

1.55

1.45

mg/l

0.22

122

Status post-ami

307

1953

1.20

2.49

3.4

2.5

2.13

1.60

mg/l

14.46

274

1749

Childhood allergy (age < 16)

246

1659

1.23

2.48

10.4

11.1

1.14

1.12

mg/l

0.28

237

1602

Marginal zone B-cell lymphoma

2.52

2.48

3.1

2.3

1.60

1.54

mg/l

0.13

Localized scleroderma [morphea]

2.18

2.47

2.8

2.2

1.50

1.57

mg/l

0.11

Leiomyosarcoma, including Hilmo

2.61

2.47

1.7

2.2

1.71

1.69

mg/l

0.03

Familial hypercholesterolemia, with ischemic heart disease

105

773

1.37

2.47

3.8

2.5

1.92

1.65

mg/l

2.59

683

Diplopia

160

1251

1.29

2.46

3.6

1.53

1.55

mg/l

0.12

143

1141

Rare circulating lymphoid malignancy

3.00

2.45

19.6

5.2

1.55

1.84

mg/l

0.58

Abrasion of teeth

412

3541

1.17

2.45

3.2

1.42

1.48

mg/l

1.15

387

3263

Colorectal cancer

234

1869

1.23

2.44

3.0

2.6

1.87

1.76

mg/l

0.88

210

1647

Deep endometriosis

681

1.39

2.44

1.9

2.9

1.23

1.45

mg/l

3.12

627

Unspecified/other endometriosis

647

1.40

2.43

2.6

3.2

1.29

1.31

mg/l

0.08

607

Interstitial emphysema and related conditions originating in the perinatal period

2.78

2.43

34.9

15.1

1.38

1.01

mg/l

1.55

Gonarthrosis

842

4303

1.12

2.41

2.7

1.64

1.48

mg/l

5.82

764

3949

Premature rupture of membranes

137

1271

0.77

2.40

2.6

3.2

1.14

1.31

mg/l

3.19

130

1196

Pediculosis, acariasis and other infestations

224

1827

1.23

2.40

5.4

5.8

1.48

1.33

mg/l

1.53

211

1730

Arthropathic psoriasis

141

1089

1.30

2.40

3.1

3.2

1.53

1.50

mg/l

0.14

121

1018

Spontaneous rupture of synovium and tendon

102

752

1.37

2.39

3.3

2.7

1.75

1.54

mg/l

1.39

687

Thyrotoxicosis

286

2390

1.20

2.38

3.0

3.2

1.65

1.50

mg/l

2.00

261

2200

Long labour

161

1745

0.79

2.38

2.4

3.2

1.36

1.31

mg/l

0.36

152

1643

Malignant neoplasm of colon

144

1116

1.30

2.37

3.2

2.6

1.91

1.78

mg/l

0.74

127

972

Fibroblastic disorders

291

2438

1.20

2.37

3.3

2.8

1.65

1.60

mg/l

0.43

265

2210

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

508

4425

1.15

2.36

4.6

4.8

1.37

1.33

mg/l

0.65

476

4162

Sequelae of other external causes

501

1.45

2.36

5.9

3.7

1.72

1.50

mg/l

1.23

462

Separation of retinal layers (serosa)

396

1.51

2.33

4.7

2.9

1.57

1.49

mg/l

0.32

370

All dysplastic lesions of the cervix uteri

250

2050

1.21

2.33

3.9

2.9

1.40

1.31

mg/l

1.02

237

1919

Unspecified parasitic disease

2.29

2.32

4.5

2.8

1.71

1.51

mg/l

0.36

Memory loss

780

0.66

2.32

3.1

2.7

1.41

1.70

mg/l

2.49

696

Abnormal pulmonary venous return

2.64

2.32

14.1

18.6

1.10

1.08

mg/l

0.11

Other and unspecified mood [affective] disorders

637

1.39

2.31

3.7

4.5

1.50

1.28

mg/l

1.25

602

Anti-inflammatory and antirheumatic products, non-steroids

439

2549

0.86

2.30

4.3

6.6

1.47

1.60

mg/l

2.66

407

2383

Fracture of neck

538

1.43

2.29

3.8

3.0

1.69

1.64

mg/l

0.18

483

Mental retardation

102

756

1.36

2.28

12.8

15.2

1.12

1.18

mg/l

0.56

734

Maternal care related to the fetus and amniotic cavity and possible delivery problems

358

2460

0.85

2.28

2.7

3.4

1.25

1.36

mg/l

2.56

337

2299

Other and unspecified visual disturbances

121

923

1.32

2.27

2.4

3.9

1.50

1.51

mg/l

0.04

114

847

Other sexually transmitted chlamydial diseases

547

1.42

2.26

3.3

3.6

1.23

1.21

mg/l

0.15

515

Supernumerary ureter

3.63

2.26

2.1

20.3

1.28

1.16

mg/l

—

Malignant neoplasm of colon, including Hilmo

188

1514

1.25

2.26

3.3

2.7

1.84

1.77

mg/l

0.40

169

1328

Other bursitis of elbow

2.26

2.25

3.7

2.8

1.52

1.62

mg/l

0.30

Other and unspecified abdominal hernia

351

1.53

2.24

6.7

3.6

1.74

1.62

mg/l

0.38

320

Status epilepticus

352

1.52

2.22

6.2

1.76

1.47

mg/l

1.02

322

Other secondary gonarthrosis

475

1.45

2.21

3.4

3.0

1.61

1.58

mg/l

0.11

433

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

294

2483

1.19

2.21

2.8

2.9

1.69

1.59

mg/l

1.10

263

2265

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

662

1.37

2.18

4.1

5.7

1.36

1.39

mg/l

0.14

620

Viral haemorrhagic fevers, not elsewhere classified/unspecified

722

1.35

2.17

3.0

3.2

1.51

1.53

mg/l

0.07

667

Other/unspecified seropositive rheumatoid arthritis

298

2524

1.19

2.17

2.8

2.9

1.69

1.60

mg/l

1.00

266

2296

Sequelae of infectious and parasitic diseases

645

1.37

2.17

4.1

2.9

1.72

1.52

mg/l

1.14

597

Burkitt lymphoma, helper endpoint

4.71

2.16

28.8

10.1

1.06

1.28

mg/l

—

Malignant neoplasm of lip

2.84

2.16

2.3

1.97

1.92

mg/l

—

Monoamine oxidase A inhibitors

138

1080

1.29

2.15

3.1

2.9

1.48

1.55

mg/l

0.52

122

993

Superficial injury of forearm

129

1002

1.30

2.14

4.8

5.9

1.45

1.38

mg/l

0.46

117

937

Acute gastritis

621

1.38

2.14

3.0

3.1

1.80

1.57

mg/l

1.36

558

Alzheimer’s disease (Atypical or mixed), excluding more controls

505

1.38

2.14

2.7

2.3

2.03

1.87

mg/l

0.84

438

Inguinal hernia

894

5426

1.10

2.14

4.7

3.8

1.58

1.52

mg/l

1.37

819

5001

Wet age-related macular degeneration

177

1384

1.25

2.14

3.3

2.4

1.92

1.83

mg/l

0.60

149

1190

Shigellosis

3.34

2.13

2.1

2.2

1.55

1.62

mg/l

—

Sequelae of other and unspecified infectious and parasitic diseases

496

1.42

2.12

4.4

3.0

1.60

1.41

mg/l

0.98

470

Pleural plaque with presence of asbestos

640

1.37

2.11

2.6

2.7

1.80

1.86

mg/l

0.24

553

Benign neoplasm: Small intestine

332

1.52

2.11

4.3

3.2

1.79

1.67

mg/l

0.34

302

Endometriosis ASRM stages 1,2

176

1423

1.24

2.09

2.3

3.0

1.22

1.37

mg/l

2.57

163

1331

Assault

181

1469

1.24

2.09

4.3

3.8

1.52

1.35

mg/l

1.85

171

1393

Female infertility, cervical, vaginal, other or unspecified origin

267

1455

1.20

2.08

2.9

3.1

1.29

1.40

mg/l

1.95

247

1357

False labour

213

1610

0.82

2.07

2.4

3.5

1.12

1.29

mg/l

4.89

203

1514

Malignant neoplasm of other and ill-defined sites, including Hilmo

2.01

2.07

3.5

4.1

1.47

1.63

mg/l

0.29

Inguinal or femoral hernia, bilateral

146

1158

1.27

2.07

4.8

3.4

1.71

1.68

mg/l

0.10

138

1055

Other female pelvic inflammatory diseases

157

1255

1.26

2.07

2.9

2.8

1.50

1.45

mg/l

0.35

143

1154

Benign neoplasm: Skin of eyelid, including canthus

174

1408

1.24

2.06

2.9

3.0

1.54

1.61

mg/l

0.63

164

1275

Infarction of spleen

2.48

2.06

2.4

2.5

1.54

1.75

mg/l

0.62

Other maternal disorders predominantly related to pregnancy

588

3280

1.13

2.04

3.2

1.44

1.37

mg/l

1.33

550

3050

Pectus carinatum

3.62

2.03

13.1

10.3

1.50

1.13

mg/l

—

Ovarian dysfunction, other/unspecified

2.71

2.03

4.3

4.0

0.93

1.18

mg/l

—

Other and unspecified injuries of ankle and foot

435

1.44

2.00

6.3

6.9

1.57

1.29

mg/l

1.31

412

Perioral dermatitis

171

1.72

1.99

15.8

3.7

1.55

1.30

mg/l

0.81

154

Fall on and from stairs and steps

320

2751

1.17

1.98

4.3

3.9

1.56

1.51

mg/l

0.48

298

2527

Bell's palsy

144

1147

1.26

1.98

4.8

3.5

1.57

1.50

mg/l

0.47

127

1056

Generalized anxiety disorder

179

1460

1.23

1.98

3.5

4.2

1.26

1.29

mg/l

0.34

164

1385

Benign neoplasm: Floor of mouth

2.85

1.97

4.0

2.4

1.38

1.60

mg/l

—

Giant cell arteritis

305

1.52

1.97

2.8

1.92

1.74

mg/l

0.61

274

Mental retardation, wide definition

102

776

1.33

1.96

12.8

14.9

1.12

1.20

mg/l

0.83

753

Special screening examination for neoplasms

504

1.40

1.96

2.9

2.6

1.61

1.57

mg/l

0.12

463

Delivery, wide proxy

280

1751

0.85

1.96

2.8

3.5

1.41

1.51

mg/l

1.63

257

1584

Fracture of forearm

729

6045

1.11

1.95

4.8

4.2

1.55

1.46

mg/l

1.83

666

5583

Sciatica+with lumbago

668

5540

1.11

1.95

2.9

3.0

1.54

1.52

mg/l

0.29

602

5118

Other benign neoplasms of connective and other soft tissue

115

894

1.29

1.93

2.2

3.5

1.54

1.53

mg/l

0.07

104

824

Dislocation, sprain and strain of joints and ligaments of knee

816

6853

1.10

1.91

2.9

3.6

1.35

1.43

mg/l

2.30

759

6377

Endometriosis ASRM stages 3,4

224

1875

1.20

1.91

2.7

2.8

1.31

1.43

mg/l

1.99

209

1734

Allergic contact dermatitis

151

1215

1.25

1.91

2.6

3.7

1.28

1.40

mg/l

1.21

135

1130

Heartburn

123

966

1.28

1.91

3.7

3.2

1.66

1.46

mg/l

1.72

116

887

Conditions involving the integument and temperature regulation of fetus and newborn

3.15

1.90

15.0

19.4

1.10

1.14

mg/l

—

Adult-onset Still disease

3.28

1.90

3.3

3.2

1.26

1.22

mg/l

—

Unspecified visual impairment (binocular)

174

1.70

1.90

4.1

8.2

1.50

1.39

mg/l

0.32

161

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

3.11

1.89

11.8

18.7

1.42

1.15

mg/l

—

Alcohol abuse, main dg, excluding more controls

190

1569

1.22

1.88

4.3

3.3

1.49

1.45

mg/l

0.26

176

1464

Other inherited muscular atrophy

3.77

1.88

11.8

8.2

0.83

1.07

mg/l

—

Abnormal involuntary movements

164

1335

1.23

1.88

4.3

1.51

1.50

mg/l

0.04

149

1236

HSIL lesion of the cervix uteri

171

1398

1.23

1.87

3.6

2.9

1.38

1.30

mg/l

0.57

163

1320

Malignant neoplasm of breast, HER-negative

161

1283

1.24

1.87

2.2

2.7

1.47

1.59

mg/l

1.36

139

1143

Benign neoplasm of bone and articular cartilage

102

785

1.31

1.86

4.2

3.8

1.38

1.45

mg/l

0.43

734

Somnolence, stupor and coma

375

1.45

1.86

4.6

4.4

1.74

1.61

mg/l

0.49

342

Migraine without aura and triptan purchases

186

1535

1.22

1.86

6.2

4.5

1.19

1.29

mg/l

1.72

174

1463

Varicose veins of other sites

638

1.34

1.86

3.8

3.5

1.38

1.44

mg/l

0.35

586

Raynaud syndrome

742

1.32

1.85

2.3

3.5

1.32

1.46

mg/l

1.20

692

Artificial joint operation, meniscal resection

1258

7580

1.08

1.85

2.7

3.1

1.59

1.57

mg/l

0.31

1134

6958

Pilonidal cyst

113

883

1.29

1.84

3.2

3.7

1.50

1.33

mg/l

1.16

102

830

Inguinal hernia, bilateral

142

1141

1.25

1.84

4.8

3.4

1.69

1.68

mg/l

0.02

134

1042

Thyrotoxicosis with toxic multinodular goitre

468

1.40

1.84

2.4

3.1

1.80

1.59

mg/l

1.05

429

Superficial injury of wrist and hand

273

2336

1.17

1.83

4.8

5.5

1.41

1.36

mg/l

0.47

257

2194

Ulcer of vagina/vulva

191

1.64

1.83

4.9

5.1

1.50

1.39

mg/l

0.25

171

Arthropathy in Crohn disease

2.04

1.82

3.6

3.1

1.37

1.49

mg/l

0.27

Other conditions originating in the perinatal period

2.97

1.82

33.2

25.2

2.32

1.16

mg/l

—

Other noninflammatory disorders of uterus, except cervix

220

1240

1.20

1.81

3.3

3.0

1.69

1.56

mg/l

1.38

205

1127

Pustulosis palmaris et plantaris

336

1.47

1.81

3.1

3.3

1.60

1.51

mg/l

0.27

316

Medical treatment for female infertility

192

1584

1.21

1.81

2.4

3.1

1.11

1.27

mg/l

5.49

179

1501

Salpingitis and oophoritis

177

1459

1.22

1.80

3.7

2.8

1.53

1.44

mg/l

0.70

167

1342

Postmenopausal atrophic vaginitis

271

1273

1.18

1.78

2.8

3.0

1.45

1.53

mg/l

0.89

237

1160

Other conditions of integument specific to fetus and newborn

3.29

1.77

8.4

21.0

1.05

1.18

mg/l

—

Family history of certain disabilities and chronic diseases leading to disablement

346

1.46

1.76

3.0

3.2

1.13

1.20

mg/l

0.55

323

Other symptoms and signs involving cognitive functions and awareness

567

4644

1.11

1.76

3.2

1.66

1.63

mg/l

0.23

515

4200

Disorder of bilirubin metabolism, other/unspecified

4.11

1.75

10.0

16.8

1.34

1.03

mg/l

—

Postmenopausal bleeding

276

1257

1.17

1.75

2.6

3.0

1.58

1.57

mg/l

0.10

257

1142

Use of riluzole

0.00

1.74

0.0

2.2

—

1.43

—

Scissor bite

555

1.36

1.74

18.3

16.3

1.16

1.09

mg/l

0.57

543

Mouth breathing

586

5283

1.11

1.74

6.1

5.2

1.47

1.46

mg/l

0.10

546

4927

Sleep terrors [night terrors]

4.01

1.74

13.8

21.5

1.35

1.12

mg/l

—

Tick-borne viral encephalitis

0.00

1.73

0.0

3.9

—

1.54

—

Smoking dependency

103

803

1.29

1.73

3.2

3.0

1.67

1.50

mg/l

1.19

750

Other otitis externa (chronic)

585

1.34

1.73

6.8

4.2

1.56

1.50

mg/l

0.26

540

Severe visual impairment, monocular

2.04

1.72

2.9

3.7

1.70

1.56

mg/l

0.25

Other/unspecified reactive arthropathies

603

1.34

1.72

3.7

4.5

1.50

1.47

mg/l

0.17

561

Tick-borne viral encephalitis

0.00

1.71

0.0

3.8

—

1.53

—

Postpartum haemorrhage

181

1829

0.83

1.71

2.8

3.3

1.21

1.31

mg/l

1.73

172

1722

Viral meningitis

316

1.47

1.70

3.4

3.1

1.28

1.37

mg/l

0.50

294

Dementia

387

3018

0.88

1.70

2.2

2.7

1.72

1.80

mg/l

0.96

325

2684

2.59

1.69

4.5

2.0

1.76

1.70

mg/l

—

Mental and behavioural disorders due to tobacco

103

807

1.28

1.68

3.2

3.0

1.67

1.50

mg/l

1.11

755

Blepharochalasis

323

2820

1.15

1.68

2.8

1.54

1.66

mg/l

1.83

289

2547

Malignant neoplasm of pancreas

468

1.38

1.67

1.9

2.6

1.49

1.74

mg/l

1.92

403

Benign neoplasm: Choroid

529

1.35

1.66

3.1

1.67

1.59

mg/l

0.33

486

Any dementia

342

2709

0.87

1.66

2.3

2.7

1.80

1.83

mg/l

0.20

286

2391

Female infertility

284

1485

1.16

1.66

3.1

1.29

1.40

mg/l

1.98

264

1382

Dermatographic urticaria

555

1.34

1.65

7.6

3.8

1.40

1.41

mg/l

0.02

522

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

379

3349

1.14

1.65

3.4

3.3

1.48

mg/l

0.04

350

3080

Unspecified urinary incontinence

712

1.30

1.65

4.3

4.4

1.66

1.53

mg/l

0.70

650

Complications of labour and delivery

541

3343

0.90

1.65

2.8

3.3

1.33

1.42

mg/l

2.02

499

3104

Bus occupant injured in other and unspecified transport accidents

2.20

1.64

2.8

2.2

1.62

1.38

mg/l

0.56

Early lumbar disc prolapse operation

1100

0.77

1.64

3.2

1.32

mg/l

0.00

1054

Other osteochondropathies

687

1.30

1.63

7.1

3.8

1.34

1.46

mg/l

1.04

643

Infective bursitis

270

1.50

1.63

4.0

3.1

1.65

1.58

mg/l

0.23

250

Cluster headache, wide

336

1.44

1.62

2.5

3.3

1.25

1.39

mg/l

0.56

312

Supervision of normal pregnancy

158

1095

0.82

1.62

2.2

3.6

1.12

1.31

mg/l

4.64

148

1033

Benign neoplasm: Appendix

1.94

1.62

4.2

2.6

1.58

1.67

mg/l

0.23

ILD and respiratory illness in diseases classified elsewhere

2.40

1.61

4.5

2.0

1.76

1.69

mg/l

—

Focal epilepsy

287

2493

1.15

1.61

5.8

6.1

1.50

1.44

mg/l

0.52

262

2311

Pituitary-dependent Cushing's disease

2.80

1.61

2.4

2.2

1.84

1.58

mg/l

—

Impingement syndrome of shoulder

219

2564

0.85

1.59

2.9

1.55

1.53

mg/l

0.11

198

2357

Atopic dermatitis

788

5933

1.09

1.59

5.1

4.8

1.34

1.36

mg/l

0.29

745

5557

Focal epilepsy, strict definition

267

2311

1.16

1.58

5.9

6.0

1.50

1.46

mg/l

0.36

245

2138

Other/unspecified synovitis and tenosynovitis

133

1082

1.24

1.58

4.2

3.1

1.71

1.45

mg/l

2.47

124

997

Neurofibromatosis, type 1

2.16

1.57

6.3

5.7

1.24

1.31

mg/l

0.23

Malignant neoplasm of breast, ER-negative, including Hilmo

180

1437

1.20

1.57

2.2

2.7

1.47

1.56

mg/l

0.82

157

1286

HSIL lesion of the vagina

107

1.81

1.56

3.6

2.2

1.99

1.38

mg/l

1.32

Uterine polyps

775

0.73

1.56

2.8

3.1

1.53

1.48

mg/l

0.16

725

Asthma, including avohilmo

1789

9492

1.06

1.56

3.7

4.5

1.50

1.48

mg/l

0.30

1649

8783

Dementia, including avohilmo

423

3257

0.89

1.55

2.2

2.8

1.71

1.80

mg/l

1.39

352

2908

Convergent concomitant strabismus

614

1.31

1.55

8.7

7.8

1.30

1.28

mg/l

0.10

585

Obstructed labour due to maternal pelvic abnormality

102

1281

0.79

1.55

2.7

3.1

1.44

mg/l

0.01

1196

Sequelae of injuries, of poisoning and of other consequences of external causes

293

2559

1.15

1.54

3.0

3.3

1.49

mg/l

0.02

267

2378

Pain in thoracic spine

183

1541

1.19

1.54

3.6

3.4

1.51

1.47

mg/l

0.25

168

1434

Benign neoplasm: Skin of other and unspecified parts of face

113

908

1.25

1.52

4.8

3.1

1.75

1.60

mg/l

1.02

100

817

Shoulder lesions

1030

5799

1.08

1.52

3.0

1.58

1.52

mg/l

1.25

939

5332

Disorders of vestibular function (Vertigo)

554

4945

1.10

1.51

3.0

1.56

1.60

mg/l

0.50

505

4471

Preterm labour and delivery

253

2191

1.16

1.50

3.4

3.1

1.43

1.40

mg/l

0.30

237

2043

Endometriosis of rectovaginal septum and vagina

565

1.32

1.49

1.8

2.9

1.25

1.49

mg/l

2.99

524

Open wound of wrist and hand

638

5703

1.10

1.49

3.4

4.0

1.38

1.47

mg/l

2.43

578

5307

Metatarsalgia

104

830

1.26

1.49

3.0

3.4

1.54

1.45

mg/l

0.44

769

Entropion and trichiasis of eyelid

697

1.28

1.49

3.2

2.8

1.93

1.76

mg/l

1.02

609

Other endophthalmitis

2.43

1.47

5.4

3.3

1.73

1.60

mg/l

—

Rheumatism, unspecified

138

1137

1.22

1.47

2.6

2.9

1.52

1.48

mg/l

0.23

121

1044

Congenital heart conduction disorder

3.33

1.47

9.4

21.9

1.05

1.14

mg/l

—

Congenital malformations of nose

3.31

1.47

6.0

26.4

1.11

1.12

mg/l

—

Acute alcohol intoxication, ICD10

264

2300

1.15

1.46

4.0

3.7

1.52

1.48

mg/l

0.30

245

2147

Colon adenocarcinoma

107

859

1.25

1.46

2.6

2.5

1.93

1.76

mg/l

0.92

742

Palatinal maxillary operation

141

1.68

1.45

18.7

14.2

1.17

1.05

mg/l

0.46

136

Acute myeloid leukaemia

1.95

1.45

7.8

5.6

1.24

1.58

mg/l

1.91

Acute myeloid leukaemia, helper endpoint

1.95

1.45

7.8

5.6

1.24

1.58

mg/l

1.91

Acute myeloid leukaemia, including Hilmo

1.95

1.45

7.8

5.6

1.24

1.58

mg/l

1.91

Postinfectious hypothyroidism

2.37

1.45

2.4

1.9

1.78

1.35

mg/l

—

Unspecified maternal hypertension

2.00

1.44

2.2

3.0

1.40

1.24

mg/l

0.44

Cluster headache, strict

311

1.43

1.44

2.6

3.2

1.26

1.37

mg/l

0.37

288

Dementia due to Parkinsons disease, excluding more controls

151

0.46

1.44

1.0

2.4

1.39

1.85

mg/l

—

125

Early lumbar disc prolapse, operated

1045

0.78

1.44

3.3

3.1

1.33

1.30

mg/l

0.14

1001

Trigeminal neuralgia

465

1.34

1.43

2.3

3.1

1.53

mg/l

0.01

428

Amoebiasis

2.23

1.42

5.1

9.8

1.71

1.40

mg/l

—

Malignant neoplasm of corpus uteri, including Hilmo

605

1.30

1.41

2.5

2.7

1.61

1.67

mg/l

0.24

537

Other enthesopathy of foot (+metatarsalgia)

111

899

1.24

1.41

3.2

3.4

1.55

1.45

mg/l

0.57

832

L02BB Anti-androgens

862

0.76

1.41

2.4

2.6

2.00

1.86

mg/l

0.51

749

Epidermolysis bullosa

2.80

1.41

4.5

22.4

0.99

1.35

mg/l

—

Pregnancy, childbirth and the puerperium

257

1543

0.87

1.40

3.1

3.8

1.45

1.51

mg/l

0.62

233

1389

Scabies

183

1556

1.18

1.40

5.7

6.1

1.46

1.31

mg/l

1.26

171

1481

Contact with sharp object, undetermined intent

237

0.54

1.40

2.6

4.0

1.20

1.37

mg/l

0.57

219

Appendicitis, broad definition

1008

8515

1.07

1.39

3.5

3.3

1.53

1.49

mg/l

0.76

934

7877

Bronchitis, not specified as acute or chronic

100

802

1.25

1.39

3.7

3.3

1.59

1.51

mg/l

0.36

738

Diseases of appendix

1015

8547

1.07

1.39

3.5

3.3

1.53

1.49

mg/l

0.69

941

7906

Benign leiomyoma with endometriosis

146

1218

1.20

1.39

3.1

2.8

1.62

1.52

mg/l

0.65

132

1118

Pulmonary eosinophilia, not elsewhere classified

1.83

1.39

2.6

2.7

1.67

1.63

mg/l

0.08

Pustular psoriasis

390

1.37

1.39

3.1

3.7

1.57

1.51

mg/l

0.15

368

Otalgia

104

839

1.25

1.38

6.9

8.7

1.41

1.36

mg/l

0.29

793

Other and unspecified disorders of vitreous body

468

4179

1.11

1.37

3.0

2.8

1.55

1.61

mg/l

0.76

423

3789

Maternal care for known or suspected abnormality of pelvic organs

243

1437

1.15

1.35

3.0

3.2

1.30

1.32

mg/l

0.14

234

1349

Other bursopathies

151

1268

1.20

1.35

3.3

3.0

1.66

1.54

mg/l

0.95

132

1157

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

370

0.64

1.34

1.3

3.4

1.38

1.51

mg/l

0.39

349

Hereditary corneal dystrophies

274

1.44

1.34

4.2

3.0

1.45

1.63

mg/l

0.61

250

Fibromyalgia

717

1.26

1.34

3.0

2.9

1.27

1.37

mg/l

1.00

670

Nontraumatic intracranial haemmorrhage

223

1934

1.16

1.34

5.1

3.0

1.78

1.68

mg/l

0.88

205

1729

Other congenital malformations of skin

798

1.25

1.33

5.8

6.6

1.37

1.38

mg/l

0.01

749

Atypical virus infections of central nervous system

1.84

1.33

2.0

2.6

1.18

1.48

mg/l

1.25

Other arthrosis

651

4147

1.09

1.32

3.2

2.8

1.61

1.48

mg/l

3.00

591

3808

Abnormal findings in cerebrospinal fluid

2.58

1.32

4.2

2.0

2.16

1.36

mg/l

—

Benign paroxysmal vertigo

326

2903

1.13

1.32

3.2

3.0

1.62

1.60

mg/l

0.20

299

2640

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

1.88

1.32

9.6

2.8

2.07

1.67

mg/l

0.45

Lateral epicondylitis

106

1297

0.81

1.32

2.8

1.37

1.43

mg/l

0.42

1204

Sleep disorders

1213

8247

1.06

1.32

2.8

3.6

1.37

1.48

mg/l

5.87

1120

7635

Pectus carinatum

2.96

1.31

18.0

10.8

1.83

1.12

mg/l

—

Hemiplegia

455

1.33

1.31

9.5

3.9

1.61

1.57

mg/l

0.10

422

Malignant neoplasm of eye and adnexa

1.92

1.30

12.3

4.7

1.05

1.57

mg/l

4.12

Rickettsioses

2.89

1.30

6.2

2.7

1.68

1.66

mg/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

111

909

1.23

1.30

3.3

3.1

1.52

1.55

mg/l

0.14

103

840

Temporal arteritis

276

1.43

1.30

3.0

2.8

1.96

1.73

mg/l

0.73

246

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

2.13

1.29

1.5

2.8

1.44

1.59

mg/l

—

Overexertion and strenuous or repetitive movements

119

982

1.22

1.29

3.2

3.4

1.40

1.45

mg/l

0.27

114

917

Injuries to the neck

274

2418

1.14

1.29

2.9

3.9

1.47

1.44

mg/l

0.25

256

2252

Birth injury to scalp

3.09

1.29

39.2

23.3

1.02

1.05

mg/l

—

Cluster headache, wide,, including avohilmo

474

1.32

1.28

2.4

3.2

1.24

1.40

mg/l

0.88

443

Other and unspecified nonscarring hair loss

2.08

1.28

5.3

2.6

1.29

1.32

mg/l

—

Transient global amnesia

792

0.77

1.27

2.4

2.9

1.52

1.67

mg/l

0.88

709

Benign neoplasm: Long bones of lower limb

311

1.40

1.27

6.4

3.6

1.32

1.41

mg/l

0.38

289

Spinal stenosis

627

4384

1.09

1.26

2.7

2.9

1.72

1.64

mg/l

1.74

559

3985

Contact with machinery

1189

0.81

1.25

2.4

3.1

1.53

1.56

mg/l

0.14

1099

Other and unspecified trigeminal disorders

131

1.62

1.25

1.8

3.1

1.33

1.50

mg/l

0.35

122

Other puerperal infections

529

1.29

1.24

2.9

3.0

1.19

1.23

mg/l

0.23

502

Acute alcohol intoxication

333

2983

1.12

1.24

3.9

3.5

1.60

1.54

mg/l

0.53

311

2749

Purulent endophthalmitis

2.09

1.24

3.0

2.1

1.62

1.73

mg/l

—

Prepatellar bursitis

460

1.31

1.23

3.8

3.1

1.67

1.50

mg/l

0.79

425

Benign mammary dysplasia

1132

0.81

1.23

3.3

2.8

1.58

1.51

mg/l

0.36

1032

Dermatophytosis

819

7635

1.07

1.22

3.5

3.6

1.52

1.51

mg/l

0.23

759

7031

Residual foreign body in soft tissue

478

1.31

1.22

5.0

3.4

1.44

1.42

mg/l

0.08

445

Palmar fascial fibromatosis [Dupuytren]

179

1541

1.17

1.22

3.3

2.7

1.69

mg/l

0.03

162

1377

Appendectomy

851

7601

1.07

1.22

3.5

3.3

1.49

1.46

mg/l

0.62

799

7031

Lesion of ulnar nerve

166

1421

1.17

1.22

3.1

3.0

1.74

1.50

mg/l

2.03

151

1316

Other disorders of the genitourinary system

124

1035

1.20

1.21

3.3

3.0

1.71

1.60

mg/l

0.62

114

942

Disorders of breast

416

4158

0.91

1.21

3.4

3.1

1.46

1.44

mg/l

0.25

389

3814

Amoebiasis

1.87

1.21

4.4

10.5

1.55

1.25

mg/l

0.51

Oter anti-inflammatory and antirheumatic agents, non-steroids

263

1643

0.88

1.20

2.7

3.9

1.63

1.82

mg/l

3.00

237

1506

Antenatal screening

173

1132

0.86

1.20

2.7

3.6

1.19

1.31

mg/l

1.82

163

1068

Enthesopathies of lower limb, excluding foot

270

2396

1.13

1.19

3.4

3.3

1.41

1.47

mg/l

0.71

244

2224

Open wound of thorax

149

1.57

1.19

4.2

3.3

1.83

1.44

mg/l

0.87

139

Diseases of inner ear

654

5863

1.08

1.17

3.0

1.56

1.59

mg/l

0.58

596

5329

Placental disorders

2.03

1.17

1.2

3.2

1.05

1.42

mg/l

—

Abnormal serum enzyme levels

392

3464

1.11

1.17

4.2

3.3

1.59

1.67

mg/l

1.01

368

3139

Giant cell arteritis with polymyalgia rheumatica

282

1.39

1.17

3.0

2.8

1.96

1.72

mg/l

0.75

249

Hypertrophy of breast

121

1442

0.84

1.17

3.1

3.2

1.36

1.38

mg/l

0.07

113

1347

Spirochaetal infections, other/unspecified

794

1.23

1.17

3.8

4.4

1.28

1.54

mg/l

3.14

732

Other parasitologically confirmed or unspecified malaria

2.59

1.16

4.2

2.1

1.61

1.75

mg/l

—

Excessive vomiting in pregnancy

570

1.27

1.16

3.7

2.9

1.43

1.27

mg/l

0.99

536

Cluster headache, strict, including avohilmo

447

1.31

1.16

2.5

3.2

1.25

1.39

mg/l

0.69

419

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

118

1.62

1.15

2.2

3.1

0.91

1.27

mg/l

3.89

110

Acetic acid derivatives and related substances

363

2089

0.90

1.15

2.8

4.2

1.59

1.72

mg/l

1.94

330

1931

Carbimazole or st.post thyroidectomy, condition for graves disease

222

1951

1.14

1.15

2.9

3.2

1.54

1.46

mg/l

0.78

211

1810

Schizophrenia or delusion, excluding more controls

366

3279

1.11

1.14

3.4

3.0

1.50

1.40

mg/l

1.43

336

3047

therapeutic use

250

1.41

1.13

6.0

3.3

1.92

1.57

mg/l

1.38

228

Psychotic depression

519

1.28

1.13

3.2

4.0

1.63

1.47

mg/l

0.61

487

Other psoriatic arthropathies

116

971

1.20

1.12

2.7

3.0

1.48

1.49

mg/l

0.04

101

908

Additional codes for the location of defect, injury or illness

538

1.27

1.12

5.0

4.8

1.60

1.49

mg/l

0.48

500

Chronic respiratory disease originating in the perinatal period

1.84

1.12

12.3

22.0

1.09

1.02

mg/l

0.38

Chronic Coagulation defects

226

1.43

1.11

8.7

6.5

1.63

1.34

mg/l

0.63

211

Congenital malformations of the nervous system

329

1.35

1.11

12.3

13.2

1.13

1.15

mg/l

0.14

315

Other specified/unspecified nutritional deficiencies

1.86

1.11

4.5

2.4

1.80

1.43

mg/l

0.60

Certolizumab pegol

138

0.50

1.10

2.0

3.3

1.45

1.29

mg/l

—

123

Psoriatic arthropathies, ICD10

119

1001

1.19

1.10

2.7

3.1

1.48

1.49

mg/l

0.08

103

937

Triptan medication for migraine, min. 3 purchases

667

4732

1.08

1.10

3.1

3.8

1.19

1.38

mg/l

14.97

617

4441

Placenta praevia

340

0.67

1.10

2.1

3.1

1.17

1.28

mg/l

0.36

322

Medical abortion

664

3343

1.08

1.09

2.9

3.1

1.41

1.44

mg/l

0.48

618

3070

Cervicobrachial syndrome

200

2277

0.88

1.09

2.8

3.1

1.43

1.48

mg/l

0.37

184

2114

Benign neoplasm: Parathyroid gland

1.71

1.09

3.5

2.2

2.05

1.63

mg/l

0.97

Left hemicolectomy

202

1.45

1.09

2.8

3.3

1.67

1.74

mg/l

0.18

184

LSIL lesion of the cervix uteri

101

838

1.21

1.08

4.0

2.8

1.38

1.30

mg/l

0.58

793

Colorectal adenocarcinoma

181

1573

1.15

1.08

2.6

2.7

1.88

1.78

mg/l

0.72

162

1378

Other specified disorders of external ear

331

1.34

1.06

3.3

3.0

1.71

1.62

mg/l

0.20

302

Liveborn infants according to place of birth

205

1.44

1.06

13.2

19.2

0.98

mg/l

0.03

199

Glaucoma-related operations

445

1.29

1.05

2.8

3.0

1.63

1.71

mg/l

0.26

397

Alcohol dependence

343

3112

1.10

1.05

3.6

3.0

1.63

1.56

mg/l

0.75

315

2870

Vestibular neuronitis

805

1.21

1.05

3.0

3.1

1.52

1.56

mg/l

0.15

736

Crushing injury of wrist and hand

148

0.53

1.05

7.9

3.8

1.69

1.54

mg/l

—

135

Other and specified injuries of hip and thigh

187

1.46

1.04

3.7

3.2

1.66

1.59

mg/l

0.18

167

Dissection of cerebral arteries, nonruptured

1.87

1.04

2.1

2.4

1.52

1.38

mg/l

0.18

Other appendicitis

815

1.21

1.04

4.3

3.2

1.46

1.49

mg/l

0.20

763

Torsion of ovary, ovarian pedicle and fallopian tube

148

0.54

1.04

1.4

3.3

1.24

1.31

mg/l

—

141

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

455

1.28

1.04

2.5

3.2

1.51

1.57

mg/l

0.18

419

Maternal care for known or suspected disproportion

311

0.67

1.02

3.6

3.0

1.50

1.30

mg/l

0.36

301

Labour and delivery complicated by umbilical cord complications

369

0.70

1.01

2.0

3.3

1.18

1.36

mg/l

1.17

345

Hallux rigidus

103

1225

0.84

1.01

2.5

2.7

1.51

1.50

mg/l

0.02

1116

Pigmented purpuric dermatosis

1.74

1.00

3.8

2.3

1.70

1.47

mg/l

0.42

Injury of cranial nerves

1.84

1.00

2.3

2.9

1.21

1.34

mg/l

0.28

Acute appendicitis, with complications

230

2050

1.12

0.99

3.5

3.0

1.80

1.53

mg/l

3.99

214

1892

Café au lait spots

0.00

0.99

0.0

21.7

—

1.01

—

Parkinson's disease, strict definition, excluding more controls

1019

0.83

0.99

2.2

2.7

1.54

1.69

mg/l

1.13

910

Other secondary coxarthrosis

283

1.35

0.99

3.6

2.9

1.71

1.61

mg/l

0.33

259

Mixed disorders of conduct and emotions, excluding more controls

232

1.39

0.98

12.8

11.7

1.45

1.07

mg/l

1.96

222

Alzheimer’s disease (Late onset), excluding more controls

106

824

0.84

0.98

2.2

2.5

1.73

1.78

mg/l

0.22

726

Carcinoma in situ of endometrium

0.00

0.98

0.0

1.6

—

1.25

—

Lichen planus

131

1125

1.17

0.98

2.4

2.9

1.64

1.59

mg/l

0.27

117

1022

Disorders of pituitary gland, other and/or unspecified

1.83

0.98

12.8

2.2

1.47

1.48

mg/l

—

Benign neoplasm of brain and other parts of central nervous system

603

1.23

0.98

5.5

4.5

1.39

1.50

mg/l

0.63

560

Exposure to other and unspecified inanimate mechanical forces

794

1.20

0.98

6.7

6.0

1.62

1.37

mg/l

1.60

743

Secondary malignant neoplasm of other and unspecified sites

116

1.57

0.97

1.7

2.6

1.42

1.69

mg/l

0.86

103

Chronic suppurative otitis media

667

1.22

0.97

8.4

5.8

1.52

1.43

mg/l

0.43

615

Neuroendocrine tumor and carcinoma of pancreas

1.80

0.96

2.6

1.67

1.45

mg/l

—

Laparoscopic right hemicolectomy

461

1.27

0.95

2.6

2.9

1.84

1.73

mg/l

0.40

415

Complications predominantly related to the puerperium

241

2160

1.12

0.95

3.1

3.0

1.39

1.35

mg/l

0.41

224

2025

Use of galantamine

591

0.78

0.95

2.3

2.5

1.58

1.84

mg/l

1.84

504

Burn and corrosion confined to eye and adnexa

209

0.62

0.94

3.8

3.1

1.12

1.41

mg/l

1.35

194

Benign neoplasm of meninges

100

843

1.19

0.94

2.7

3.0

1.54

1.60

mg/l

0.33

770

Malignant neoplasm of rectum

715

1.21

0.93

2.4

2.7

1.82

1.73

mg/l

0.40

632

Unspecified renal colic

1.86

0.93

8.4

4.1

1.57

1.54

mg/l

—

Nail dystrophy

1.86

0.93

3.4

2.9

1.70

1.47

mg/l

—

Fracture at wrist and hand level

470

4345

1.08

0.93

3.6

4.2

1.49

1.43

mg/l

0.89

446

4049

Primary coxarthrosis, bilateral

318

2897

1.10

0.93

2.8

2.7

1.77

1.70

mg/l

0.65

281

2581

Other hyperalimentation

2.20

0.93

1.3

2.0

1.56

1.32

mg/l

—

Stenosis and insufficiency of lacrimal passages

817

1.19

0.92

3.5

4.2

1.48

1.55

mg/l

0.46

745

Event of undetermined intent

671

1.21

0.92

3.1

5.1

1.54

1.37

mg/l

1.07

626

Other and unspecified nonorganic psychotic disorders

238

2137

1.12

0.92

3.4

1.40

1.36

mg/l

0.37

219

2016

Chronic suppurative otitis media, including avohilmo

104

882

1.18

0.92

8.4

7.9

1.48

1.41

mg/l

0.41

823

Torsion of testis

244

1.37

0.92

8.7

8.8

1.27

1.24

mg/l

0.12

235

Other mental disorders due to brain damage and dysfunction and to physical disease

121

1040

1.17

0.91

3.3

2.7

1.64

1.70

mg/l

0.28

109

925

Necrosis of pulp, including avohilmo

757

7116

1.06

0.91

3.3

3.6

1.53

1.45

mg/l

2.05

688

6637

Benign neoplasm of thyroid gland

253

1.35

0.91

2.1

2.6

1.21

1.50

mg/l

2.59

233

Degenerative macular diseases, drug-induced

2.12

0.90

2.8

2.6

1.95

1.71

mg/l

—

severe traumatic brain injury, does not include concussion

257

2322

1.11

0.89

4.2

3.0

1.85

1.66

mg/l

2.30

229

2094

Use of levodopa decarbox-comt-inhibitor

254

0.66

0.89

2.1

3.0

1.46

1.83

mg/l

1.34

226

Postprocedural musculoskeletal disorders, not elsewhere classified

619

1.22

0.89

3.8

3.1

1.73

1.63

mg/l

0.48

563

Parkinson's disease, excluding more controls

1098

0.85

0.89

2.3

2.7

1.59

1.67

mg/l

0.53

988

L02BG Aromatase inhibitors

280

2537

1.10

0.89

2.4

2.8

1.41

1.57

mg/l

2.84

251

2299

Organic, including symptomatic, mental disorders

588

3911

1.07

0.89

2.7

2.8

1.75

1.73

mg/l

0.23

512

3511

Other and unspecified injuries of thorax

152

1.46

0.89

3.9

2.8

1.32

1.50

mg/l

0.72

139

Dacryoadenitis

1.81

0.89

21.2

3.5

1.66

1.50

mg/l

—

Spondylopathies in diseases classified elsewhere

1.60

0.88

6.9

3.3

1.55

1.67

mg/l

0.27

Cholesteatoma of middle ear

460

0.76

0.88

4.9

3.4

1.87

1.62

mg/l

0.68

416

Ankylosing spondylitis

105

896

1.18

0.88

2.6

3.3

1.43

1.47

mg/l

0.27

840

Idiopathic peripheral autonomic neuropathy

1.98

0.85

1.7

2.9

0.95

1.77

mg/l

—

Malignant neoplasm of heart, mediastinum and pleura

1.64

0.85

11.5

3.0

1.15

1.74

mg/l

2.25

Insomnia

1159

8062

1.05

0.84

2.6

3.6

1.36

1.48

mg/l

6.40

1071

7460

Injury of muscle and tendon at shoulder and upper arm level

379

4101

0.92

0.84

2.7

3.0

1.55

1.60

mg/l

0.52

344

3759

Other disorders of binocular vision

114

0.52

0.83

10.5

4.6

1.15

1.31

mg/l

—

104

Multifocal fibrosclerosis

1.77

0.83

4.3

2.3

2.22

1.62

mg/l

—

Precocious central puberty

1.64

0.83

29.7

11.0

1.16

1.05

mg/l

0.39

Acute and transient psychotic disorders

131

1145

1.15

0.81

3.5

3.2

1.68

1.44

mg/l

2.39

120

1079

Postpartum hemorraghe, all women as controls

181

1993

0.89

0.81

2.8

3.1

1.21

1.29

mg/l

1.17

172

1888

Focal epilepsy, mode (most common among epilepsy diagnosis)

239

2166

1.11

0.81

4.9

5.9

1.52

1.45

mg/l

0.62

219

2011

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

122

1.49

0.80

8.6

2.7

1.13

1.65

mg/l

3.13

106

Ankylosing spondylitis, ICD10

101

867

1.17

0.80

2.7

3.3

1.42

1.47

mg/l

0.26

803

Spermatocele

747

1.18

0.80

2.9

3.0

1.89

1.66

mg/l

1.20

682

Unspecified abortion

347

1.27

0.80

3.7

3.2

1.54

1.39

mg/l

0.57

334

Schizoid personality disorder

148

0.60

0.80

2.7

2.9

1.74

1.42

mg/l

—

138

Divergent concomitant strabismus

748

1.18

0.79

6.0

5.3

1.43

1.40

mg/l

0.14

707

Arnold-Chiari syndrome

1.58

0.79

15.9

8.2

1.15

1.16

mg/l

0.03

Disorders of brain, other and unspecified

1.58

0.79

13.6

3.3

1.41

1.60

mg/l

0.41

Prominent ears

0.51

0.79

8.0

9.6

1.10

1.07

mg/l

—

Hyperkinetic disorders (excl. ADHD)

399

1.26

0.79

9.9

15.1

1.16

1.08

mg/l

0.61

390

Palatinal maxillary canine

115

1.51

0.79

23.1

14.9

1.28

1.07

mg/l

0.71

110

Other cestode infections

0.00

0.78

0.0

2.7

—

1.55

—

Haemorrhage in early pregnancy

254

2252

1.10

0.78

2.6

2.9

1.41

1.33

mg/l

0.72

241

2095

Temporomandibular joint disorders, including avohilmo

496

4579

1.07

0.77

3.0

3.7

1.26

1.40

mg/l

4.80

454

4277

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

496

1.23

0.77

17.6

22.2

1.04

1.06

mg/l

0.21

491

Glaucoma, exfoliation

853

1.16

0.76

2.4

2.5

1.93

1.81

mg/l

0.56

736

Any dementia, excluding more controls

326

2432

0.92

0.76

2.3

2.6

1.79

1.80

mg/l

0.11

272

2142

Other peripheral vertigo

770

1.17

0.76

2.6

3.0

1.57

1.61

mg/l

0.13

695

Other nonscarring hair loss

1.66

0.76

4.6

2.4

1.64

1.46

mg/l

0.26

Enterobiasis

227

1.33

0.75

6.3

13.1

1.23

1.17

mg/l

0.21

213

Helminthiases

158

1.41

0.75

5.2

7.0

1.23

1.42

mg/l

0.75

146

Labour and delivery complicated by fetal stress [distress]

181

1321

0.90

0.75

2.4

3.3

1.15

1.24

mg/l

1.18

169

1244

Maternal care for other known or suspected fetal problems

219

1254

1.11

0.75

2.7

3.4

1.22

1.27

mg/l

0.62

205

1176

Mental disorders, not otherwise specified

744

1.17

0.74

3.4

3.6

1.48

1.37

mg/l

0.67

706

Other disorders of breast

1024

0.86

0.73

3.9

3.1

1.49

1.43

mg/l

0.30

950

Acute appendicitis

925

8254

1.05

0.73

3.5

3.3

1.53

1.49

mg/l

0.93

856

7635

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

1.83

0.73

1.6

2.3

1.49

1.48

mg/l

—

Neonatal aspiration syndromes

2.03

0.73

19.4

27.6

0.93

1.02

mg/l

—

Deep bite that required surgery

109

0.54

0.73

3.8

3.2

1.08

1.35

mg/l

—

102

Transitory endocrine and metabolic disorders specific to fetus and newborn

508

1.22

0.73

17.3

21.9

1.04

1.06

mg/l

0.16

503

Monocytic leukaemia

1.80

0.72

6.1

3.7

1.32

1.60

mg/l

—

Carcinoma in situ of cervix uteri, endocervix

1.56

0.72

3.5

2.5

1.45

1.37

mg/l

0.10

Nontoxic multinodular goitre

184

1659

1.11

0.72

3.1

2.9

1.69

1.58

mg/l

0.82

163

1491

Other acantholytic disorders

1.97

0.71

10.2

2.8

2.50

1.85

mg/l

—

Neuralgia and neuritis, unspecified

435

1.22

0.71

2.4

2.8

1.62

1.48

mg/l

0.45

404

Medicines for HER+ breast cancer

346

3045

1.08

0.70

2.5

2.8

1.37

1.54

mg/l

3.97

309

2775

Pedal cyclist injured in noncollision transport accidents

106

1211

0.87

0.70

5.0

5.1

1.37

1.42

mg/l

0.34

100

1139

Disorders of other and unspecified cranial nerves

1.69

0.69

3.4

2.9

1.89

1.70

mg/l

—

Benign neoplasm: Other/unspecified site

127

1.43

0.68

2.0

2.9

1.62

1.61

mg/l

0.01

115

Other disorders of the musculoskeletal system and connective tissue

155

1390

1.12

0.68

3.2

3.1

1.61

1.56

mg/l

0.30

136

1270

Congenital malformations of breast

102

1.48

0.68

5.1

3.1

1.42

1.24

mg/l

0.26

Coxibs

381

2152

0.93

0.68

2.5

4.4

1.39

1.70

mg/l

11.88

340

1991

Glucosamine medication

473

4012

0.94

0.67

2.6

2.8

1.71

1.69

mg/l

0.17

422

3577

Dislocation, sprain and strain of joints and ligaments of elbow

696

1.17

0.67

9.4

7.5

1.21

1.30

mg/l

0.82

660

Mandibular retrognathia

787

1.16

0.67

15.0

9.6

1.17

1.24

mg/l

0.81

757

Unequal limb length (acquired)

1.53

0.67

10.2

7.8

1.08

1.13

mg/l

0.21

Alcohol abuse, main dg

190

1726

1.10

0.66

4.3

3.9

1.49

1.47

mg/l

0.15

176

1611

Coxarthrosis, primary

701

5652

1.05

0.64

2.9

2.8

1.73

1.66

mg/l

1.27

627

5096

Transient synovitis

1.51

0.64

36.2

8.6

1.24

1.18

mg/l

0.10

Viral haemorrhagic fevers, not elsewhere classified/unspecified

197

1796

1.10

0.64

6.0

6.1

1.47

1.46

mg/l

0.06

183

1675

Other benign neoplasms of uterus

350

1.23

0.64

2.0

2.4

1.71

1.64

mg/l

0.22

310

Personal history of allergy to drugs, medicaments and biological substances

1.51

0.64

4.2

3.4

1.50

1.32

mg/l

0.48

Benign neoplasm: Cerebral meninges

765

1.15

0.64

2.8

3.1

1.59

1.61

mg/l

0.07

702

Contact with heat and hot substances

626

1.17

0.63

4.1

7.3

1.61

1.37

mg/l

1.53

590

Osteochondrodysplasia with defects of growth of tubular bones and spine

1.72

0.62

1.8

17.3

0.85

1.14

mg/l

—

Noise effects on inner ear

402

0.79

0.62

2.9

3.0

1.64

1.57

mg/l

0.18

365

Benign neoplasm: Anus and anal canal

217

1.30

0.62

3.5

3.0

2.16

1.73

mg/l

0.86

197

Fibrosarcoma

1.62

0.62

7.3

4.7

1.22

1.70

mg/l

—

Acute poliomyelitis

113

1.43

0.62

2.1

2.4

1.16

1.50

mg/l

1.91

104

Burns and corrosions confined to eye and internal organs

256

0.74

0.61

4.1

3.5

1.15

1.44

mg/l

2.12

237

Spontaneous abortion

394

2830

0.94

0.61

3.0

1.40

mg/l

0.01

360

2630

Benign neoplasm: Orbit, unspecified

1.59

0.61

2.4

2.7

1.44

1.61

mg/l

—

Foreign body entering into or through eye or natural orifice

102

900

1.14

0.61

7.2

5.2

1.50

1.42

mg/l

0.38

839

Unspecified mental disorder

495

4683

1.06

0.61

3.1

1.51

1.44

mg/l

1.04

449

4354

Unspecified dementia

799

0.86

0.61

2.5

2.04

1.92

mg/l

0.59

688

Lichen sclerosus et atrophicus

797

1.14

0.60

2.5

2.9

1.48

mg/l

0.01

719

Other specified/unspecified inflammatory spondylopathies

426

1.20

0.60

2.5

3.1

1.51

1.40

mg/l

0.37

404

Malignant neoplasm of corpus uteri

518

1.18

0.60

2.4

2.7

1.65

1.68

mg/l

0.11

453

Meralgia paraesthetica

281

1.25

0.60

2.4

3.1

1.55

1.54

mg/l

0.04

259

Other congenital malformations of female genitalia

1.54

0.59

2.8

5.9

1.64

1.15

mg/l

1.01

L02BX Other hormone antagonists and related agents

509

0.82

0.59

3.0

2.8

1.90

1.82

mg/l

0.20

446

Pedal cyclist injured in transport accident

232

2511

0.92

0.59

4.4

4.7

1.34

1.43

mg/l

1.39

212

2342

Achilles tendinitis

118

1054

1.12

0.58

2.7

3.1

1.45

1.51

mg/l

0.34

104

975

Poisoning by medicine, drug-induced

113

0.61

0.58

1.9

3.0

1.39

1.33

mg/l

—

104

Foreign body on external eye

158

1738

0.91

0.58

3.9

3.5

1.53

1.47

mg/l

0.30

147

1623

Other and unspecified nerve root and plexus disorders, also in other diseases

223

2058

1.09

0.58

2.6

3.0

1.54

1.49

mg/l

0.39

198

1909

Benign neoplasm: Spinal meninges

1.50

0.57

1.9

2.3

1.17

1.54

mg/l

1.84

Yaws

1.70

0.57

5.5

4.2

1.46

1.49

mg/l

—

Congenital malformations of oesophagus

1.54

0.57

3.5

14.1

0.95

1.26

mg/l

1.71

Endometriosis diagnosis and infertility diagnosis occurring together

782

1.14

0.57

2.2

2.9

1.13

1.32

mg/l

2.93

737

Contraceptive management

470

3480

0.95

0.57

4.0

3.3

1.27

1.39

mg/l

3.99

446

3280

Cramp and spasm

457

1.19

0.57

3.5

4.5

1.38

1.47

mg/l

0.40

429

Other contact dermatitis

708

1.15

0.56

5.8

3.4

1.49

1.47

mg/l

0.06

654

Triptan medication for migraine, single purchase ok

950

6682

0.96

0.56

3.6

3.9

1.30

1.42

mg/l

6.14

891

6243

Migraine, single triptan purchase ok & required. ICD-code if available is included

950

6682

0.96

0.56

3.6

3.9

1.30

1.42

mg/l

6.14

891

6243

Sequelae of injuries of lower limb

100

887

1.13

0.56

3.6

3.1

1.53

1.47

mg/l

0.34

829

Inflammatory diseases of prostate (prostatitis)

147

1333

1.11

0.56

3.1

2.9

1.67

1.60

mg/l

0.41

129

1215

Hereditary ataxia

124

1.38

0.56

4.5

7.0

1.70

1.49

mg/l

0.31

113

Other congenital malformations of tongue, mouth and pharynx

292

1.24

0.56

17.0

18.0

1.19

1.09

mg/l

0.53

284

Rheumatic fever with heart involvement

1.64

0.56

4.0

2.6

1.91

1.60

mg/l

—

Alopecia areata

239

1.26

0.55

6.0

7.2

1.18

1.32

mg/l

0.75

223

Other and unspecified hydrocephalus

168

1.32

0.55

12.4

5.7

1.92

1.45

mg/l

1.17

153

Chalazion

124

1116

1.11

0.55

3.6

4.0

1.44

1.49

mg/l

0.34

116

1037

Viral conjunctivitis

339

1.22

0.55

10.3

5.3

1.46

1.33

mg/l

0.30

315

Other and unspecified vaccines and biological substances

1.52

0.55

2.7

5.4

1.12

1.30

mg/l

—

Other extrapyramidal and movement disorders in other diseases

256

2383

1.08

0.54

3.4

3.3

1.55

1.57

mg/l

0.10

233

2176

Use of interferon beta-1a

182

0.71

0.54

1.8

2.8

1.19

1.33

mg/l

0.46

171

Respiratory tuberculosis, bacteriologically and histologically confirmed

160

1.32

0.54

4.3

2.9

1.56

1.77

mg/l

0.36

145

Osteitis due to dental implant

1.47

0.53

5.3

2.4

1.80

1.61

mg/l

—

Conductive hearing loss, unspecified

806

1.13

0.53

9.6

5.5

1.55

1.46

mg/l

0.41

748

Fibrosarcoma, including Hilmo

1.46

0.53

8.6

5.3

1.19

1.61

mg/l

—

Examination and encounter for administrative purposes

414

1.19

0.53

5.0

2.8

1.89

1.64

mg/l

0.72

377

Radiculopathy

172

1578

1.09

0.53

3.0

2.8

1.68

1.61

mg/l

0.43

153

1429

Pollen allergy

259

2385

1.07

0.53

4.5

8.8

1.20

1.23

mg/l

0.23

245

2294

Motor neuron disease (with DMD)

143

1.34

0.53

4.3

4.9

1.09

1.57

mg/l

2.30

129

Impacted maxillary canine

179

1.31

0.53

18.7

15.8

1.30

1.10

mg/l

0.64

174

Spondylolisthesis/Spondylolysis

201

1857

1.08

0.52

2.6

3.1

1.51

1.53

mg/l

0.13

186

1712

Ectopic testis

189

1.31

0.52

12.1

22.4

1.08

1.09

mg/l

0.07

189

Migraine with aura and triptan purchases

161

1473

1.09

0.52

3.6

4.6

1.18

1.31

mg/l

2.78

149

1390

D07AA Corticosteroids, weak (group I)

200

1845

1.08

0.52

7.3

8.1

1.47

1.30

mg/l

2.02

191

1750

Polyp of the female genital tract

287

1540

1.07

0.52

3.0

3.1

1.56

1.50

mg/l

0.59

269

1409

Malignant neoplasm of gallbladder, including Hilmo

1.51

0.52

3.0

2.0

1.33

1.59

mg/l

—

conjunctival degenerations and deposits

170

1.30

0.52

2.9

1.50

1.59

mg/l

0.17

151

Trichomoniasis

1.42

0.52

4.3

3.0

1.89

1.48

mg/l

—

Malignant neoplasm of ovary

296

1.22

0.51

4.3

3.1

1.53

1.58

mg/l

0.15

267

Asthma/COPD (KELA code 203)

1356

9020

1.03

0.51

3.8

4.4

1.51

1.46

mg/l

1.31

1245

8367

Abscess of external ear

109

1.39

0.51

7.8

4.1

1.59

1.38

mg/l

0.58

Atopic conjunctivitis

453

1.17

0.51

11.0

7.4

1.40

1.33

mg/l

0.23

426

Lichen ruber planus, wide definition including periferal and oral lichen planus

226

2102

1.08

0.51

2.2

2.9

1.45

1.57

mg/l

1.44

204

1931

Assault by sharp object

162

1.31

0.50

7.0

3.2

2.05

1.37

mg/l

1.78

152

Other deformities of toe(s)

258

0.77

0.50

1.9

2.7

1.94

1.55

mg/l

1.09

242

Leiomyoma of uterus

621

3366

1.05

0.50

2.9

2.8

1.51

1.46

mg/l

0.70

563

3098

Toxic effect of alcohol

180

1.29

0.50

7.0

3.2

1.92

1.48

mg/l

1.25

166

Plantar fascial fibromatosis

858

1.12

0.50

3.2

2.8

1.47

1.44

mg/l

0.16

795

Exposure to other and unspecified man-made environmental factors

136

1.33

0.49

5.3

3.3

1.27

1.36

mg/l

0.36

125

Artrosis, including avohilmo

1115

6299

0.97

0.48

2.8

3.1

1.55

1.52

mg/l

0.38

1017

5831

Foreign body in alimentary tract

587

1.15

0.48

3.8

5.8

1.39

1.49

mg/l

0.44

541

Other noninflammatory disorders of cervix uteri

354

1.19

0.48

2.0

2.9

1.59

1.52

mg/l

0.21

324

Sequelae of other and unspecified effects of external causes

1.51

0.48

4.0

2.2

1.47

1.48

mg/l

—

Impaction of intestines

1.50

0.48

3.0

2.3

1.42

1.74

mg/l

—

Tic disorders

218

1.25

0.47

8.1

15.0

1.10

1.06

mg/l

0.14

210

Ulcer of oesophagus, drug-induced

1.48

0.47

2.9

2.6

1.94

1.80

mg/l

—

Respiratory tuberculosis, confirmed

155

1.30

0.47

4.5

2.9

1.56

1.76

mg/l

0.33

140

Malignant neoplasm of ovary, including Hilmo

392

1.18

0.47

5.9

3.0

1.55

1.56

mg/l

0.04

351

Other fall from one level to another

300

2827

1.06

0.47

6.0

6.3

1.40

1.41

mg/l

0.08

278

2646

Universal erythroderma, KELA reimbursement

120

1.34

0.46

3.4

3.2

1.78

1.51

mg/l

0.52

110

Galactorrhea

0.61

0.46

6.0

2.7

1.39

1.42

mg/l

—

Unattended death

0.60

0.46

3.4

2.7

1.74

mg/l

—

Reduction defects of upper limb

1.43

0.46

2.7

16.4

1.05

1.06

mg/l

—

Open wound of neck

1.44

0.46

2.6

3.5

1.54

1.39

mg/l

0.20

Other congenital malformations of upper alimentary tract

1.41

0.45

30.7

8.9

1.35

1.39

mg/l

0.10

Restless leg syndrome

133

1218

1.09

0.45

3.3

3.2

1.50

1.52

mg/l

0.12

118

1122

Multiple gestation

727

0.88

0.45

3.3

3.2

1.35

1.32

mg/l

0.10

687

Paranoid personality disorder

141

0.71

0.45

8.2

3.0

1.76

1.47

mg/l

—

129

Nasal polyp

192

2062

0.93

0.45

2.9

3.0

1.53

1.58

mg/l

0.43

176

1888

Congenital malformations of breast

112

1.35

0.45

5.1

3.1

1.42

1.27

mg/l

0.21

100

Contusion of ankle

413

1.17

0.45

10.6

6.4

1.80

1.31

mg/l

1.23

385

Other disturbances of cerebral status of newborn

1.43

0.44

21.6

24.2

1.20

1.06

mg/l

—

820

0.89

0.44

3.1

2.9

1.95

1.69

mg/l

1.14

742

Demyelinating diseases of the central nervous system

746

0.88

0.44

1.9

3.3

1.31

1.39

mg/l

0.31

703

Chronic diseases of tonsils and adenoids

1130

6938

1.03

0.43

5.1

4.8

1.33

1.44

mg/l

5.58

1053

6486

Congenital malformations of oesophagus

1.45

0.42

3.7

14.6

0.94

1.26

mg/l

—

Unspecified organic or symptomatic mental disorder

1.58

0.42

1.4

2.3

2.02

1.61

mg/l

—

Other adrenocortical overactivity

1.38

0.42

13.1

11.3

1.17

1.04

mg/l

0.45

Other abnormal auditory perceptions

0.63

0.42

6.2

5.1

1.07

1.30

mg/l

—

Extrapyramidal and movement disorders

395

4141

0.95

0.42

3.2

1.56

1.63

mg/l

0.84

357

3737

Adenocarcinoma and papillary adenocarcinoma of stomach

173

0.75

0.42

3.2

2.4

2.14

1.69

mg/l

0.48

151

1.39

0.42

4.1

4.9

2.09

1.85

mg/l

—

Coxarthrosis, primary, with hip surgery

525

4716

1.04

0.42

2.8

1.75

1.69

mg/l

0.81

464

4230

Burns and corrosions of external body surface, specified by site

135

1244

1.09

0.41

4.5

6.3

1.51

1.40

mg/l

0.90

127

1168

Other/unspecified enthesopathies of lower limb, excluding foot

680

1.12

0.41

4.0

3.6

1.31

1.45

mg/l

1.27

637

Pedestrian injured in collision with pedal cycle

277

1.20

0.41

2.6

3.3

1.34

1.50

mg/l

0.95

256

Other congenital malformations of nervous system

114

1.33

0.41

15.0

11.1

1.15

mg/l

0.02

109

Assault by drugs, medicaments and biological substances

0.00

0.41

0.0

3.1

—

1.47

—

Gonarthrosis,primary

1088

6892

0.97

0.41

2.7

3.0

1.68

1.59

mg/l

2.38

985

6293

Somnolence

123

1.31

0.41

5.9

6.9

1.44

1.42

mg/l

0.04

112

Other vitreous opacities

333

1.18

0.41

2.8

3.1

1.84

1.61

mg/l

0.44

304

Other disorders of peripheral nervous system

1.35

0.40

1.6

2.3

1.60

1.58

mg/l

—

Other specified/unspecified diseases of inner ear

1.48

0.40

2.0

2.6

1.44

1.80

mg/l

—

Other or unspecified paralytic strabismus

1.34

0.40

2.8

2.6

1.56

1.41

mg/l

—

Macular hole

464

1.15

0.40

3.7

2.7

1.80

1.68

mg/l

0.25

425

Benign neoplasm: Brain, supratentorial

159

1.27

0.40

8.8

5.3

1.19

1.41

mg/l

1.42

146

Inflammatory disease of uterus

118

1083

1.09

0.40

2.7

2.9

1.37

mg/l

0.03

111

1013

Superficial injury of shoulder and upper arm

124

1144

1.09

0.38

3.2

4.1

1.53

1.46

mg/l

0.36

110

1059

Alzheimer’s disease (Atypical or mixed)

802

1.10

0.38

2.7

2.4

2.01

1.93

mg/l

0.34

687

Acute myringitis

1.33

0.38

9.3

7.1

1.33

1.23

mg/l

—

Xanthelasma of eyelid

1.33

0.38

3.1

2.8

1.92

1.53

mg/l

—

Benign neoplasm: Bronchus and lung

112

0.71

0.37

1.5

2.9

1.43

1.58

mg/l

—

102

Convergence insufficiency and excess

113

0.70

0.37

2.5

4.3

1.08

1.26

mg/l

—

104

Postpartum hemorraghe, parous women as controls

181

1644

0.94

0.37

2.8

3.0

1.21

1.28

mg/l

0.90

172

1567

Postpartum haemorrhage due to anatomy

694

0.89

0.37

2.1

2.9

1.19

1.21

mg/l

0.10

667

Other neurotic disorders

402

1.15

0.37

2.6

3.0

1.68

1.54

mg/l

0.50

370

Other menopausal disorders

228

1362

0.94

0.37

2.1

3.0

1.26

1.49

mg/l

6.19

212

1250

Malignant neoplasm of prostate, including Hilmo

311

1759

1.05

0.36

2.9

2.8

1.84

1.79

mg/l

0.34

272

1556

Twin gestation

703

0.89

0.36

3.3

3.2

1.35

1.32

mg/l

0.14

665

Cleft lip and cleft lip and palate

0.63

0.36

15.8

11.1

1.34

1.21

mg/l

—

Intussusception

162

1.24

0.35

6.3

5.6

1.31

1.51

mg/l

0.88

153

Exposure to other and unspecified animate mechanical forces

310

1.17

0.35

3.3

8.2

1.58

1.34

mg/l

0.95

292

Guillain-Barre syndrome

135

1.27

0.35

4.5

3.5

1.57

1.52

mg/l

0.10

125

Chondropathies

170

1594

1.07

0.35

6.2

4.0

1.30

1.43

mg/l

1.84

154

1491

Thiamine deficiency

1.41

0.35

3.5

2.7

1.47

1.42

mg/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

216

2041

1.06

0.35

5.8

5.7

1.47

1.48

mg/l

0.07

199

1897

Kela-code for severe mental illness

435

4185

1.04

0.34

3.0

3.1

1.51

1.45

mg/l

0.81

392

3883

Other superficial mycoses

105

968

1.09

0.34

4.1

4.0

1.39

1.38

mg/l

0.05

910

Drug-induced gout

1.35

0.34

8.0

2.4

2.93

1.76

mg/l

—

Primary gonarthrosis, bilateral

553

4898

0.97

0.34

2.6

2.9

1.77

1.64

mg/l

2.25

492

4437

Thyrotoxicosis with diffuse goitre

129

1200

1.08

0.34

2.6

3.2

1.56

1.44

mg/l

0.90

122

1118

Undefined dementia

808

0.91

0.33

2.5

2.4

2.08

1.88

mg/l

1.19

686

Benign neoplasm: Short bones of lower limb

0.69

0.33

6.2

3.2

2.24

1.47

mg/l

—

Vasomotor and allergic rhinitis

490

4643

1.04

0.33

4.4

5.5

1.33

1.38

mg/l

0.83

461

4359

Sixth [abducent] nerve palsy

294

1.16

0.32

6.1

4.8

1.66

1.62

mg/l

0.09

269

Gastrointestinal stromal tumor and sarcoma

1.36

0.32

2.4

2.3

1.34

1.62

mg/l

—

Gestational diabetes (for exclusion)

321

2137

1.05

0.32

2.9

3.1

1.30

1.26

mg/l

0.43

302

2026

Single delivery by caesarean section

171

1042

0.94

0.31

3.1

3.8

1.20

1.37

mg/l

4.11

163

980

Assault by bodily force

800

1.09

0.31

3.7

3.8

1.53

1.31

mg/l

1.50

758

Pregnancy with abortive outcome

668

3382

1.03

0.31

3.0

3.2

1.42

1.44

mg/l

0.24

622

3105

Inhalation and ingestion of food causing obstruction of respiratory tract

0.71

0.31

7.0

8.8

1.27

1.40

mg/l

—

Reduction defects of upper limb

1.32

0.31

2.7

15.3

1.05

1.11

mg/l

—

Communicating hydrocephalus

186

0.80

0.31

4.7

6.1

1.57

1.49

mg/l

0.10

168

Causalgia

131

0.76

0.31

3.6

2.9

1.68

1.45

mg/l

—

119

Other degenerative diseases of the nervous system

282

2013

1.05

0.30

2.4

2.8

1.62

1.58

mg/l

0.40

238

1828

Inhalation and ingestion of other objects causing obstruction of respiratory tract

1.31

0.30

10.7

7.8

1.28

1.36

mg/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

705

1.09

0.30

2.5

2.7

1.85

1.73

mg/l

0.50

622

Exophthalmic conditions

1.32

0.30

3.2

2.4

1.76

1.53

mg/l

0.35

Chondrocostal junction syndrome [Tietze]

306

1.15

0.30

3.2

1.33

1.50

mg/l

0.84

283

Burns and corrosions

169

1599

1.06

0.29

4.3

6.0

1.48

1.40

mg/l

0.75

159

1504

Ankyloglossia

363

1.13

0.29

16.3

17.9

1.12

1.09

mg/l

0.14

353

Nontoxic diffuse goitre

232

1.17

0.28

2.5

2.7

1.80

1.50

mg/l

0.58

210

Vascular dementia (mixed)

121

1.24

0.28

2.0

2.4

1.86

2.02

mg/l

0.24

102

Fenamates

185

1323

0.95

0.28

2.4

4.2

1.38

1.73

mg/l

9.12

170

1219

Degeneration of nervous system due to alcohol

205

1.18

0.27

2.7

3.2

1.62

1.71

mg/l

0.21

185

Degeneration of the brain due to alcohol

205

1.18

0.27

2.7

3.2

1.62

1.71

mg/l

0.21

187

Dislocation, sprain and strain of joints and ligaments of head

413

1.12

0.27

10.2

9.2

1.42

1.30

mg/l

0.39

388

Melanoma in situ of upper limb, including shoulder

1.24

0.27

10.0

2.2

2.35

1.63

mg/l

—

Female genital prolapse

266

1440

1.04

0.27

2.8

2.9

1.42

1.52

mg/l

1.44

230

1317

Vascular dementia

695

1.08

0.26

2.1

2.4

1.89

1.92

mg/l

0.10

600

Other and unspecified spinal muscular atrophies

1.20

0.26

6.8

4.2

2.22

1.63

mg/l

—

Sequelae of injuries of upper limb

103

963

1.07

0.26

2.4

3.6

1.52

1.48

mg/l

0.24

903

Pedestrian injured in transport accident

635

1.09

0.26

4.0

3.7

1.52

1.50

mg/l

0.10

587

Malignant neoplasm of prostate

295

1697

1.04

0.26

2.9

2.8

1.87

1.80

mg/l

0.58

258

1498

Vascular dementia (subcortical)

244

1.15

0.26

1.3

2.4

1.62

1.89

mg/l

0.96

207

Outcome of delivery

145

847

1.06

0.25

2.5

3.5

1.14

1.28

mg/l

2.88

135

794

Brachial plexus disorders

810

1.08

0.25

2.6

3.2

1.33

1.38

mg/l

0.24

760

Ectopic pregnancy

134

1417

0.94

0.25

2.8

2.9

1.49

1.39

mg/l

0.63

126

1322

Pedal cyclist injured in other and unspecified transport accidents

122

1150

1.06

0.25

3.9

4.4

1.32

1.45

mg/l

1.44

109

1073

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

733

1.08

0.25

2.5

2.7

1.87

1.73

mg/l

0.65

646

Artificial joint re-operation

589

1.09

0.24

3.1

2.8

1.65

1.68

mg/l

0.16

533

Disorders of acoustic nerve

217

1.16

0.24

5.3

3.6

1.50

1.55

mg/l

0.11

198

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

1.29

0.24

5.1

2.3

2.19

1.55

mg/l

—

Other diseases caused by chlamydiae

1.17

0.24

8.0

3.1

1.88

1.38

mg/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

326

3372

0.97

0.24

3.5

4.4

1.35

1.39

mg/l

0.52

297

3158

Other and unspecified injuries of abdomen, lower back and pelvis

143

1.19

0.23

3.2

3.4

1.76

1.43

mg/l

1.04

129

Drug-induced headache, not elsewhere classified

1.29

0.23

3.2

2.9

1.01

1.47

mg/l

—

Carcinoma in situ of middle ear and respiratory system

1.26

0.22

2.4

2.5

1.12

1.70

mg/l

—

Typhoid and paratyphoid fevers

1.26

0.22

1.4

2.5

1.43

1.42

mg/l

—

Lumbosacral root disorders, not elsewhere classified

0.74

0.22

3.4

2.9

1.67

1.55

mg/l

—

Pregnancy examination and test

121

794

0.95

0.22

2.4

3.5

1.19

1.27

mg/l

0.85

115

742

Lumbar disc prolapse

782

6118

0.98

0.22

2.8

3.0

1.53

1.52

mg/l

0.11

714

5647

Tinnitus

246

2372

1.04

0.22

3.6

2.9

1.39

1.54

mg/l

2.96

225

2184

Other sex chromosome abnormalities, female phenotype, not elsewhere classified

0.00

0.22

0.0

14.9

—

1.43

—

Hereditary angioödema type 1

0.00

0.22

0.0

2.4

—

1.59

—

Explosion and rupture of other specified pressurized devices

0.00

0.21

0.0

1.7

—

1.16

—

Carpal tunnel syndrome

720

6215

1.02

0.21

2.9

1.67

1.52

mg/l

4.99

656

5703

Benign neoplasm: Connective and other soft tissue of thorax

1.20

0.21

1.6

2.5

1.14

1.52

mg/l

—

Hypersensitivity pneumonitis due to organic dust

135

1.19

0.21

9.1

3.1

1.74

1.64

mg/l

0.13

124

Acute otitis externa, noninfective

135

1.19

0.21

8.0

2.9

1.62

1.44

mg/l

0.45

122

Exposure to electric transmission lines

0.00

0.21

0.0

2.7

—

1.41

—

Biological medicines for asthma

182

1.16

0.21

1.8

3.6

1.23

1.37

mg/l

0.52

169

Traumatic subcutaneous emphysema

0.00

0.21

0.0

3.0

—

2.06

—

Other birth injuries

0.00

0.21

0.0

16.1

—

1.17

—

Previous suicide attempt

102

0.78

0.21

1.3

6.3

1.48

1.23

mg/l

—

Contact with venomous snakes and lizards

103

0.77

0.21

2.5

5.7

1.01

1.39

mg/l

—

Lichen planus, including avohilmo

185

1775

1.04

0.21

2.2

3.0

1.51

1.57

mg/l

0.49

166

1629

Ménière disease

808

1.07

0.21

2.3

2.9

1.40

1.61

mg/l

2.37

727

Thyroiditis

585

1.08

0.21

2.2

3.7

1.35

1.47

mg/l

0.85

548

Other abnormal products of conception

290

1857

1.03

0.21

2.6

3.1

1.21

1.30

mg/l

1.38

271

1756

Viral conjunctivitis

192

1.15

0.21

7.5

4.6

1.69

1.33

mg/l

0.51

177

Maze procedure for atrial fibrillation

1.26

0.20

1.7

2.2

2.13

1.60

mg/l

—

Benign neoplasm: Retina

1.26

0.20

5.0

2.4

1.33

1.60

mg/l

—

Benign neoplasm: Brain, unspecified

1.26

0.20

7.5

3.5

1.30

1.55

mg/l

—

Fall on and from ladder

769

0.93

0.20

2.9

3.4

1.44

1.64

mg/l

1.63

700

Algoneurodystrophy

259

1.12

0.20

2.7

3.2

1.20

1.42

mg/l

1.63

240

Premature separation of placenta [abruptio placentae]

155

0.84

0.20

2.8

3.3

1.17

1.30

mg/l

0.63

149

Crushed, pushed or stepped on by crowd or human stampede

849

1.06

0.20

3.4

7.1

1.30

1.29

mg/l

0.04

801

Typhoid and paratyphoid fevers

1.18

0.19

1.3

2.5

1.34

1.36

mg/l

—

Optic neuritis

327

1.10

0.19

2.9

3.3

1.69

1.37

mg/l

1.06

305

Mesothelioma, including Hilmo

1.23

0.19

11.4

3.3

1.75

1.76

mg/l

0.01

Contact with nonpowered hand tool

433

1.09

0.19

3.4

3.3

1.47

1.50

mg/l

0.13

402

Habitual aborter

118

1.19

0.19

3.6

2.8

1.33

1.23

mg/l

0.26

113

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

1.18

0.19

31.9

30.1

1.16

1.01

mg/l

—

Fetus and newborn affected by complications of placenta, cord and membranes

1.25

0.19

9.7

22.3

1.00

1.13

mg/l

—

Other abortion

1.21

0.18

3.7

2.5

2.14

1.34

mg/l

—

Cervicocranial syndrome

105

999

1.05

0.18

2.7

3.2

1.60

1.53

mg/l

0.40

922

Motorcycle rider injured in other and unspecified transport accidents

648

1.07

0.18

3.4

4.3

1.30

1.35

mg/l

0.24

614

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

527

1.08

0.17

18.6

22.1

1.07

1.05

mg/l

0.16

521

Other congenital malformations of ear

142

0.84

0.17

5.5

14.6

1.09

mg/l

0.02

136

Dissocial personality disorder

157

1.15

0.17

2.7

3.2

1.80

1.35

mg/l

0.80

150

Trichomoniasis

1.13

0.17

5.1

2.9

2.08

1.48

mg/l

—

Unspecified lump in breast

130

1246

1.04

0.17

2.8

1.44

1.47

mg/l

0.18

121

1144

Fatigue fracture of vertebra

0.74

0.17

2.8

11.5

1.31

1.43

mg/l

—

Injury of muscle and tendon at wrist and hand level

143

1488

0.96

0.17

3.2

3.4

1.38

1.51

mg/l

1.72

135

1390

Congenital malformations of eyelid, lacrimal apparatus and orbit

167

1.15

0.17

13.3

17.8

1.08

1.14

mg/l

0.40

162

0.73

0.17

3.2

2.7

1.85

1.44

mg/l

—

Drug-induced tremor

1.18

0.17

2.0

4.0

1.37

1.51

mg/l

—

Acute alcohol intoxication ICD-9

288

0.90

0.16

3.8

3.0

1.63

mg/l

0.01

263

Follicular adenocarcinoma of thyroid gland, including Hilmo

1.15

0.16

3.4

3.8

1.68

1.54

mg/l

—

Cervical disc disorders

418

4092

1.02

0.16

2.6

3.0

1.52

1.57

mg/l

0.59

373

3759

Other hammer toe(s) (acquired)

149

1324

1.04

0.16

2.9

2.6

1.66

1.52

mg/l

1.24

136

1192

Osteomalacia

1.10

0.16

2.8

2.5

1.74

1.42

mg/l

—

Nontoxic single thyroid nodule

575

1.06

0.15

3.3

3.2

1.60

1.50

mg/l

0.36

535

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

121

1.16

0.15

3.4

5.5

1.63

1.34

mg/l

0.59

113

Dementia in Alzheimer disease

147

1286

0.96

0.15

2.4

2.5

1.87

1.92

mg/l

0.24

115

1113

Schizophrenia, schizotypal and delusional disorders

371

3632

1.02

0.15

3.4

3.2

1.51

1.43

mg/l

1.04

341

3388

Chronic conjunctivitis

323

1.09

0.15

7.1

7.8

1.52

1.34

mg/l

0.50

302

Flat foot [pes planus] (acquired)

830

1.05

0.15

3.4

3.9

1.62

1.41

mg/l

1.32

767

Oral lichen planus, including avohilmo , including avohilmo

557

1.06

0.14

2.2

3.1

1.21

1.55

mg/l

4.32

519

Sequelae of tuberculosis

118

0.85

0.14

2.5

2.2

2.13

2.00

mg/l

—

Subarachnoid haemorrhage

900

0.95

0.14

3.7

3.0

1.76

1.60

mg/l

0.86

803

Toxic effect of carbon monoxide

139

0.86

0.14

3.4

2.9

1.56

1.57

mg/l

0.02

127

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

133

1284

1.04

0.14

2.7

3.0

1.49

1.52

mg/l

0.15

122

1191

Congenital musculoskeletal deformities of head, face, spine and chest

199

1.11

0.13

11.3

14.1

1.35

1.17

mg/l

0.46

190

Cleft lip, lip and palate or palate

180

0.89

0.13

10.2

10.6

1.44

1.23

mg/l

0.49

171

Epiphora

180

0.89

0.13

1.9

3.6

1.23

1.65

mg/l

2.00

161

Dental pulpitis, including avohilmo

1221

8005

0.99

0.13

3.1

3.7

1.48

1.44

mg/l

1.00

1128

7452

Gonarthrosis, primary, with knee surgery

646

5216

0.99

0.13

2.6

2.9

1.71

1.66

mg/l

0.79

569

4720

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

106

0.85

0.13

4.3

2.5

1.92

1.67

mg/l

—

Dislocation, sprain and strain of joints and ligaments at neck level

152

1474

1.03

0.13

2.7

3.8

1.38

1.37

mg/l

0.06

145

1388

Prolapse and hernia of ovary and fallopian tube

229

0.91

0.12

2.6

2.5

1.61

1.76

mg/l

0.32

202

Nontoxic goitre/thyroid nodule

265

2709

0.98

0.12

3.0

2.9

1.67

1.58

mg/l

0.87

235

2453

Supervision of high-risk pregnancy

181

1059

1.03

0.12

3.0

3.5

1.19

1.31

mg/l

2.54

171

998

Congenital musculoskeletal deformities of head, face, spine and chest

181

1.11

0.12

12.3

13.4

1.41

1.17

mg/l

0.65

173

Mixed conductive and sensorineural hearing loss

108

1119

0.96

0.12

4.8

3.6

1.57

1.62

mg/l

0.32

1021

Benign neoplasm of breast

924

1.04

0.12

3.0

1.44

1.48

mg/l

0.21

851

Recurrent dislocation and subluxation of joint

630

1.05

0.11

3.1

3.5

1.33

1.28

mg/l

0.21

594

Trochanteric bursitis

126

1222

1.03

0.11

3.0

2.8

1.50

1.51

mg/l

0.08

111

1113

Motorcycle rider injured in noncollision transport accidents

322

0.93

0.11

3.1

4.5

1.55

1.35

mg/l

0.57

302

Acute appendicitis, no complications

695

6837

1.01

0.11

3.6

3.3

1.44

1.45

mg/l

0.10

642

6349

Allergic rhinitis

397

3865

1.02

0.10

4.4

6.5

1.28

1.29

mg/l

0.15

374

3664

Family history of other specific disorders

1.15

0.10

8.2

4.2

1.27

1.29

mg/l

0.03

Dystonia

476

1.05

0.10

2.7

4.3

1.48

1.45

mg/l

0.08

447

Carcinoma in situ of breast, intraductal

647

0.96

0.10

2.9

1.42

1.50

mg/l

0.41

594

Suggestive for eosinophilic asthma

850

1.04

0.10

3.5

3.0

1.49

1.57

mg/l

0.43

784

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

640

6149

1.01

0.10

3.4

4.2

1.34

1.41

mg/l

1.55

587

5707

Unspecified threat to breathing

106

1.14

0.10

4.0

8.0

1.29

1.23

mg/l

0.13

Cervicalgia

219

2147

1.02

0.09

2.5

3.2

1.60

1.52

mg/l

0.65

198

1977

Other and unspecified hypertrophic disorders of skin

1.07

0.09

9.4

2.2

1.65

1.42

mg/l

—

Vascular dementia (other)

1.04

0.09

1.6

2.2

1.81

2.27

mg/l

—

Seropositive rheumatoid arthritis, strict definition

132

1354

0.97

0.09

2.4

3.0

1.63

1.54

mg/l

0.53

117

1241

Thyroiditis, unspecified

124

0.88

0.09

2.5

3.6

1.35

1.43

mg/l

0.23

114

Exclusion endpoint for supernumerary teeth

194

1.09

0.09

10.7

14.7

1.17

1.15

mg/l

0.05

187

Pemphigus

1.11

0.09

11.0

2.3

2.40

1.44

mg/l

—

Carcinoma in situ of breast, lobular

1.11

0.09

4.7

2.4

1.97

1.46

mg/l

—

Endometroid carcinoma of ovary, including Hilmo

1.09

0.09

1.2

2.8

1.33

1.70

mg/l

—

Caught, crushed, jammed or pinched in or between objects

563

0.96

0.09

3.4

6.2

1.44

1.39

mg/l

0.21

529

Patellar tendinitis

165

1.09

0.09

7.8

4.1

1.27

1.36

mg/l

0.28

155

Cutis laxa senilis

1.07

0.08

2.5

2.6

1.15

1.45

mg/l

—

Other benign neoplasm of uterus: Corpus uteri

1.07

0.08

1.8

2.6

1.73

1.53

mg/l

—

Injury of nerves at ankle and foot level

0.80

0.08

4.4

2.5

1.30

1.36

mg/l

—

Narcolepsy and cataplexy

1.06

0.08

4.6

3.5

1.48

1.32

mg/l

—

Other disorders of patella

165

1682

0.98

0.07

2.9

2.8

1.38

1.35

mg/l

0.18

154

1567

Calcific tendinitis

0.80

0.07

3.0

2.6

1.28

1.53

mg/l

—

Rotator cuff syndrome

734

5308

0.99

0.07

2.8

2.9

1.59

1.54

mg/l

0.59

667

4865

Migraine without aura, drug-induced

0.87

0.07

4.4

2.4

1.56

1.40

mg/l

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

196

1.08

0.07

12.9

17.1

1.06

1.13

mg/l

0.56

189

Serous carcinoma of ovary, including Hilmo

204

0.93

0.07

5.3

3.3

1.37

1.57

mg/l

0.96

189

Evidence of alcohol involvement determined by level of intoxication

1.05

0.07

4.0

5.0

1.17

1.32

mg/l

—

Panniculitis, unspecified

1.04

0.07

8.1

3.1

2.06

1.51

mg/l

—

Burns and corrosions of multiple body regions

0.85

0.07

2.0

5.0

1.65

1.44

mg/l

—

Muscle strain

295

1.05

0.06

6.3

3.7

1.47

1.42

mg/l

0.12

275

Nonspecific lymphadenitis

522

1.04

0.06

8.2

4.0

1.41

1.37

mg/l

0.14

486

Mixed disorders of conduct and emotions

305

1.05

0.06

12.8

14.1

1.45

1.09

mg/l

1.80

293

Use of disulfiram, acamprosate or naltrexone

938

1.02

0.06

2.9

3.1

1.40

1.46

mg/l

0.35

877

Schizophrenia or delusion

366

3622

1.01

0.06

3.4

3.2

1.50

1.43

mg/l

0.83

336

3379

Retained placenta and membranes, without haemorrhage

972

0.98

0.06

2.7

2.9

1.34

1.42

mg/l

0.48

912

L02BA Anti-estrogens

132

1344

0.98

0.06

3.2

2.8

1.23

1.50

mg/l

6.37

120

1234

Other diseases caused by chlamydiae

121

0.91

0.06

8.8

4.6

1.69

1.26

mg/l

0.89

113

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

731

1.03

0.06

3.1

3.5

1.33

1.31

mg/l

0.10

688

Alzheimer disease, excluding more controls

157

1018

1.02

0.05

2.5

2.7

1.76

1.72

mg/l

0.20

127

902

Other enthesopathies

320

3170

1.01

0.05

2.9

3.1

1.49

1.47

mg/l

0.22

290

2912

Maternal care for known or suspected malpresentation of fetus

154

1099

1.02

0.05

2.9

3.2

1.18

1.28

mg/l

1.21

147

1031

Other specified and unspecified disorders of eyelid

110

1.09

0.05

3.6

2.6

1.38

1.62

mg/l

0.56

Asymmetry of jaw

140

0.93

0.04

5.2

6.1

1.21

1.33

mg/l

0.31

129

Burn and corrosion of head and neck

211

0.95

0.04

3.7

4.4

1.26

1.38

mg/l

0.68

195

Effects of foreign body entering through natural orifice

309

3064

1.01

0.04

5.5

4.8

1.46

1.44

mg/l

0.10

288

2853

Diseases caused by chlamydiae

109

0.92

0.04

9.4

4.7

1.49

1.21

mg/l

—

103

Benign lipomatous neoplasm of other sites/unspecified

754

0.98

0.03

2.8

2.9

1.59

1.61

mg/l

0.08

681

Other intervertebral disc disorders

1065

6432

1.00

0.03

2.9

3.0

1.56

1.52

mg/l

0.76

967

5932

Synovial cyst of popliteal space [Baker]

642

0.98

0.03

2.4

3.2

1.66

1.56

mg/l

0.36

586

Polypectomy (DHB20)

652

0.98

0.03

3.3

3.0

1.55

1.56

mg/l

0.03

603

Sequelae of injuries of head

541

0.98

0.03

2.6

3.1

1.33

1.49

mg/l

1.19

507

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

118

0.93

0.03

2.7

1.77

1.56

mg/l

0.29

106

Shoulder region

122

1.07

0.02

5.2

5.5

1.95

1.50

mg/l

0.69

109

Benign neoplasm of ovary

141

1397

1.01

0.02

2.9

3.0

1.48

1.52

mg/l

0.26

130

1276

Dependent personality disorder

172

1.05

0.02

2.6

3.2

1.85

1.55

mg/l

0.47

162

Puerperal sepsis

100

1011

0.99

0.02

3.2

3.0

1.47

1.43

mg/l

0.18

946

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

411

1.02

0.02

2.1

3.1

1.43

1.51

mg/l

0.35

383

Radial styloid tenosynovitis [de Quervain]

431

1.02

0.02

2.9

1.54

1.36

mg/l

0.71

408

Deviated nasal septum

404

4051

1.00

0.02

2.8

3.2

1.49

1.56

mg/l

1.09

372

3739

Caries in Clefts patients

117

0.94

0.01

14.1

9.8

1.39

1.20

mg/l

0.58

111

Persistent delusional disorders

689

0.99

0.01

3.7

2.9

1.60

1.50

mg/l

0.42

640

Schizoaffective disorder

721

1.01

0.01

3.5

3.3

1.50

1.37

mg/l

0.66

679

Assault by blunt object

143

1.05

0.01

3.3

3.7

1.51

1.32

mg/l

0.55

133

Other demyelinating diseases of the central nervous system

307

0.98

0.01

1.8

3.4

1.26

1.38

mg/l

0.49

286

Benign neoplasm: Cranial nerves

244

1.03

0.00

5.6

3.6

1.57

1.59

mg/l

0.03

221

Hallux valgus (acquired)

320

2306

1.00

0.00

2.8

2.7

1.51

1.46

mg/l

0.50

288

2108

Benign lipomatous neoplasm

311

3117

1.00

0.00

3.0

1.54

1.55

mg/l

0.12

291

2856

Allergic conjunctivitis

676

6582

1.00

0.00

3.8

4.4

1.35

1.41

mg/l

1.56

619

6125

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

1.05

0.00

7.8

2.2

1.70

1.35

mg/l

—

Contact with lifting and transmission devices, not elsewhere classified

175

0.97

0.00

2.8

3.4

1.37

1.49

mg/l

0.26

163

Systemic atrophies primarily affecting the central nervous system

384

0.99

0.00

6.9

5.3

1.62

1.64

mg/l

0.04

353

Contracture of joint

102

0.98

0.00

3.2

3.8

1.17

1.38

mg/l

—

Cleft palate

118

1.02

0.00

7.2

10.5

1.19

1.21

mg/l

0.08

112

Operations for atrial fibrillation

132

0.98

0.00

2.6

2.9

2.12

1.69

mg/l

0.65

118

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

722

1.00

0.00

2.9

3.2

1.49

1.55

mg/l

0.31

669

Ganglion

209

2092

1.00

0.00

3.7

3.1

1.40

1.42

mg/l

0.18

195

1935

Peritonsillar abscess

234

2339

1.00

0.00

3.1

3.5

1.34

1.43

mg/l

1.08

222

2196

Hypertrophy of breast in women and men

176

1763

1.00

0.00

3.9

3.2

1.47

1.41

mg/l

0.43

168

1642

Idiopathic urticaria

181

0.99

0.00

6.0

4.8

1.25

1.36

mg/l

0.46

170

Ankylosing spondylitis, strict definition

427

1.01

0.00

2.8

3.1

1.27

1.37

mg/l

0.64

401

Polymorphous light eruption

0.94

0.00

2.6

3.8

1.16

1.38

mg/l

—

Other congenital malformations of integument

0.00

0.0

26.3

—

0.96

—

Foreign body in genitourinary tract

0.91

0.00

1.4

3.5

1.07

1.45

mg/l

—

Carcinoma in situ, other and unspecified urinary organs

0.00

0.0

2.4

—

2.11

—

Drowning and submersion, undetermined intent

0.00

0.0

1.6

—

1.02

—

Compression of brain

0.00

0.0

3.7

—

2.19

—

Accident to watercraft causing other injury

0.00

0.0

4.6

—

1.22

—

Other protozoal diseases, not elsewhere classified/unspecified

0.00

0.0

2.6

—

1.31

—

Miliaria rubra

0.00

0.0

3.0

—

1.78

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

-0.00

0.0

2.8

—

1.02

—

Exposure to other and unspecified forces of nature

0.94

-0.00

4.5

5.0

1.82

1.47

mg/l

—

Migraine with aura, drug-induced

0.98

-0.00

7.4

2.4

1.65

1.46

mg/l

—

Haematosalpinx/Haematoma of broad ligament

0.00

-0.00

0.0

3.4

—

1.31

—

Drug photoallergic response

0.00

-0.00

0.0

1.6

—

1.63

—

Pedal cyclist injured in collision with train or tram

0.00

-0.00

0.0

2.8

—

1.37

—

Vascular dementia (multiple infarctions)

0.94

-0.00

3.4

2.1

1.70

2.21

mg/l

—

Drug-induced tics and other tics of organic origin

0.00

-0.00

0.0

12.5

—

1.27

—

Obstetric and gynaecological devices associated with adverse incidents

0.00

-0.00

0.0

1.6

—

1.03

—

Benign neoplasm: Mesothelial tissue of peritoneum

0.00

-0.00

0.0

1.3

—

1.43

—

Localized hypertrichosis

0.00

-0.00

0.0

2.0

—

1.48

—

Hereditary motor and sensory neuropathy

0.92

-0.00

4.3

4.6

1.32

1.53

mg/l

—

Defects in glycoprotein degradation

0.00

-0.00

0.0

9.0

—

0.90

—

Melanocytic naevi of eyelid, including canthus

0.91

-0.00

3.3

2.2

1.47

1.53

mg/l

—

Mental and behavioural disorders due to hallucinogens

1.02

-0.00

4.6

3.9

1.55

1.15

mg/l

—

Carcinoma in situ of other/unspecified digestive organs

0.00

-0.00

0.0

2.6

—

2.01

—

Mesothelioma

1.02

-0.00

1.5

2.3

1.60

1.77

mg/l

—

Total (external) ophthalmoplegia

0.00

-0.00

0.0

2.0

—

1.64

—

Benign neoplasm: Brain, infratentorial

1.01

-0.00

8.3

9.1

1.11

1.36

mg/l

—

Transitory neonatal disorders of calcium and magnesium metabolism

0.00

-0.00

0.0

38.2

—

0.87

—

Retained (old) foreign body following penetrating wound of orbit

0.00

-0.00

0.0

2.0

—

1.49

—

Lymphocyte function antigen-1 [LFA-1] defect

0.00

-0.00

0.0

3.1

—

2.44

—

Other and unspecified disorders of refraction

0.00

-0.00

0.0

3.0

—

2.20

—

Lesion of femoral nerve

0.89

-0.00

1.4

2.6

1.00

1.54

mg/l

—

Osteolysis

0.00

-0.00

0.0

1.6

—

1.36

—

Congenital and developmental myasthenia

0.00

-0.00

0.0

18.2

—

1.35

—

Accident to powered aircraft causing injury to occupant

0.00

-0.00

0.0

3.0

—

2.04

—

Pedal cyclist injured in collision with pedestrian or animal

0.89

-0.00

4.3

2.9

1.34

1.36

mg/l

—

IPHG Phlebitis and thrombophlebitis of intracranial venous sinuses

0.00

-0.00

0.0

2.4

—

0.97

—

Other acute disseminated demyelination

0.99

-0.00

4.7

3.3

1.26

1.38

mg/l

—

Multiple superficial injuries of ankle and foot

0.00

-0.00

0.0

2.7

—

0.96

—

Melanoma in situ of eyelid, including canthus

0.00

-0.00

0.0

6.4

—

2.52

—

Other intestinal obstruction of newborn

0.00

-0.00

0.0

43.1

—

1.07

—

Other specified and unspecified disorders of conjunctiva

0.95

-0.00

9.5

3.3

1.91

1.40

mg/l

—

Androgen resistance syndrome

0.00

-0.00

0.0

12.8

—

0.90

—

Fasciculation

0.93

-0.00

3.3

3.2

1.39

1.43

mg/l

—

Flexion deformity

0.00

-0.00

0.0

3.3

—

1.39

—

Sequelae of other accidents

120

1.00

-0.00

1.8

2.9

1.11

1.54

mg/l

3.34

108

Malignant neoplasm of placenta, including Hilmo

0.00

-0.00

0.0

1.4

—

1.32

—

Infantile papular acrodermatitis [Gianotti-Crosti]

0.00

-0.00

0.0

6.4

—

1.05

—

Handgun discharge

0.00

-0.00

0.0

2.3

—

1.39

—

Unspecified drowning and submersion

0.00

-0.00

0.0

3.4

—

2.06

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cystatin C [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS